
<html lang="en"     class="pb-page"  data-request-id="1f474442-df66-488c-ba1e-5fa931653060"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm100540x;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2010.53.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases" /></meta><meta name="dc.Creator" content="Chunjian  Liu" /></meta><meta name="dc.Creator" content="James  Lin" /></meta><meta name="dc.Creator" content="Stephen T.  Wrobleski" /></meta><meta name="dc.Creator" content="Shuqun  Lin" /></meta><meta name="dc.Creator" content="John  Hynes, Jr." /></meta><meta name="dc.Creator" content="Hong  Wu" /></meta><meta name="dc.Creator" content="Alaric J.  Dyckman" /></meta><meta name="dc.Creator" content="Tianle  Li" /></meta><meta name="dc.Creator" content="John  Wityak" /></meta><meta name="dc.Creator" content="Kathleen M.  Gillooly" /></meta><meta name="dc.Creator" content="Sidney  Pitt" /></meta><meta name="dc.Creator" content="Ding Ren  Shen" /></meta><meta name="dc.Creator" content="Rosemary F.  Zhang" /></meta><meta name="dc.Creator" content="Kim W.  McIntyre" /></meta><meta name="dc.Creator" content="Luisa  Salter-Cid" /></meta><meta name="dc.Creator" content="David J.  Shuster" /></meta><meta name="dc.Creator" content="Hongjian  Zhang" /></meta><meta name="dc.Creator" content="Punit H.  Marathe" /></meta><meta name="dc.Creator" content="Arthur M.  Doweyko" /></meta><meta name="dc.Creator" content="John S.  Sack" /></meta><meta name="dc.Creator" content="Susan E.  Kiefer" /></meta><meta name="dc.Creator" content="Kevin F.  Kish" /></meta><meta name="dc.Creator" content="John A.  Newitt" /></meta><meta name="dc.Creator" content="Murray  McKinnon" /></meta><meta name="dc.Creator" content="John H.  Dodd" /></meta><meta name="dc.Creator" content="Joel C.  Barrish" /></meta><meta name="dc.Creator" content="Gary L.  Schieven" /></meta><meta name="dc.Creator" content="Katerina  Leftheris" /></meta><meta name="dc.Description" content="The discovery and characterization of 7k (BMS-582949), a highly selective p38α MAP kinase inhibitor that is currently in phase II clinical trials for the treatment of rheumatoid arthritis, is descr..." /></meta><meta name="Description" content="The discovery and characterization of 7k (BMS-582949), a highly selective p38α MAP kinase inhibitor that is currently in phase II clinical trials for the treatment of rheumatoid arthritis, is descr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 30, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100540x" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100540x" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100540x" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100540x" /></link>
        
    
    

<title>Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100540x" /></meta><meta property="og:title" content="Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0013.jpeg" /></meta><meta property="og:description" content="The discovery and characterization of 7k (BMS-582949), a highly selective p38α MAP kinase inhibitor that is currently in phase II clinical trials for the treatment of rheumatoid arthritis, is described. A key to the discovery was the rational substitution of N-cyclopropyl for N-methoxy in 1a, a previously reported clinical candidate p38α inhibitor. Unlike alkyl and other cycloalkyls, the sp2 character of the cyclopropyl group can confer improved H-bonding characteristics to the directly substituted amide NH. Inhibitor 7k is slightly less active than 1a in the p38α enzymatic assay but displays a superior pharmacokinetic profile and, as such, was more effective in both the acute murine model of inflammation and pseudoestablished rat AA model. The binding mode of 7k with p38α was confirmed by X-ray crystallographic analysis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100540x"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100540x">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100540x&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100540x&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100540x&amp;href=/doi/10.1021/jm100540x" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 6629-6639</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm1005513" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm1005989" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-<i>N</i>-propylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases<a class="ref internalNav" href="#ac1" aria-label=""></a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chunjian++Liu">Chunjian Liu</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Lin">James Lin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+T.++Wrobleski">Stephen T. Wrobleski</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuqun++Lin">Shuqun Lin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Hynes%2C++Jr.">John Hynes, Jr.</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Wu">Hong Wu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alaric+J.++Dyckman">Alaric J. Dyckman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tianle++Li">Tianle Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Wityak">John Wityak</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathleen+M.++Gillooly">Kathleen M. Gillooly</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sidney++Pitt">Sidney Pitt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ding+Ren++Shen">Ding Ren Shen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosemary+F.++Zhang">Rosemary F. Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kim+W.++McIntyre">Kim W. McIntyre</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luisa++Salter-Cid">Luisa Salter-Cid</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Shuster">David J. Shuster</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongjian++Zhang">Hongjian Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Punit+H.++Marathe">Punit H. Marathe</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arthur+M.++Doweyko">Arthur M. Doweyko</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+S.++Sack">John S. Sack</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+E.++Kiefer">Susan E. Kiefer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+F.++Kish">Kevin F. Kish</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+A.++Newitt">John A. Newitt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Murray++McKinnon">Murray McKinnon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+H.++Dodd">John H. Dodd</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel+C.++Barrish">Joel C. Barrish</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary+L.++Schieven">Gary L. Schieven</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katerina++Leftheris">Katerina Leftheris</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 609-252-3682. Fax: 609-252-7410. E-mail: <a href="/cdn-cgi/l/email-protection#67040f12090d0e0609490b0e1227050a144904080a"><span class="__cf_email__" data-cfemail="204348554e4a49414e0e4c495560424d530e434f4d">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100540x&amp;href=/doi/10.1021%2Fjm100540x" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 6629–6639</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 30, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 May 2010</li><li><span class="item_label"><b>Published</b> online</span>30 August 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 September 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100540x" title="DOI URL">https://doi.org/10.1021/jm100540x</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6629%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChunjian%2BLiu%252C%2BJames%2BLin%252C%2BStephen%2BT.%2BWrobleski%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D18%26contentID%3Djm100540x%26title%3DDiscovery%2Bof%2B4-%25285-%2528Cyclopropylcarbamoyl%2529-2-methylphenylamino%2529-5-methyl-N-propylpyrrolo%255B1%252C2-f%255D%255B1%252C2%252C4%255Dtriazine-6-carboxamide%2B%2528BMS-582949%2529%252C%2Ba%2BClinical%2Bp38%25CE%25B1%2BMAP%2BKinase%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BInflammatory%2BDiseases%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6639%26publicationDate%3DSeptember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100540x"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3282</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">41</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100540x" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chunjian&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;T. Wrobleski&quot;},{&quot;first_name&quot;:&quot;Shuqun&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Hynes&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Alaric&quot;,&quot;last_name&quot;:&quot;J. Dyckman&quot;},{&quot;first_name&quot;:&quot;Tianle&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Wityak&quot;},{&quot;first_name&quot;:&quot;Kathleen&quot;,&quot;last_name&quot;:&quot;M. Gillooly&quot;},{&quot;first_name&quot;:&quot;Sidney&quot;,&quot;last_name&quot;:&quot;Pitt&quot;},{&quot;first_name&quot;:&quot;Ding&quot;,&quot;last_name&quot;:&quot;Ren Shen&quot;},{&quot;first_name&quot;:&quot;Rosemary&quot;,&quot;last_name&quot;:&quot;F. Zhang&quot;},{&quot;first_name&quot;:&quot;Kim&quot;,&quot;last_name&quot;:&quot;W. McIntyre&quot;},{&quot;first_name&quot;:&quot;Luisa&quot;,&quot;last_name&quot;:&quot;Salter-Cid&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Shuster&quot;},{&quot;first_name&quot;:&quot;Hongjian&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Punit&quot;,&quot;last_name&quot;:&quot;H. Marathe&quot;},{&quot;first_name&quot;:&quot;Arthur&quot;,&quot;last_name&quot;:&quot;M. Doweyko&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;S. Sack&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;E. Kiefer&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;F. Kish&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A. Newitt&quot;},{&quot;first_name&quot;:&quot;Murray&quot;,&quot;last_name&quot;:&quot;McKinnon&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;H. Dodd&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;C. Barrish&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;L. Schieven&quot;},{&quot;first_name&quot;:&quot;Katerina&quot;,&quot;last_name&quot;:&quot;Leftheris&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;6629-6639&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100540x&quot;},&quot;abstract&quot;:&quot;The discovery and characterization of 7k (BMS-582949), a highly selective p38α MAP kinase inhibitor that is currently in phase II clinical trials for the treatment of rheumatoid arthritis, is described. A key to the discovery was the rational substitution of N-cyclopropyl for N-methoxy in 1a, a previously reported clinical candidate p38α inhibitor. Unlike alkyl and other cycloalkyls, the sp2 character of the cyclopropyl group can confer improved H-bonding characteristics to the directly substituted amide NH. Inhibitor 7k is slightly less active than 1a in the p38α enzymatic assay but displays a superior pharmacokinetic profile and, as such, was more effective in both the acute murine model of inflammation and pseudoestablished rat AA model. The binding mode of 7k with p38α was confirmed by X-ray crystallographic analysis.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100540x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100540x" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100540x&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100540x" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100540x&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100540x" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100540x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100540x&amp;href=/doi/10.1021/jm100540x" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100540x" /></input><a href="/doi/pdf/10.1021/jm100540x" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100540x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100540x%26sid%3Dliteratum%253Aachs%26pmid%3D20804198%26genre%3Darticle%26aulast%3DLiu%26date%3D2010%26atitle%3DDiscovery%2Bof%2B4-%25285-%2528Cyclopropylcarbamoyl%2529-2-methylphenylamino%2529-5-methyl-N-propylpyrrolo%255B1%252C2-f%255D%255B1%252C2%252C4%255Dtriazine-6-carboxamide%2B%2528BMS-582949%2529%252C%2Ba%2BClinical%2Bp38%25CE%25B1%2BMAP%2BKinase%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BInflammatory%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D18%26spage%3D6629%26epage%3D6639%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a>,</li><li><a href="/action/doSearch?ConceptID=291161" title="Inflammation">Inflammation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jmcmar.2010.53.issue-18/production/jmcmar.2010.53.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery and characterization of <b>7k</b> (BMS-582949), a highly selective p38α MAP kinase inhibitor that is currently in phase II clinical trials for the treatment of rheumatoid arthritis, is described. A key to the discovery was the rational substitution of <i>N</i>-cyclopropyl for <i>N</i>-methoxy in <b>1a</b>, a previously reported clinical candidate p38α inhibitor. Unlike alkyl and other cycloalkyls, the sp<sup>2</sup> character of the cyclopropyl group can confer improved H-bonding characteristics to the directly substituted amide NH. Inhibitor <b>7k</b> is slightly less active than <b>1a</b> in the p38α enzymatic assay but displays a superior pharmacokinetic profile and, as such, was more effective in both the acute murine model of inflammation and pseudoestablished rat AA model. The binding mode of <b>7k</b> with p38α was confirmed by X-ray crystallographic analysis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span>†</span> </h4><p class="last">PDB deposition number: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MVL">3MVL</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The identification and development of inhibitors of p38α mitogen-activated protein (MAP<a class="ref internalNav" href="#fn2" aria-label="a">a</a><div class="NLM_fn" id="fn2">a<p class="last">Abbreviations: MAP, mitogen-activated protein; TNF-α, tumor necrosis factor alpha; IL-1β, interleukin-1 beta; hPBMC, human peripheral blood mononuclear cells; LPS, lipopolysaccharide; AA, adjuvant arthritis; HHA, human hepatotoxicity assay; hERG, human ether-a-go-go-related gene.</p></div>) kinase as orally active therapeutic agents for the treatment of inflammatory diseases has been one of the most active research areas in drug discovery for the past decade. Because p38α MAP kinase plays a critical role in regulating the biosynthesis of many inflammatory cytokines, including tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β), p38α inhibitors have been considered a promising solution for the treatment of inflammatory diseases.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Numerous preclinical studies<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> have demonstrated that inhibition of p38α MAP kinase can effectively inhibit TNF-α production both in vitro and in vivo. Excessive production of TNF-α and IL-1β is believed to underlie many inflammatory diseases.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Blockage of TNF-α function by biological agents such as etanercept, a soluble TNF-α receptor, and infliximab, a TNF-α antibody, has proven effective in the treatment of rheumatoid arthritis and other autoimmune diseases.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> A number of reviews covering the progress in this area have been published.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Despite a number of compounds having advanced into clinical trials, including VX-702,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Pamapimod,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> BIRB-796,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Scio-469,<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> and PH-797804 (aS)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), proof of concept for the efficacy and safety of a p38α inhibitor has yet to be realized.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of reported clinical p38α MAP kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A recent paper from our group has disclosed pyrrolo[2,1-<i>f</i>][1,2,4]triazine derivatives <b>1a</b> and <b>1b</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) as potent p38α MAP kinase inhibitors for consideration as clinical candidates.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, compounds <b>1a</b> and <b>1b</b> suffered from high clearance in vivo, which resulted in low exposures in animals. Subsequent studies revealed that <b>1a</b> was rapidly converted to the corresponding carboxylic acid as the major metabolite from the hydrolysis of <i>N</i>-methoxybenzamide. Naturally, efforts to modify <b>1a</b> and <b>1b</b> were focused on eliminating the presence of the problematic <i>N</i>-methoxybenzamide. In our previous disclosures,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> it was shown that the <i>N</i>-methoxybenzamide functionality in <b>1a</b> and <b>1b</b> could be replaced with urea, carbamate, and reverse amide moieties not containing the methoxylamino group, resulting in a number of highly potent p38α MAP kinase inhibitors. Herein, we describe an alternative approach to directly replace the <i>N</i>-methoxy group that ultimately led to a superior p38α inhibitor, with overall properties appropriate for clinical development, which is currently in phase II clinical trials for the treatment of rheumatoid arthritis.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0015.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Our previously disclosed p38α MAP kinase inhibitors <b>1a</b> and <b>1b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis of analogues in which the <i>N</i>-methoxy group of <b>1a</b> and <b>1b</b> was replaced was straightforward from previously described advanced intermediates. Analogues <b>7a</b>−<b>c</b>, <b>7j</b>−<b>l</b>, and <b>7n</b>−<b>p</b> were obtained according to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Treatment of ethyl 4-chloro-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>2</b>)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> with 3-amino-<i>N</i>-ethyl-4-methylbenzamide (<b>3a</b>)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> at room temperature provided <b>4a</b>. Similarly, reaction of <b>2</b> with 3-amino-<i>N</i>-cyclopropyl-4-methylbenzamide (<b>3b</b>), which was prepared from 3-amino-4-methylbenzoic acid (<b>5</b>) and cyclopropylamine, afforded <b>4b</b>. Hydrolysis of <b>4a</b>−<b>c</b><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> supplied acids <b>6a</b>−<b>c</b>. Standard coupling reaction conditions using <b>6a</b>−<b>c</b> with appropriate amines gave rise to the target amides <b>7a</b>−<b>c</b>, <b>7j</b>−<b>l</b>, and <b>7n</b>−<b>p</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0016.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) <i>N</i>-ethyl-3-amino-4-methylbenzamide (<b>3a</b>) or <i>N</i>-cyclopropyl-3-amino-4-methylbenzamide (<b>3b</b>), DMF, rt, overnight, 80% yield; (b) NaOH, THF, 50 °C to reflux, 94−100% yield; (c) R<sup>1</sup>NH<sub>2</sub>, coupling reagents such as EDC, HOBT, and BOP.</p></p></figure><div class="NLM_p">For the preparation of analogues <b>7d</b>−<b>i</b>, <b>7m</b>, <b>7q</b>−<b>v</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), we derivatized the previously described compounds <b>1a</b>−<b>c</b>.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><i>N</i>-Methoxybenzamides <b>1a</b>−<b>c</b> were treated with methanol in the presence of hydrogen chloride in 1,4-dioxane to yield the corresponding methyl benzoates. The benzoates were then hydrolyzed to give acids <b>8a</b>−<b>c</b>. Alternatively, <b>1a</b>−<b>c</b> could be directly converted to acids <b>8a</b>−<b>c</b> with 1 N hydrochloric acid. Analogues <b>7d</b>−<b>i</b>, <b>7m</b>, and <b>7q</b>−<b>v</b> were obtained from coupling reactions of <b>8a</b>−<b>c</b> with the desired amines.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) (i) MeOH, 4 N HCl in 1,4-dioxane, rt, 16 h, (ii) KOH, 50 °C, 3 h, 71−99% yields; (b) 1N HCl, reflux, 6.5 h, 95% yield; (c) R<sup>2</sup>NH<sub>2</sub>, coupling reagents such as EDC, HATU, and BOP.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We initially investigated the replacement of the methyl hydroxamate with alkyl amides (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Replacing the <i>N</i>-methoxy group in <b>1a</b> with <i>N</i>-ethyl resulted in over 35-fold loss in p38α activity, as <b>7a</b> inhibited p38α with an IC<sub>50</sub> of 110 nM versus 3.1 nM for <b>1a</b>. Similarly, the ethyl counterpart of <b>1b</b> (<b>7b</b>, p38α IC<sub>50</sub> = 64.9 nM) was nearly 30-fold less potent than <b>1b</b> (p38α IC<sub>50</sub> = 2.2 nM). In human peripheral blood mononuclear cells (hPBMC), <b>7b</b> inhibited LPS-induced TNFα production with an IC<sub>50</sub> of 380 nM, which was 38-fold less effective than <b>1b</b>. Nevertheless, <b>7a</b> and <b>7b</b> appeared to be the best <i>N</i>-alkyl analogues evaluated. The methyl, <i>n</i>-propyl, and <i>i</i>-propyl amides <b>7c</b>−<b>e</b> displayed p38α IC<sub>50</sub> values of 397, 166, and 259 nM, respectively, while the <i>n</i>-butyl and methoxyethyl analogues <b>7f</b> and <b>7g</b> both inhibited p38α with IC<sub>50</sub> values of greater than 1000 nM.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. in Vitro Activity of <b>7a</b>−<b>g</b> vs <b>1a</b> and <b>1b</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0002.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">p38α IC <sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">hPBMC TNFα IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-α-methylbenzyl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-α-methylbenzyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">380</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">397</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="left">166</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7e</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">259</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7f</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left"><i>n</i>-Bu</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7g</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>OMe</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last"><i>n</i> = 4, variation in individual values, <20%. </p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last"><i>n</i> = 3, variation in individual values, <25%.</p></div></div></div><div class="NLM_p">In considering the suboptimal potency of the <i>N</i>-ethylbenzamide <b>7a</b> relative to the <i>N</i>-methoxybenzamide <b>1a</b>, we speculated that the <i>N</i>-methoxy oxygen of <b>1a</b> could make the amide NH an excellent hydrogen bond donor due to its electron withdrawing nature. Previously, X-ray crystallographic analysis of <b>1a</b> bound to p38α had revealed that the <i>N</i>-methoxybenzamide NH in <b>1a</b> forms a key hydrogen bond with Glu 71 of p38α.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Computations using N-substituted acetamide as a hydrogen bond donor and acetone as a hydrogen bond acceptor indicated that the heat of formation of hydrogen bonding between <i>N</i>-methoxyacetamide NH and acetone carbonyl oxygen was −6.72 kcal/mol. The corresponding hydrogen bond between <i>N</i>-ethyl acetamide and acetone had a heat of formation of −4.86 kcal/mol (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Assuming that the interaction between the acetone methyl hydrogens and methoxy oxygen is negligible relative to the H-bonding component, these results suggested that the <i>N</i>-methoxybenzamide NH in <b>1a</b> could form a much stronger hydrogen bond with Glu 71 of p38α than the <i>N</i>-ethylbenzamide NH in <b>7a</b>. As a result of this analysis, replacement of <i>N</i>-methoxy in <b>1a</b> with <i>N</i>-cyclopropyl was specifically proposed, rationalizing that the sp<sup>2</sup> character of the cyclopropyl carbons would make the benzamide NH a stronger hydrogen bond donor. Similar computational analysis determined that the heat of formation of hydrogen bonding between <i>N</i>-cyclopropylacetamide NH and acetone carbonyl oxygen was −5.06 kcal/mol (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). This implied that the activity of the <i>N</i>-cyclopropylbenzamide analogues might lie between that observed for the <i>N</i>-methoxybenzamide and the <i>N</i>-ethylbenzamide analogues. It was hoped that the <i>N</i>-cyclopropylbenzamide analogues might also show improved pharmacokinetic properties, resulting in similar or better efficacy relative to <b>1a</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Heat of Formation of Hydrogen Bonding</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0003.gif" alt="" id="fx2" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center" char=".">MeO</th><th class="colsep0 rowsep0" align="center" char=".">Et</th><th class="colsep0 rowsep0" align="center" char="."><i>c</i>-Pr</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heat of formation (kcal/mol)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">−6.72<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">−4.86</td><td class="colsep0 rowsep0" align="char" char=".">−5.06</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Acetone and N-substituted acetamide were first minimized using SAM1, and then the minimized complex were subjected to geometry optimization in vacuo using DFT B3YLP/6-31+g(d,p) as implemented within Jaguar. Hydrogen bond heats of formation were calculated as the difference between components (acetone and N-substituted acetamide and the complex.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Model complex includes an additional interaction between the acetone methyl hydrogens and methoxy oxygen.</p></div></div></div><div class="NLM_p">We were encouraged that the <i>N</i>-cyclopropylbenzamide <b>7h</b> displayed a p38α IC<sub>50</sub> value of 18 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Thus, as predicted, it was ∼6-fold less potent than the <i>N</i>-methoxybenzamide and ∼5.5-fold more potent than the <i>N</i>-ethylbenzamide. Compound <b>7h</b> also inhibited LPS-induced TNFα production in hPBMC with an IC<sub>50</sub> of 191 nM. In contrast, the closely related <i>N</i>-cyclobutylbenzamide analogue <b>7i</b> was determined to be 12-fold less active against p38α relative to <b>7h</b>, with an IC<sub>50</sub> value of 222 nM.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. in Vitro Activity of <b>7h</b>−<b>p</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0004.gif" alt="" id="fx3" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0005.gif" alt="" id="_i7" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last"><i>n</i> = 4, variation in individual values, <20%.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last"><i>n</i> = 3, variation in individual values, <25%.</p></div></div></div><div class="NLM_p">With <i>N</i>-cyclopropyl being identified as a suitable replacement for <i>N</i>-methoxy in <b>1a</b>, our attention was then focused on optimization of the 6-carboxamide substitution in the <i>N</i>-cyclopropyl amide series (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The use of 6-<i>N</i>-methyl amide in place of <i>N</i>-ethyl resulted in a slight drop in both enzymatic and cellular activities, as <b>7j</b> inhibited p38α with an IC<sub>50</sub> of 24 nM and TNFα production in hPBMC with an IC<sub>50</sub> of 225 nM. However, when the 6-<i>N</i>-ethyl group in <b>7h</b> was replaced with certain more hydrophobic alkyl groups, the resulting analogues displayed improved activities in both the enzymatic and cellular assays. For example, the <i>N</i>-propyl 6-carboxamide analogue <b>7k</b> displayed a p38α IC<sub>50</sub> of 13 nM and a cellular TNFα IC<sub>50</sub> of 50 nM. Similarly, the enzymatic and cellular IC<sub>50</sub> values for the <i>N</i>-butyl 6-carboxamide analogue <b>7l</b> were determined to be 9.7 and 81 nM, respectively. Also, the <i>N</i>-(<i>S</i>)-α-methylbenzyl 6-carboxamide analogue <b>7m</b> (p38α IC<sub>50</sub> = 12 nM, TNFα IC<sub>50</sub> = 64 nM), the <i>N</i>-cyclopropylbenzamide counterpart of <b>1b</b>, was a potent p38α inhibitor and very effective in cells. The <i>N</i>-(<i>S</i>)-<i>sec</i>-butyl 6-carboxamide analogue <b>7n</b> appeared to be less potent against p38α (IC<sub>50</sub> = 27 nM) than <b>7m</b>, but its cellular potency (TNFα IC<sub>50</sub> = 57 nM) was very comparable to what was observed with <b>7m</b>. In contrast, introducing polar functionality in the 6-carboxamide moiety generally led to decreased activities in the enzymatic and cellular assays, as demonstrated by <b>7o</b> (p38α IC<sub>50</sub> = 31 nM, TNFα IC<sub>50</sub> = 188 nM) and <b>7p</b> (p38α IC<sub>50</sub> = 41 nM, TNFα IC<sub>50</sub> = 543 nM). Notably, even though <b>7k</b>−<b>m</b> are 3−9-fold less potent against p38α compared to <b>1a</b>, their cellular activities are comparable to that of <b>1a</b>. This result may be related to the improved permeability of analogues <b>7k</b>−<b>m</b> compared to <b>1a</b>. Consistent with that assumption, the Caco-2 transcellular permeability was found to be in a range of 91−134 nm/s for <b>7k</b> versus only 5 nm/s for <b>1a</b>.</div><div class="NLM_p">As anticipated, and shown by the X-ray cocrystal structure of <b>7k</b> with p38α enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), the binding mode of the <i>N</i>-cyclopropylbenzamide is similar to that observed with <b>1a</b>. The benzamide moiety provides two key hydrogen bond interactions with p38α: the carbonyl oxygen interaction with Asp168 (2.86 Å) and the NH interaction with Glu 71 (2.26 Å). Another important hydrogen bond interaction occurs between the 6-carboxamide oxygen and the Met 109 (2.49 Å) at the hinge region. Hydrophobic interactions include the angular methylaniline moiety being positioned within a hydrophobic pocket and the pendant <i>N</i>-propyl interacting with a hydrophobic site characteristically found at the outer rim of the hinge region.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystallographic structure of <b>7k</b> bound to p38α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also examined the replacement of the methyl hydroxamate with aryl amides (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The <i>N</i>-phenyl amide <b>7q</b> exhibited a p38α IC<sub>50</sub> value of 50 nM, which was less potent than <i>N</i>-methyoxybenzamide <b>1b</b> or <i>N</i>-cyclopropylbenzamide <b>7m</b> and essentially equipotent with <i>N</i>-ethylbenzamide <b>7b</b>. Our modeling studies suggested that the <i>N</i>-phenyl group was a little too large to fit into the binding pocket. This also explained the p38α activity (IC<sub>50</sub> = 72 nM) for <i>N</i>-2-thiazolylbenzamide <b>7r</b> because the actual dimensions of phenyl and thiazolyl are very similar. The cellular TNFα IC<sub>50</sub> values of <b>7q</b> and <b>7r</b> were both determined to be greater than 1000 nM. When a methyl was added to the thiazole ring in <b>7r</b>, the resulting analogue <b>7s</b> displayed a p38α IC<sub>50</sub> value of over 1000 nM. Analogue <b>7t</b> containing a smaller <i>N</i>-oxazolyl group in the benzamide moiety provided an improved p38α IC<sub>50</sub> value of 35 nM. However, the <i>N</i>-3-isoxazolylbenzamides were found to be highly potent against p38α, as <b>7u</b> and <b>7v</b> inhibited p38α with IC<sub>50</sub> values of 7.1 and 3.9 nM, respectively. These two inhibitors were also extremely active at inhibiting TNFα production in hPBMC, exhibiting IC<sub>50</sub> values of 9.7 and 6.0 nM, respectively. The significant improvement in binding affinity for <b>7u</b> and <b>7v</b> compared to <b>7t</b> was surprising. A cocrystal of <b>7v</b> with p38α was obtained,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and the X-ray crystallographic analysis showed that <b>7v</b> bound to p38α in a similar manner as inhibitor <b>7k</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) except that an active water molecule was engaged with <b>7v</b>, Asp168, and Lys 53 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystallographic structure of <b>7v</b> bound to p38α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. in Vitro Activity of <b>7q</b>−<b>v</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0008.gif" alt="" id="fx5" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0009.gif" alt="" id="fx6" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last"><i>n</i> = 4, variation in individual values, <20%.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last"><i>n</i> = 3, variation in individual values, <25%.</p></div></div></div><div class="NLM_p">On the basis of cellular activity and other profiling data (e.g., liver microsomal stability and P450 inhibition), selected compounds were evaluated in a murine model of acute inflammation. In this study, compounds were administrated to mice prior to challenging with LPS. Ninety minutes postdose, plasma samples were taken and analyzed for TNFα levels. In addition to a vehicle group, <b>1a</b> was included as a comparator and positive control in each study. Compounds were considered active if they reduced the LPS induced TNFα production by 50%. As seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, when dosed at 5 mg/kg, 2 h prior to LPS challenge, compounds <b>7k</b>, <b>7l</b>, <b>7u</b>, and <b>7v</b> all showed improved efficacy relative to <b>1a</b>, inhibiting the TNFα levels by 77−92% (versus 65−66% inhibition with <b>1a</b>). The weakest compound studied in this protocol was <b>7o</b> (41% reduction of TNFα). To differentiate these active compounds, they were further examined under a more stringent protocol, wherein the dosing interval was extended to 6 h prior to LPS challenge. Under this protocol, <b>7k</b>, <b>7u</b>, and <b>7v</b> were active, reducing TNFα production by 78%, 89%, and 83%, respectively, with <b>1a</b> giving 50−63% reduction of TNFα.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibition of LPS Induced TNFα Production in Mice<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">dosing interval prior to LPS (hr)</th><th class="colsep0 rowsep0" align="center" char=".">percent inhibition<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">percent inhibition for <b>1a</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7k</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7l</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="char" char=".">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7o</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7u</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7v</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7k</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7l</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7u</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7v</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">83</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">PEG 300 was used as the vehicle, 6−8 mice per group.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Percent inhibition was calculated relative to vehicle group.</p></div></div></div><div class="NLM_p">On the basis of the above characterization, inhibitors <b>7k</b> and <b>7u</b> were chosen to be evaluated in a pseudoestablished rat adjuvant arthritis (rat AA) model. In this study, complete Freund’s adjuvant was given to rats at day one and the rats’ immune responses were allowed to develop for 10 days. At day 11, the rats started to receive compounds orally and the paw swelling was measured periodically. Though <b>7u</b> was very active in the acute murine model of inflammation even when dosed at 5 mpk 6 h prior to LPS challenge, it was not active in the rat AA model when dosed once daily at 10 mg/kg. It was found in this study that <b>7u</b> initially provided high drug concentration, but the drug concentration dropped dramatically (by 80%) after 6 h. However, inhibitor <b>7k</b> displayed dose-dependent reduction in paw swelling with qd dosing, with efficacy observed at doses of 10 and 100 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). With bid dosing, <b>7k</b> showed improved efficacy, achieving marked reduction in paw swelling at doses of 1 and 5 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Statistically significant reduction in paw swelling was also observed at doses as low as 0.3 mg/kg bid. In addition, it was demonstrated that <b>7k</b> was more effective than <b>1a</b> in the rat AA model at a dose of 10 mg/kg qd (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>7k</b> in the rat adjuvant arthritis model (qd dosing). Vehicle: PEG 300.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>7k</b> in the rat adjuvant arthritis model (bid dosing). Vehicle: PEG 300.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>7k</b> vs <b>1a</b> in the rat adjuvant arthritis model (qd dosing). Vehicle: PEG 300.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inhibitor <b>7k</b> is approximately 4-fold less potent against p38α than <b>1a</b>, but <b>7k</b> is more effective than <b>1a</b> in both the acute and chronic disease models. This is likely due to the significantly improved pharmacokinetic profile of <b>7k</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) relative to <b>1a</b>. The most significant improvement was the dramatically reduced clearance rate which resulted in significantly increased exposure. For example, the mouse clearance rate for <b>7k</b> was 4.4 mL/min/kg versus 93 mL/min/kg for <b>1a</b>. And, at an oral dose of 10 mg/kg, the mouse AUC<sub>0−8 h</sub> for <b>7k</b> was 75.5 μM·h versus 3.6 μM·h. Compound <b>7k</b> exhibited oral bioavailability values of 90% and 60% in mice and rats, respectively.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Properties of <b>7k</b> in Mice<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> and Rats<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">mouse</th><th class="colsep0 rowsep0" align="center" char=".">rat</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% <i>F</i><sub>po</sub></td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="char" char=".">15.3</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT (h)</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0−8 h</sub> (μM·h)</td><td class="colsep0 rowsep0" align="char" char=".">75.5</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0−24 h</sub> (μM·h)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">45.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Vehicle: 20% NMP, 35% PEG 400, 10% PG, and 35% water for iv, and PEG 400 for po; dose: 5 mg/kg for iv, and 10 mg/kg for po; 3 mice per group.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Vehicle: 25% NMP, 33% PEG 400, 9% PG, and 33% water for iv, and PEG 400 for po; dose: 2.5 mg/kg for iv, and 10 mg/kg for po; 3 mice per group.</p></div></div></div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> contains the in vitro profile of <b>7k</b>. The compound had a low rate of oxidative metabolism in mouse (0.011 nmol/min/mg), rat (0.008 nmol/min/mg), and human liver microsomes (0.013 nmol/min/mg). The metabolic rate in hepatocytes was also low in these species. Compound <b>7k</b> did not significantly inhibit cytochrome P450 isozymes 1A2, 2C9, 2C19, and 2D6 with IC<sub>50</sub> values >40 μM. It was a weak inhibitor of CYP3A4, with an IC<sub>50</sub> value ranging from 18 to 40 μM based in multiple tests. As mentioned earlier, the Caco-2 permeability of <b>7k</b> was determined to be in a range of 91−134 nm/s. The serum protein binding for <b>7k</b> at 10 μM was 86%, 90%, and 82% in fresh sera isolated from mice, rats, and humans, respectively. The compound was negative in the Ames reverse-mutation and SOS chromotest assays. Also, <b>7k</b> was not cytotoxic in the human hepatotoxicity assay (HHA) (IC<sub>50</sub> > 138 μM for all isoforms), suggesting a decreased likelihood for clinical hepatic liabilities. In addition, <b>7k</b> only minimally inhibited hERG current in a patch clamp assay (16% at 30 μM). The compound proved to be highly selective over other kinases tested. It displayed >2000-fold selectivity for p38α over a diverse panel of 57 kinases that include serine kinases, nonreceptor tyrosine kinases, receptor tyrosine kinases, and the p38γ and δ isoforms. Compound <b>7k</b> was also 450-fold selective over Jnk2, a MAP kinase involved in inflammation, and 190-fold selective over Raf. However, <b>7k</b> showed only 5-fold selectivity over p38β. On the basis of its safety profile in preclinical safety studies, compound <b>7k</b>, also designated as BMS-582949, was nominated for further development and clinical studies in inflammatory disease.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vitro Profile of <b>7k</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">profiling assays</th><th class="colsep0 rowsep0" align="center">results</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver microsome metabolic rate</td><td class="colsep0 rowsep0" align="left">mouse: 0.011</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(nmol/min/mg)</td><td class="colsep0 rowsep0" align="left">rat: 0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">human: 0.013</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatocyte metabolic rate</td><td class="colsep0 rowsep0" align="left">mouse: 0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(nmol/min/million cells)</td><td class="colsep0 rowsep0" align="left">rat: 0.015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">human: 0.015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P450 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>40 for 1A2, 2C9, 2C19, and 2D6 </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">18−40 for 3A4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 permeability (nm/s)</td><td class="colsep0 rowsep0" align="left">121−134</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serum protein binding (%)</td><td class="colsep0 rowsep0" align="left">mouse: 86.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat: 89.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">human: 81.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ames</td><td class="colsep0 rowsep0" align="left">negative in T98 and T100 ± S9 activation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SOS chromotest</td><td class="colsep0 rowsep0" align="left">negative</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HHA IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>138</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG inhibition</td><td class="colsep0 rowsep0" align="left">16% at 30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kinase selectivity</td><td class="colsep0 rowsep0" align="left">>2000 fold over 57 diverse kinases</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">450 fold over Jnk2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">190 fold over Raf</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5 fold over p38β</td></tr></tbody></table></div></div><div class="NLM_p last">In summary, to improve the pharmacokinetic properties of our previously reported p38α MAP kinase inhibitors, the <i>N</i>-methoxy moiety in <b>1a</b> and <b>1b</b> was replaced with an <i>N</i>-cyclopropyl group. This specific modification was based on our hypothesis that the π-character of the cyclopropyl moiety would enhance the hydrogen bonding ability of the benzamide NH in comparison to the less potent <i>N</i>-alkyl analogues. This proposal ultimately led to the discovery of <b>7k</b>, a highly selective p38α inhibitor. Compared to <b>1a</b>, <b>7k</b> displayed a significantly improved pharmacokinetic profile and was more effective in both the acute murine model of inflammation and rat adjuvant arthritis model despite its slightly reduced potency. Compound <b>7k</b> is currently in phase II clinical trials for the treatment of rheumatoid arthritis, the results of which will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30318" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30318" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div class="NLM_p">Proton and carbon magnetic resonance (<sup>1</sup>H and <sup>13</sup>C NMR) spectra were recorded either on a Bruker Avance 400 or a JEOL Eclipse 500 spectrometer and are reported in ppm relative to the reference solvent of the sample in which they were run. HPLC and LCMS analyses were conducted using a Shimadzu LC-10AS liquid chromatograph and a SPD UV−vis detector at 220 or 254 nm with the MS detection performed with a Micromass Platform LC spectrometer. HPLC analyses were performed using the following conditions: Ballistic YMC S5 ODS 4.6 mm × 50 mm column with a binary solvent system where solvent A = 10% methanol, 90% water, 0.2% phosphoric acid, and solvent B = 90% methanol, 10% water, and 0.2% phosphoric acid, flow rate = 4 mL/min, linear gradient time = 4 min, start %B = 0, final %B = 100. All final compounds had an HPLC purity of ≥95% unless specifically mentioned. LCMS analyses were performed using the following conditions: Phenomenex 5 μm C18 4.6 mm × 50 mm column with a binary solvent system where solvent A = 10% methanol, 90% water, 0.1% trifluoroacetic acid, and solvent B = 90% methanol, 10% water, and 0.1% trifluoroacetic acid, flow rate = 4 mL/min, linear gradient time = 2 min, start %B = 0, final %B = 100. Preparative reverse-phase HPLC purifications were performed using the following conditions: Ballistic YMC S5 ODS 20 mm × 100 mm column with a binary solvent system where solvent A = 10% methanol, 90% water, 0.1% trifluoroacetic acid, and solvent B = 90% methanol, 10% water, and 0.1% trifluoroacetic acid, flow rate = 20 mL/min, linear gradient time = 10 min, start %B = 20, final %B = 100.</div><div class="NLM_p last">All reagents were purchased from commercial sources and used without further purification unless otherwise noted. All reactions were performed under an inert atmosphere. Reactions run in aqueous media were run under an ambient atmosphere unless otherwise noted.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 3-Amino-<i>N</i>-cyclopropyl-4-methylbenzamide (<b>3b</b>)</h3><div class="NLM_p last">To a solution of 3-amino-4-methylbenzoic acid (<b>5</b>) (5.12 g, 33.9 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) (9.97 g, 52.0 mol), and 4-(dimethylamino)pyridine (0.89 g, 7.3 mol) in DMF (100 mL) at 0 °C was added cyclopropylamine (4.0 mL, 57.7 mol) dropwise. After stirring for 15 min, the cold bath was removed and the reaction mixture was stirred at room temperature overnight. Volatiles were removed under vacuum, and the residue was diluted with water and extracted with dichloromethane (3 times). The organic layers were combined, dried over sodium sulfate, and concentrated under vacuum. The residue was subjected to silica gel chromatography using dichloromethane/methanol (20:1) as eluent to afford the title compound (6.98 g, 108% yield) as a yellow oil. This product was contaminated with dimethylformamide but used in the next step without further purification. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>11</sub>H<sub>14</sub>N<sub>2</sub>O (M + H)<sup>+</sup> = 191.11. Found: 192.09.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Ethyl 4-(5-(Ethylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>4a</b>)</h3><div class="NLM_p last">To a mixture of ethyl 4-chloro-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>2</b>) (4.83 g, 20.2 mmol) and the HCl salt of 3-amino-<i>N</i>-ethyl-4-methylbenzamide (<b>3a</b>)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (4.33 g, 20.2 mmol) in DMF (70 mL) was added diisopropylethylamine (2.80 mL, 16.2 mmol). The resulting mixture was heated at 60 °C for 5 h, then cooled to rt and slowly added to a mixture of crushed ice (100 mL) and saturated aqueous NaHCO<sub>3</sub> solution (200 mL). After stirring overnight, the solid was collected by suction filtration and rinsed with water (200 mL) to afford a pale-yellow solid. Recrystallization from ethanol/water (1:1) afforded the title compound (5.50 g, 71%) as white crystals. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>20</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> = 382.28. Found: 382.30.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Ethyl 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>4b</b>)</h3><div class="NLM_p last">A solution of ethyl 4-chloro-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>2</b>) (1.30 g, 5.40 mmol) and 3-amino-<i>N</i>-cyclopropyl-4-methylbenzamide (<b>3b</b>) (1.60 g, 8.40 mmol) in DMF (13 mL) was stirred at room temperature overnight. Water was added, and the precipitated product (1.70 g, 80% yield) was collected as an off-white solid by filtration, followed by trituration with diethyl ether. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> = 394.18. Found: 394.31.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 4-(5-(Ethylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylic Acid (<b>6a</b>)</h3><div class="NLM_p last">To a solution of ethyl 4-(5-(ethylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>4a</b>) (1.81 g, 4.74 mmol) in THF/MeOH (1:1 v/v, 7 mL) at rt was added aqueous 3 N KOH solution (4.7 mL, 14.2 mmol). The reaction mixture was stirred at 60 °C for 6 h, then concentrated under vacuum to remove THF and methanol. The residue was cooled at 0 °C, and the pH value was adjusted to ∼3 by addition of aqueous 6 N HCl. The resulting solid was collected by filtration, washed with water (5 mL × 3), and dried under vacuum to afford the title compound (1.64 g, 90% yield) as a white solid. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>19</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> = 354.15. Found: 354.30.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylic Acid (<b>6b</b>)</h3><div class="NLM_p last">A mixture of ethyl 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>4b</b>) (5.00 g, 12.7 mmol) and 1 N NaOH solution (51 mL, 51 mmol) in THF (30 mL) was heated at reflux for 16 h, then concentrated under vacuum. The residue was extracted with ethyl acetate. The aqueous solution was neutralized with aqueous 6 N HCl solution to pH 6. The precipitating product (4.35 g, 94% yield) was collected as a white solid by suction filtration, washed with water, and dried over Drierite under vacuum. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>/D<sub>2</sub>O) δ 8.46 (s, 1H), 8.02 (s, 1H), 7.84 (s, 1H), 7.78 (s, 1H), 7.67 (d, <i>J</i> = 7.8 Hz, 1H), 7.38 (d, <i>J</i> = 7.8 Hz, 1H), 2.83 (m, 1H), 2.81 (s, 3H), 2.22 (s, 3H), 0.69 (m, 2H), 0.55 (m, 2H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 5-Methyl-4-(2-methyl-5-(methylcarbamoyl)phenylamino)pyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylic Acid (<b>6c</b>)</h3><div class="NLM_p last">To a solution of methyl 5-methyl-4-(2-methyl-5 (methylcarbamoyl)phenylamino)pyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylate (<b>4c</b>) (0.17 g, 0.48 mmol) in THF (1 mL) was added aqueous 1 N NaOH solution (1.0 mL, 1.0 mmol). The homogeneous solution was stirred at 50 °C. Upon complete conversion by HPLC analysis, aqueous 1 N HCl was slowly added with vigorous stirring to give a precipitate. The mixture was agitated for 2 h, then the precipitate was collected by filtration to afford the title compound as a tan solid in quantitative yield (92% purity by HPLC analysis). The material was used directly for the next step without further purification.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 3-(6-(Ethylcarbamoyl)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazin-4-ylamino)-4-methylbenzoic Acid (<b>8a</b>)</h3><div class="NLM_p last">To a slurry of <i>N</i>-ethyl-4-(5-(methoxycarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>1a</b>)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (2.0 g, 4.20 mmol) in anhydrous methanol (12 mL) was added a solution of HCl in dioxane (4 N, 18 mL, 72 mmol) at rt. The resulting clear solution was stirred at rt for 16 h, then concentrated under vacuum. The resulting oil was dissolved in aqueous 1.5 N potassium hydroxide solution (16 mL) and heated to 50 °C for 3 h. After cooling to rt, the mixture was diluted with water (50 mL) and 10% aqueous HCl was added until pH was approximately 3 or 4. The precipitating product was collected by vacuum filtration, washed with water (50 mL), and dried under vacuum to afford the title product (1.47 g, 99% yield) as a white solid. An analytical sample was obtained after recrystallization from 10% aqueous acetonitrile. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>18</sub>H<sub>19</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> = 354.15. Found: 354.20. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.21 (br s, 1H), 8.11 (br s, 1H), 7.89−7.91 (m, 2H), 7.67 (br s, 1H), 7.44 (d, 1H), 3.40 (q, 2H), 2.86 (s, 3H), 2.36 (s, 3H), 1.25 (s, 3H).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>S</i>)-4-Methyl-3-(5-methyl-6-(1-phenylethylcarbamoyl)pyrrolo[1,2-<i>f</i>][1,2,4]triazin-4-ylamino)benzoic Acid (<b>8b</b>)</h3><div class="NLM_p last">This compound was prepared from (<i>S</i>)-4-(5-(methoxycarbamoyl)-2-methylphenylamino)-5-methyl-<i>N</i>-(1-phenylethyl)pyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>1b</b>) in the same way as <b>8a</b> was from <b>1a</b>; yield 71%. <sup>1</sup>H NMR (MeOD) δ 8.54 (br s, 1H), 8.12 (br s, 1H), 8.02 (br s, 1H), 7.88 (br s, 1H), 7.69 (br s, 1H), 7.41−7.44 (m, 3H), 7.32−7.36 (m, 2H), 7.22−7.26 (m, 1H), 5.19−5.27 (m, 1H), 2.81 (s, 3H), 2.34 (s, 3H), 1.56 (d, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 4-Methyl-3-(5-methyl-6-(propylcarbamoyl)pyrrolo[1,2-<i>f</i>][1,2,4]triazin-4-ylamino)benzoic Acid (<b>8c</b>)</h3><div class="NLM_p last">A solution of <i>N</i>-<i>n</i>-propyl-4-(2-methyl-5-(methoxycarbamoyl)phenylamino)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>1c</b>) (2.28 g) in aqueous 1 N HCl (30 mL) was heated at 85 °C for 6.5 h. Upon cooling to rt, the mixture was neutralized with aqueous 1 N NaOH solution to pH 6. The precipitating product (1.60 g, 95% yield) was collected by suction filtration and dried. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>19</sub>H<sub>21</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> = 368.10. Found: 368.17. NMR (400 MHz, MeOD) δ 8.20 (br s, 1H), 8.12 (br s, 1H), 7.92−7.89 (m, 2H), 7.69 (br s, 1H), 7.45 (d, <i>J</i> = 8.0 Hz, 1H), 3.35 (m, 2H), 2.86 (s, 3H), 2.36 (s, 3H), 1.67 (m, 2H), 1.02 (t, <i>J</i> = 7.5 Hz, 3H).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-Ethyl-4-(5-(ethylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7a</b>)</h3><div class="NLM_p last">To a solution of 4-(5-(ethylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylic acid (<b>6a</b>) (20.0 mg, 0.057 mmol) in DMF (0.30 mL) were added HOBt (9.1 mg, 0.068 mmol) and EDC (13.0 mg, 0.068 mmol). The resulting solution was stirred at rt for 1 h before ethylamine hydrochloride (12.6 mg, 0.068 mmol) and diisopropylethylamine (24 μL, 0.14 mmol) were added. The mixture was stirred at rt for 16 h, then subjected to preparative HPLC to afford a TFA salt of the title compound (10.0 mg, 46% yield) as a white solid; 97% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>20</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 381.20. Found: 381.10. <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.85 (s, 1H), 7.76 (s, 1H), 7.62 (d, <i>J</i> = 8.0 Hz, 1H), 7.65 (s, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 1H), 3.32−3.26 (m, 4H), 2.74 (s, 3H), 2.23 (s, 3H), 1.13 (t, <i>J</i> = 7.2 Hz, 3H), 1.11 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>S</i>)-4-(5-(Ethylcarbamoyl)-2-methylphenylamino)-5-methyl-<i>N</i>-(1-phenylethyl)pyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7b</b>)</h3><div class="NLM_p last">To a solution of 4-(5-(ethylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylic acid (<b>6a</b>) (20 mg, 0.056 mmol) in DMF (0.3 mL) were successively added HOBt (8.4 mg, 0.062 mmol) and EDC (12 mg, 0.062 mmol). The resulting solution was stirred at rt for 1 h before (<i>S</i>)-α-methylbenzylamine (14 μL, 0.112 mmol) was added. After stirring at rt for 16 h, the mixture was subjected to preparative HPLC to obtain a TFA salt of the title compound (13.0 mg, 52% yield) as a white solid; 99% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 457.23. Found: 457.30. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.12 (s, 1H), 7.90 (s, 1H), 7.78 (d, <i>J</i> = 8.0 Hz, 1H), 7.71 (s, 1H), 7.49 (d, <i>J</i> = 8.0 Hz, 1H), 7.44−7.43 (m, 2H), 7.38−7.35 (m, 2H), 7.26 (m, 1H), 5.25 (q, <i>J</i> = 7.0 Hz, 1H), 3.43 (q, <i>J</i> = 7.3 Hz, 2H), 2.84 (s, 3H), 2.36 (s, 3H), 1.58 (d, <i>J</i> = 7.0 Hz, 3H), 1.24 (t, <i>J</i> = 7.3 Hz, 3H).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-Ethyl-5-methyl-4-(2-methyl-5-(methylcarbamoyl)phenylamino)pyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7c</b>)</h3><div class="NLM_p last">To a solution of 5-methyl-4-(2-methyl-5-(methylcarbamoyl)phenylamino)pyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylic acid (<b>6c</b>) (0.15 g, 0.442 mmol) in DMF (2.5 mL) was added BOP (0.215 g, 0.486 mmol). In a second vial, ethylamine hydrochloride (0.072 g, 0.884 mmol) was dissolved in DMF (0.5 mL) and DIPEA (0.15 mL, 0.884 mmol), and 0.50 mL of the acid (<b>6c</b>)/BOP solution was introduced. The reaction was agitated at room temperature overnight and then diluted slowly with water (5 mL) with vigorous stirring and cooling in an ice bath. The resulting solid was collected by filtration and air-dried to afford the title compound (0.0267 g, 82% yield) as an off-white solid. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>19</sub>H<sub>22</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 367.18. Found: 367.10. NMR (400 MHz, MeOD) δ 8.09 (s, 1H), 7.89 (d, <i>J</i> = 1.8 Hz, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 1H), 7.73 (s, 1H), 7.54 (d, <i>J</i> = 8.0 Hz, 1H), 3.40 (q, <i>J</i> = 7.3 Hz, 2H), 2.93 (s, 3H), 2.87 (s, 3H), 2.37 (s, 3H), 1.24 (t, <i>J</i> = 7.3 Hz, 3H).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-Methyl-4-(2-methyl-5-(propylcarbamoyl)phenylamino)-<i>N</i>-propylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7d</b>)</h3><div class="NLM_p last">To a solution of 4-methyl-3-(5-methyl-6-(propylcarbamoyl)pyrrolo[1,2-<i>f</i>][1,2,4]triazin-4-ylamino)benzoic acid (<b>8c</b>) (47.5 mg, 0.13 mmol) in DMF (0.4 mL) were added HOBt (21 mg, 0.16 mmol) and EDC (30 mg, 0.16 mmol), and the solution was stirred for 2 h. <i>n</i>-Propylamine (21.4 μL, 0.26 mmol) was added, and the mixture was stirred for 15 h. Water (0.4 mL) was added and the precipitated solids were collected by filtration, washed with water, and dried under vacuum to afford the title compound (45 mg, 85% yield) as a white solid; 96% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>22</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub>, (M + H)<sup>+</sup> = 409.10. Found 409.20. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49 (s, 1H), 8.25 (br m, 1H), 7.93 (m, 2H), 7.75 (s, 1H), 7.61 (s, 1H), 7.53 (d, <i>J</i> = 7.6 Hz, 1H), 7.20 (d, <i>J</i> = 7.9 Hz, 1H), 7.15 (m, 1H), 3.03 (m, 4H), 2.60 (s, 3H), 2.06 (s, 3H), 1.35 (m, 4H), 0.72 (m, 6H).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-Ethyl-4-(5-(isopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7e</b>)</h3><div class="NLM_p last">This compound was prepared as a TFA salt in a similar way as <b>7l</b> was yield 20%, 98% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>26</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 395.21. Found: 395.21. <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.91 (s, 1H), 7.77 (s, 1H), 7.67 (d, <i>J</i> = 8.0 Hz, 1H), 7.59 (s, 1H), 7.37 (d, <i>J</i> = 8.0 Hz, 1H), 4.11 (m, 1H), 3.30 (q, <i>J</i> = 7.3 Hz, 2H), 2.76 (s, 3H), 2.25 (s, 3H), 1.15 (d, <i>J</i> = 6.7 Hz, 6H), 1.14 (t, <i>J</i> = 7.3 Hz, 3H).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-(5-(Butylcarbamoyl)-2-methylphenylamino)-<i>N</i>-ethyl-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7f</b>)</h3><div class="NLM_p last">To a solution of 4-(5-(ethylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylic acid (<b>8a</b>) (80 mg, 0.225 mmol) and <i>n</i>-butylamine (44 μL, 0.45 mmol) in DMF (0.7 mL) was added HATU (68 mg, 0.27 mmol), and the resulting solution was stirred for 2 h. At this time, additional HATU (68 mg, 0.27 mmol) was added, and the mixture was allowed to stir at rt for an additional 1 h. The resulting mixture was then added dropwise into water (2.0 mL) with stirring. The solids were dispersed by sonicating for 1 min, and the suspension was stirred at rt for 1 h. The solid was collected by suction filtration and dried to afford the title compound (70 mg, 76% yield) as a white powder; 98% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>22</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 409.23. Found: 409.28. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (s, 1H), 8.40 (t, <i>J</i> = 5.6 Hz, 1H), 8.11 (s, 1H), 8.09 (m, 1H), 7.94 (s, 1H), 7.79 (s, 1H), 7.72 (d, <i>J</i> = 8.0 Hz, 1H), 7.38 (d, <i>J</i> = 8.0 Hz, 1H), 3.30−3.24 (m, 4H), 2.83 (s, 3H), 2.25 (s, 3H), 1.51 (m, 2H), 1.33 (m, 2H), 1.13 (t, <i>J</i> = 7.2 Hz, 3H), 0.90 (t, <i>J</i> = 7.4 Hz, 3H).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-Ethyl-4-(5-(2-methoxyethylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7g</b>)</h3><div class="NLM_p last">To a solution of 3-(6-(ethylcarbamoyl)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazin-4-ylamino)-4-methylbenzoic acid (<b>8a</b>) (19 mg, 0.054 mmol) in DMF (0.4 mL) was added HOBt (8 mg, 0.06 mmol) and EDC (11.5 mg, 0.06 mmol). The mixture was stirred at rt for 1 h before 2-methoxyethanamine (4.5 mg, 0.06 mmol) and DIPEA (14 mg, 0.11 mmol) were added. After stirring at rt for 16 h, the mixture was subjected to reverse-phase preparative HPLC to obtain the TFA salt of the title compound (14.0 mg, 49%) as a white solid; 98% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> = 411.21. Found: 211.20. <sup>1</sup>H NMR (500 MHz, MeOD) δ 8.28 (s, 1H), 7.97 (d, <i>J</i> = 7.7 Hz, 1H), 7.95 (s, 1H), 7.84 (s, 1H), 7.63 (d, <i>J</i> = 7.7 Hz, 1H), 3.57 (s, 3H), 3.41 (q, <i>J</i> = 7.3 Hz, 2H), 3.30 (m, 2H), 2.91 (s, 3H), 2.70 (br s, 2H), 2.42 (s, 3H), 1.24 (t, <i>J</i> = 7.3 Hz, 3H).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-<i>N</i>-ethyl-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7h</b>)</h3><div class="NLM_p last">A mixture of 3-(6-(ethylcarbamoyl)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazin-4-ylamino)-4-methylbenzoic acid (<b>8a</b>) (0.936 g, 2.65 mmol), cyclopropylamine (0.360 mL, 5.20 mmol), EDC (0.635 g, 3.31 mmol), and 4-(dimethylamino)pyridine (65 mg, 0.532 mmol) in DMF (7 mL) was stirred at 45 °C for 20 h. The mixture was diluted with ethyl acetate (120 mL), washed sequentially with water (2 × 25 mL), 10% aqueous Na2CO<sub>3</sub> solution (25 mL), and brine (25 mL). The organic solution was dried over anhydrous MgSO<sub>4</sub> and concentrated under vacuum. The residue was subjected to flash chromatography (silica gel, 10% MeOH/CHCl<sub>3</sub>) to provide the title product (0.448 g, 43% yield) as a white solid; 100% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 393.20. Found: 393.33. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31 (s, 1H), 8.23 (s, 1H), 7.93 (s, 1H), 7.92 (s, 1H), 7.70 (s, 1H), 7.57−7.54 (m, 2H), 7.28 (d, <i>J</i> = 7.8 Hz, 1H), 3.25 (m, 2H), 2.85 (m, 1H), 2.78 (s, 3H), 2.18 (s, 3H), 1.12 (t, <i>J</i> = 7.2 Hz, 3H), 0.68 (m, 2H), 0.57 (m, 2H).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-(5-(Cyclobutylcarbamoyl)-2-methylphenylamino)-<i>N</i>-ethyl-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7i</b>)</h3><div class="NLM_p last">This compound was prepared as a TFA salt in a similar way as <b>7l</b> was; Yield: 6.4%; 100% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>22</sub>H<sub>26</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 407.21. Found: 407.19. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.76 (br s, 1H), 8.62 (br s, 1H), 8.18−8.08 (m, 2H), 7.98 (br s, 1H), 7.87−7.73 (m, 2H), 7.43 (d, <i>J</i> = 7.5 Hz, 1H), 4.48 (m, 1H), 3.31 (m, 2H), 2.86 (s, 3H), 2.28 (s, 3H), 2.27−2.24 (m, 2H), 2.14 (m, 2H), 1.71 (m, 2H), 1.18 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-<i>N</i>,5-dimethylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7j</b>)</h3><div class="NLM_p last">A mixture of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylic acid (<b>6b</b>) (0.026 g, 0.071 mmol), EDC (0.021 g, 0.11 mmol), HOBt (0.015 g, 0.11 mmol), methylamine hydrochloride (8.0 mg,, 0.12 mmol), and diisopropylethylamine (0.040 mL, 0.23 mmol) in dimethylformamide (0.20 mL) was mechanically shaken at rt overnight. Water (1 mL) was added, and the precipitated material was collected by filtration, washed with water, and dried to give the title compound (0.019 g, 72% yield) as a white solid; 100% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>20</sub>H<sub>22</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 379.18. Found: 379.17. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (s, 1H), 8.44 (d, <i>J</i> = 4.4 Hz, 1H), 8.12−8.11 (m, 2H), 7.96 (s, 1H), 7.84 (s, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 1H), 2.92 (m, 1H), 2.87 (s, 3H), 2.81 (d, <i>J</i> = 4.4 Hz, 3H), 2.29 (s, 3H), 0.75 (m, 2H), 0.63 (m, 2H).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-<i>N</i>-propylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7k</b>)</h3><div class="NLM_p last">A mixture of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylic acid (<b>6b</b>) (2.16 g, 5.91 mmol), <i>n</i>-propylamine (1.0 mL, 12.2 mmol), BOP (3.40 g, 7.69 mmol), and <i>N</i>-methylmorpholine (2.5 mL, 22.7 mmol) in DMF (10 mL) was stirred at 50 °C for 3 h. The mixture was poured into a mixture prepared from saturated NaHCO<sub>3</sub> solution (60 mL) and water (60 mL). The precipitating product was collected by suction filtration was washed with water. This crude product was suspended into ethyl acetate (100 mL) and stirred at 70 °C for 1 h. Upon cooling to rt, the title compound (2.07 g, 86% yield) was collected as a white solid by suction filtration; 98% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>22</sub>H<sub>26</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 407.21. Found: 407.22. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49 (d, <i>J</i> = 3.6 Hz, 1H), 8.23 (s, 1H), 8.21 (s, 1H), 7.86 (s, 1H), 7.80 (s, 1H), 7.77 (d, <i>J</i> = 7.8 Hz, 1H), 7.42 (d, <i>J</i> = 7.8 Hz, 1H), 3.20 (m, 2H), 2.87 (m, 1H), 2.82 (s, 3H), 2.25 (s, 3H), 1.54 (m, 2H), 0.91 (t, <i>J</i> = 7.4 Hz, 3H), 0.68 (m, 2H), 0.59 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.3, 164.45, 155.3, 148.7, 138.8, 137.1, 133.0, 130.6, 127.2, 125.8, 119.6, 118.8, 114.4, 113.3, 41.0, 23.6, 23.1, 18.5, 12.1, 12.0, 6.2.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-Butyl-4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7l</b>)</h3><div class="NLM_p last">A mixture of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxylic acid (<b>6b</b>) (0.026 g, 0.071 mmol), EDC (0.021 g, 0.11 mmol), HOBt (0.015 g, 0.11 mmol), <i>n</i>-butylamine (0.015 mL, 0.15 mmol), and diisopropylethylamine (0.040 mL, 0.23 mmol) in dimethylformamide (0.20 mL) was mechanically shaken at rt overnight. Water (1 mL) was added, and the precipitated material was collected by filtration, washed with water, and dried to give the title compound (0.021 g, 70% yield) as a white solid; 98% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>23</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 421.23. Found: 421.18. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (s, 1H), 8.46 (d, <i>J</i> = 4.2 Hz, 1H), 8.16 (s, 1H), 8.11 (t, <i>J</i> = 5.7 Hz, 1H), 7.96 (s, 1H), 7.84 (s, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 1H), 3.28 (m, 2H), 2.92 (m, 1H), 2.87 (s, 3H), 2.29 (s, 3H), 1.56 (m, 2H), 1.41 (m, 2H), 0.98 (t, <i>J</i> = 7.4 Hz, 3H), 0.74 (m, 2H), 0.63 (m, 2H).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-<i>N</i>-(1-phenylethyl)pyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7m</b>)</h3><div class="NLM_p last">A mixture of (<i>S</i>)-4-methyl-3-(5-methyl-6-(1-phenylethylcarbamoyl)pyrrolo[1,2-<i>f</i>][1,2,4]triazin-4-ylamino)benzoic acid (<b>8b</b>) (34.4 mg, 0.080 mmol), cyclopropylamine (0.010 mL, 0.144 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) (20.1 mg, 0.104 mmol), and <i>N</i>,<i>N</i>-dimethylpyridin-4-amine (DMAP) (2.4 mg, 0.020 mmol) in DMF (0.5 mL) was stirred at rt for 16 h. The reaction mixture was diluted with methanol (1.5 mL) and injected to prep. HPLC to afford the title compound (30.2 mg, 81% yield) as a white solid; 100% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>27</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 469.23. Found: 469.35. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59 (s, 1H), 5.06 (m, 1H), 8.37 (d, <i>J</i> = 8.0 Hz, 1H), 8.32 (d, <i>J</i> = 4.2 Hz, 1H), 8.20 (s, 1H), 7.82 (s, 1H), 7.72 (s, 1H), 7.61 (d, <i>J</i> = 7.7 Hz, 1H), 7.32−7.23 (m, 5H), 7.14 (m, 1H), 2.76 (m, 1H), 2.70 (s, 3H), 2.14 (s, 3H), 1.38 (d, <i>J</i> = 7.2 Hz, 3H), 0.59 (m, 2H), 0.48 (m, 2H).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-<i>N</i>-<i>sec</i>-Butyl-4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7n</b>)</h3><div class="NLM_p last">This compound was prepared in the same way as <b>7l</b>; Yield: 76%; 100% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>23</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 421.23. Found: 421.22. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (s, 1H), 8.46 (s, 1H), 8.22 (s, 1H), 7.98 (s, 1H), 7.86 (s, 1H), 7.83 (s, 1H), 7.76 (d, <i>J</i> = 8.0 Hz, 1H), 7.44 (d, <i>J</i> = 8.0 Hz, 1H), 3.97 (m, 1H), 2.93 (m, 1H), 2.88 (s, 3H), 2.30 (s, 3H), 1.56 (m, 2H), 1.20 (d, <i>J</i> = 6.7 Hz, 3H), 0.96 (t, <i>J</i> = 7.4 Hz, 3H), 0.76 (m, 2H), 0.64 (m, 2H).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-<i>N</i>-(2-methoxyethyl)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7o</b>)</h3><div class="NLM_p last">This compound was prepared in the same way as <b>7l</b>; Yield: 73%; 100% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>22</sub>H<sub>26</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 423.21. Found: 423.17. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.73 (s, 1H), 8.46 (d, <i>J</i> = 4.4 Hz, 1H), 8.22 (t, <i>J</i> = 5.4 Hz, 1H), 8.20 (s, 1H), 7.96 (s, 1H), 7.85 (s, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 1H), 3.51 (m, 2H), 3.46 (m, 2H), 3.38 (s, 3H), 2.92 (m, 1H), 2.88 (s, 3H), 2.29 (s, 3H), 0.75 (m, 2H), 0.63 (m, 2H).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>R</i>)-4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-<i>N</i>-(2-hydroxy-1-phenylethyl)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7p</b>)</h3><div class="NLM_p last">This compound was prepared in the same way as <b>7l</b>; Yield: 59%; 100% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>27</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> = 485.22. Found: 485.92. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.73 (s, 1H), 8.46 (d, <i>J</i> = 4.4 Hz, 1H), 8.41 (d, <i>J</i> = 8.2 Hz, 1H), 8.39 (s, 1H), 7.97 (s, 1H), 7.87 (s, 1H), 7.75 (d, <i>J</i> = 7.7 Hz), 7.47−7.37 (m, 5H), 7.30 (m, 1H), 5.11 (m, 1H), 5.00 (m, 1H), 3.72 (m, 2H), 2.92 (m, 1H), 2.85 (s, 3H), 2.29 (s, 3H), 0.74 (m, 2H), 0.63 (m, 2H).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>S</i>)-5-Methyl-4-(2-methyl-5-(phenylcarbamoyl)phenylamino)-<i>N</i>-(1-phenylethyl)-pyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7q</b>)</h3><div class="NLM_p last">To a solution of (<i>S</i>)-4-methyl-3-(5-methyl-6-(1-phenylethylcarbamoyl)pyrrolo[1,2-<i>f</i>][1,2,4]triazin-4-ylamino)benzoic acid (<b>8b</b>) (50 mg, 0.116 mmol) in DMF (0.3 mL) were successively added diisopropylethylamine (61 μL, 0.348 mmol) and HATU (66 mg, 0.174 mmol). The resulting solution was stirred at rt for 20 min before aniline (21 μL, 0.232 mmol) was added. The mixture was heated at 70 °C for 15 h, then subjected to preparative HPLC to afford the title compound (2.0 mg, 3% yield) as a tan solid; 98% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>30</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> = 505.23. Found: 505.30.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-Ethyl-5-methyl-4-(2-methyl-5-(thiazol-2-ylcarbamoyl)phenylamino)pyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7r</b>)</h3><div class="NLM_p last">A mixture of 3-(6-(ethylcarbamoyl)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazin-4-ylamino)-4-methylbenzoic acid (<b>8a</b>) (97.2 mg, 0.275 mmol), 2-aminothiazole (42.7 mg, 42.6 mmol), benzotriazole-1-yl-oxytris(dimethylamino)phosphonium hexafluorophosphate (BOP) (250 mg, 0.565 mmol), and <i>N</i>-methylmorpholine (0.15 mL, 1.36 mmol) in DMF (1 mL) was heated at 55 °C for 16 h. The mixture was diluted with ethyl acetate, washed sequentially with water, saturated NaHCO<sub>3</sub> solution, and brine. The organic solution was dried over anhydrous MgSO<sub>4</sub> and concentrated under vacuum. The residue was subjected to preparative HPLC to provide the desired product (36.4 mg, 30% yield) as an off-white solid; 100% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>21</sub>N<sub>7</sub>O<sub>2</sub>S (M + H)<sup>+</sup> = 436.15. Found: 436.36. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.52 (s, 1H), 8.59 (s, 1H), 8.17 (s, 1H), 8.04 (s, 1H), 8.02 (t, <i>J</i> = 5.6 Hz, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 1H), 7.74 (s, 1H), 7.48 (d, <i>J</i> = 3.2 Hz, 1H), 7.39 (d, <i>J</i> = 8.0 Hz, 1H), 7.20 (d, <i>J</i> = 3.2 Hz, 1H), 3.18 (m, 2H), 2.76 (s, 3H), 2.22 (s, 3H), 1.04 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-Ethyl-5-methyl-4-(2-methyl-5-(5-methylthiazol-2-ylcarbamoyl)phenylamino)pyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7s</b>)</h3><div class="NLM_p last">This compound was prepared in the same way as <b>7r</b>; yield 71%; 100% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>22</sub>H<sub>23</sub>N<sub>7</sub>O<sub>2</sub>S (M + H)<sup>+</sup> = 450.16. Found: 450.19. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>/D<sub>2</sub>O) δ ppm 8.12 (s, 1H)), 8.02 (s, 1H), 7.87 (d, <i>J</i> = 7.2 Hz, 1H), 7.75 (s, 1H), 7.42 (d, <i>J</i> = 8.05 Hz, 1H), 7.15 (s, 1H), 3.20 (q, <i>J</i> = 7.2 Hz, 2H), 2.76 (s, 3H), 2.31 (s, 3H), 2.23 (s, 3H), 1.07 (t, <i>J</i> = 7.21 Hz, 3H).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-Ethyl-5-methyl-4-(2-methyl-5-(oxazol-2-ylcarbamoyl)phenylamino)pyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7t</b>)</h3><div class="NLM_p last">A mixture of 3-(6-(ethylcarbamoyl)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazin-4-ylamino)-4-methylbenzoic acid (<b>8a</b>) (120 mg, 0.306 mmol), 2-aminoxazole (103 mg, 1.22 mmol), BOP (271 mg, 0.613 mmol), and <i>N</i>-methylmorpholine (0.20 mL, 1.80 mmol) in DMF (1 mL) was heated at 70 °C for 16 h. The mixture was diluted with ethyl acetate (60 mL), and washed sequentially with water, saturated NaHCO<sub>3</sub> solution, and brine. The organic solution was dried over anhydrous MgSO<sub>4</sub> and concentrated under vacuum. The residue was subjected to flash chromatography (silica gel, 8% MeOH/CHCl<sub>3</sub>) to provide the desired product (53 mg, 41% yield) as beige solid; 100% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>21</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> = 420.17. Found: 420.25. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>/D<sub>2</sub>O) δ 8.22 (s, 1H), 8.15 (s, 1H), 8.00 (s, 1H), 7.91 (d, <i>J</i> = 7.4 Hz, 1H), 7.87 (s, 1H), 7.54 (d, <i>J</i> = 7.4 Hz, 1H), 7.25 (s, 1H), 3.33 (q, <i>J</i> = 7.2 Hz, 2H), 2.88 (s, 3H), 2.35 (s, 3H), 1.19 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-Ethyl-4-(5-(isoxazol-3-ylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7u</b>)</h3><div class="NLM_p last">A mixture of 3-(6-(ethylcarbamoyl)-5-methylpyrrolo[1,2-<i>f</i>][1,2,4]triazin-4-ylamino)-4-methylbenzoic acid (<b>8a</b>) (12.0 g, 34.0 mmol), 3-aminoisoxazole (12.5 mL, 169 mmol), BOP (30.1 g, 68.0 mmol), and <i>N</i>-methylmorpholine (22.4 mL, 204 mmol) in DMF (100 mL) was heated at 65 °C for 48 h. The mixture was concentrated under vacuum to approximately two-thirds of its original volume and then poured into saturated NaHCO<sub>3</sub> solution (900 mL). The precipitating product was collected by suction filtration and dried over Drierite under vacuum. The crude product was subjected to flash chromatography (silica gel, 5% MeOH/CHCl<sub>3</sub>). The correct fractions were combined and concentrated to a volume of approximately 100 mL. The insoluble product (3.38 g, 24%) was collected as a white solid by suction filtration; 100% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>21</sub>H<sub>21</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> = 420.17. Found: 420.20. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.4 (s, 1H), 8.86 (s, 1H), 8.69 (s, 1H), 8.18 (s, 1H), 8.12 (s, 1H), 8.11 (t, <i>J</i> = 5.5 Hz, 1H), 7.93 (d, <i>J</i> = 8.0 Hz, 1H), 7.83 (s, 1H), 7.47 (d, <i>J</i> = 8.0 Hz, 1H), 7.06 (s, 1H), 3.27 (m, 2H), 2.84 (s, 3H), 2.30 (s, 3H), 1.13 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-(5-(Isoxazol-3-ylcarbamoyl)-2-methylphenylamino)-5-methyl-<i>N</i>-propylpyrrolo[1,2-<i>f</i>][1,2,4]triazine-6-carboxamide (<b>7v</b>)</h3><div class="NLM_p last">This compound was prepared in a similar way from <b>8c</b> as <b>7u</b> was from <b>8a</b>; yield 20%; 99% purity by HPLC. LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>22</sub>H<sub>23</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> = 420.19. Found: 434.29. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.4 (s, 1H), 8.86 (s, 1H), 8.68 (s, 1H), 8.18 (s, 1H), 8.13 (s, 1H), 8.09 (t, <i>J</i> = 5.6 Hz, 1H), 7.92 (d, <i>J</i> = 8.0 Hz, 1H), 7.82 (s, 1H), 7.47 (d, <i>J</i> = 8.0 Hz,1H), 7.06 (s, 1H), 3.19 (m, 2H), 2.84 (s, 3H), 2.30 (s, 3H), 1.53 (m, 2H), 0.91 (t, <i>J</i> = 7.4 Hz, 3H).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> p38α Kinase Assay</h3><div class="NLM_p last">The assays were performed in V-bottomed 96-well plates. The final assay volume was 60 μL, which was from three 20 μL additions of enzyme, substrates (myelin basic protein (MBP) and ATP), and test compounds in assay buffer (50 mM Tris pH 7.5, 10 mM MgCl<sub>2</sub>, 50 mM NaCl, and 1 mM DTT). Bacterially expressed, activated p38 was preincubated with test compounds for 10 min prior to the initiation of reaction by adding substrates. The plates were incubated at room temperature for 45 min. The reaction was terminated by adding 5 μL of 0.5 M EDTA to each well. The reaction mixture was aspirated onto a prewet filter mat using a Skatron Micro96 cell harvester (Skatron) and washed with PBS. The filtermat was dried in a microwave oven for 1 min, coated with a layer of MeltilLex A scintillation wax (PerkinElmer), and counted on a Microbeta scintillation counter (model 1450, PerkinElmer). The data were analyzed using the Prizm nonlinear least-squares regression (GraphPad Software). The final concentrations of reagents in the assays were [ATP], 1 μM; [[γ-<sup>33</sup>P]ATP]], 3 nM; [MBP] (Sigma, M1891), 2 μg/well; [p38], 15 ng/well; [DMSO], 0.3%.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> LPS-Induced TNFα Production in Human PBMC</h3><div class="NLM_p last">Human PBMCs were isolated from whole blood collected from healthy donors. Blood was diluted into RPMI 1640 (Life Technologies) containing 2.5 mM EDTA (Life Technologies), 10 μg/mL polymyxin (Sigma), and then underlaid with ficoll (Accurate Scientific Co.) and centrifuged at 600<i>g</i> for 25 min. The interface was collected and cells were washed twice and resuspended in RPMI, 10% FBS. Cells are then distributed (200 μL/well) into 96-well tissue culture treated plates (Falcon) at 1 × 106 cells/mL in RPMI, 10% FBS. Test compounds were added to appropriate wells and incubated with cells for 30 min. Cells were then stimulated by the addition of lipopolysaccharide (LPS, BioWhittaker), with a final concentration of 25 ng/mL, and incubated for 6 h at 37 °C, 5% CO<sub>2</sub>. The cell supernatants were removed and assayed for TNFα by ELISA (R&D Systems).</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Inhibition of TNFα Release in Mice</h3><div class="NLM_p last">BALB/c female mice, 6−8 weeks of age, were obtained from Harlan Laboratories and maintained ad libitum on water and standard rodent chow (Harlan Teklad). Mice were acclimated to ambient conditions for at least one week prior to use. For oral dosing, the compounds were prepared in a solution of 100% polyethylene glycol (mw 300) and a dosing volume of 0.2 mL per mouse was administered by gavage at various times (see Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) prior to LPS injection (0.5 mL of LPS suspended at 2 μg/mL in PBS, administered ip). Blood samples were obtained 90 min after LPS injection. Serum was separated from clotted blood samples by centrifugation (5 min, 5000<i>g</i>, room temperature) and analyzed for levels of TNFα by ELISA assay (R&D Systems) according to the manufacturer’s directions. Results are shown as mean ± SD of <i>n</i> = 8 mice per treatment group. All procedures involving animals were reviewed and approved by the Institutional Animal Care and Use Committee.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Rat Adjuvant Arthritis</h3><div class="NLM_p last">Male Lewis rats (Harlan, 175−200 g) were immunized sc at the base of the tail with 0.1 mL complete Freund’s adjuvant containing 10 mg/mL <i>Mycobacterium butyricum</i>. Seven days later, baseline (predisease) measurements of hind paw volume were determined by volume displacement plethysmometry (Ugo Basile, Italy). Compounds were administered orally in 1 mL PEG 300 beginning on day 11. Paw volume mesurements were repeated 3 times/week for the remainder of the study. Data are presented as the summed increase in volume (expressed in mL) above baseline for each rat’s two hind paws.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Mouse Pharmacokinetic Study of <b>7k</b></h3><div class="NLM_p last">Three groups of male BALB/c mice (20−25 g) were fasted overnight and received compound <b>7k</b> as an intravenous (IV) bolus dose (5 mg/kg with 20% NMP, 35% PEG 400, 10% PG, and 35% water as a vehicle) or by oral gavage (10 mg/kg with PEG 400 as a vehicle). Blood samples (0.2 mL) were obtained retro-orbital bleeding at 0.05, 0.25, 0.5, 1, 3, 6, 8, and 24 h post dose for the IV group and at 0.25, 0.5, 1, 3, 6, 8, and 24 h post dose for the PO dose group. At each time point, three mice were bled, resulting in a composite pharmacokinetic profile. The tubes were inverted several times to ensure mixing and placed on ice. Plasma was obtained following centrifugation at 4 °C (1500−2000<i>g</i>). Plasma samples were stored at −20 °C until analysis by a nonchiral LC/MS/MS assay.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Rat Pharmacokinetic Study of <b>7k</b></h3><div class="NLM_p last">Three groups of male Sprague−Dawley rats (250−300 g) were fasted overnight and received compound <b>7k</b> as an intravenous (IV) bolus dose (2.5 mg/kg with 25% NMP, 33% PEG 400, 9% PG, and 33% water as a vehicle) or by oral gavage (10 mg/kg with PEG 400 as a vehicle). Blood samples (0.3 mL) were obtained retro-orbital bleeding at 0.05, 0.25, 0.5, 1, 3, 6, 8, and 24 h post dose for the IV group and at 0.25, 0.5, 1, 3, 6, 8, and 24 h post dose for the PO dose group. At each time point, three mice were bled resulting in a composite pharmacokinetic profile. The tubes were inverted several times to ensure mixing and placed on ice. Plasma was obtained following centrifugation at 4 °C (1500−2000<i>g</i>). Plasma samples were stored at −20 °C until analysis by a nonchiral LC/MS/MS assay.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Co-Crystal Structure of <b>7k</b> and <b>7v</b> with p38 MAP Kinase</h3><div class="NLM_p last">His-p38 MAP kinase was expressed in <i>Escherichia coli</i> (BL21 DE3) and purified by sequential anion exchange, nickel chelate affinity, and size exclusion chromatography. The protein at 2 mg/mL, in 25 mM Tris (pH 7.4), 50 mM NaCl, 5% glycerol, 2 mM DTT, was complexed with a 5-fold molar excess of <b>7k</b> or <b>7v</b> and then concentrated to 17 mg/mL. Co-crystals were grown by the hanging drop method from solutions containing 30% PEG 10K, 5 mM MgSO<sub>4</sub>, 50 mM MES, pH 6.0. Data were collected to approximately 2.2 Å resolution on the R-AXIS IV area detector, reduced using the Denzo/HKL package, and refined by the method of simulated annealing using program CNX.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunjian Liu</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#90f3f8e5fefaf9f1febefcf9e5d0f2fde3bef3fffd"><span class="__cf_email__" data-cfemail="a8cbc0ddc6c2c1c9c686c4c1dde8cac5db86cbc7c5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Lin</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen T. Wrobleski</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuqun Lin</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Hynes</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Wu</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alaric J. Dyckman</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tianle Li</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Wityak</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathleen M. Gillooly</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sidney Pitt</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ding Ren Shen</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosemary F. Zhang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kim W. McIntyre</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luisa Salter-Cid</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Shuster</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongjian Zhang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Punit H. Marathe</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arthur M. Doweyko</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John S. Sack</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan E. Kiefer</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin F. Kish</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A. Newitt</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Murray McKinnon</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John H. Dodd</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel C. Barrish</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary L. Schieven</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katerina Leftheris</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm100540x" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 15 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schieven, G. L.</span><span> </span><span class="NLM_article-title">The biology of p38 kinase: A central role in inflammation</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=921-928&author=G.+L.+Schieven&title=The+biology+of+p38+kinase%3A+A+central+role+in+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of p38 kinase: A central role in inflammation</span></div><div class="casAuthors">Schieven, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">921-928</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The p38 kinase plays a central role in inflammation, and it has been the subject of extensive efforts in both basic research and drug discovery.  This review summarizes the biol. of the p38 kinase with a focus on its role in inflammation.  The p38 kinase regulates the prodn. of key inflammatory mediators, including TNFα, IL-1β, and COX-2.  In addn., p38 also acts downstream of cytokines such as TNFα, mediating some of their effects.  The potential efficacy of p38 inhibitors may thus be greater than would be expected from the inhibition of the mediators alone.  Inhibitors of p38 kinase are currently in development for the treatment of rheumatoid arthritis.  The biol. processes regulated by p38 kinase suggest a wide variety of addnl. potential indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMrGjukF3_1bVg90H21EOLACvtfcHk0ljQI9zbGTWQ6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrnF&md5=477b596143660343b98e6748c0c36430</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.2174%2F1568026054985902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985902%26sid%3Dliteratum%253Aachs%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26atitle%3DThe%2520biology%2520of%2520p38%2520kinase%253A%2520A%2520central%2520role%2520in%2520inflammation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D921%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Saklatvala, J.</span><span> </span><span class="NLM_article-title">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1016%2Fj.coph.2004.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=15251131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=372-377&author=J.+Saklatvala&title=The+p38+MAP+kinase+pathway+as+a+therapeutic+target+in+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span></div><div class="casAuthors">Saklatvala, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The p38 MAPK signalling pathway plays an important role in inflammation and other physiol. processes.  Specific inhibitors of p38 α and β MAPK block prodn. of the major inflammatory cytokines (i.e. tumor necrosis factor-α and interleukin-1) and other proteins (e.g. cyclooxygenase-2), and are anti-inflammatory in animal models of disease.  A major function of the pathway is post-transcriptional control of inflammatory gene expression.  Many of the mRNAs are unstable (or untranslatable) because of AU-rich elements in the 3'untranslated region.  Signalling in the p38 pathway counteracts these and stabilizes the mRNAs by preventing their otherwise rapid de-adenylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpglO4EVBhJ-LVg90H21EOLACvtfcHk0ljQI9zbGTWQ6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D&md5=5678936250f1dbc9c27707bd7edf6108</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DSaklatvala%26aufirst%3DJ.%26atitle%3DThe%2520p38%2520MAP%2520kinase%2520pathway%2520as%2520a%2520therapeutic%2520target%2520in%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2004%26volume%3D4%26spage%3D372%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">P38 MAP Kinases: Key Signaling Molecules as Therapeutic Targets for Inflammatory Diseases</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=717-726&author=S.+Kumarauthor=J.+Borhmauthor=J.+C.+Lee&title=P38+MAP+Kinases%3A+Key+Signaling+Molecules+as+Therapeutic+Targets+for+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DBorhm%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DP38%2520MAP%2520Kinases%253A%2520Key%2520Signaling%2520Molecules%2520as%2520Therapeutic%2520Targets%2520for%2520Inflammatory%2520Diseases%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D717%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badge, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1016%2FS0079-6468%2808%2970091-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=11774793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVGntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=1-60&author=J.+L.+Adamsauthor=A.+M.+Badgeauthor=S.+Kumarauthor=J.+C.+Lee&title=p38+MAP+kinase%3A+molecular+target+for+the+inhibition+of+pro-inflammatory+cytokines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines</span></div><div class="casAuthors">Adams, Jerry L.; Badger, Alison M.; Kumar, Sanjay; Lee, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-60</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 286 refs.  Topics discussed include the discovery of p38 kinase; the relationship of p38 to the MAP kinases; the p38 kinase family; upstream activators; downstream substrates; medicinal chem. preceding the discovery of p38; p38 structure-activity relationships; the structural basis of kinase selectivity; the pharmacol. of p38 inhibitors; and preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob8EiblMQiarVg90H21EOLACvtfcHk0ljQI9zbGTWQ6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVGntbw%253D&md5=fb9d63787dfe16059715b6a68afa41a3</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2808%2970091-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252808%252970091-2%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DBadge%26aufirst%3DA.%2BM.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3Dp38%2520MAP%2520kinase%253A%2520molecular%2520target%2520for%2520the%2520inhibition%2520of%2520pro-inflammatory%2520cytokines%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D38%26spage%3D1%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, Z.</span><span> </span><span class="NLM_article-title">p38 MAPK signaling cascades in inflammatory disease</span> <span class="citation_source-journal">Mol. Med. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1016%2FS1357-4310%2899%2901544-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=10498912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVWiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=439-447&author=E.+Herlaarauthor=Z.+Brown&title=p38+MAPK+signaling+cascades+in+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1eR"><div class="casContent"><span class="casTitleNuber">1e</span><div class="casTitle"><span class="NLM_cas:atitle">p38 MAPK signalling cascades in inflammatory disease</span></div><div class="casAuthors">Herlaar, E.; Brown, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Today</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">439-447</span>CODEN:
                <span class="NLM_cas:coden">MMTOFK</span>;
        ISSN:<span class="NLM_cas:issn">1357-4310</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 44 refs.  Inflammatory mediators released during acute and chronic diseases activate multiple intracellular signaling cascades including the mitogen-activated protein kinase (MAPK) signal transduction pathway, which plays a significant role in the recruitment of leukocytes to sites of inflammation.  Stimulation of leukocytes by pro-inflammatory cytokines is known to result in the activation of the MAPK isoform p38.  However, the functional consequences of p38 MAPK activation during leukocyte recruitment, including adhesion, migration and effector functions such as oxidative burst and degranulation, are only just beginning to be elucidated.  Specific p38 inhibitors aimed at reducing the prodn. of inflammatory mediators are now being developed, and might in the future provide more effective treatment for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIhoJ67g0sRrVg90H21EOLACvtfcHk0liYmpm4u18isA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVWiu7g%253D&md5=3bf8c8ba39b01b5a3188d75b06107709</span></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1016%2FS1357-4310%2899%2901544-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-4310%252899%252901544-0%26sid%3Dliteratum%253Aachs%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DZ.%26atitle%3Dp38%2520MAPK%2520signaling%2520cascades%2520in%2520inflammatory%2520disease%26jtitle%3DMol.%2520Med.%2520Today%26date%3D1999%26volume%3D5%26spage%3D439%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laydon, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenthal, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heys, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landvatter, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemens, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livi, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span> </span><span class="NLM_article-title">A protein kinase involved in the regulation of inflammatory cytokine biosynthesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=739-745&author=J.+C.+Leeauthor=J.+T.+Laydonauthor=P.+C.+McDonnellauthor=T.+F.+Gallagherauthor=S.+Kimarauthor=D.+Greenauthor=D.+McNultyauthor=M.+J.+Blumenthalauthor=J.+R.+Heysauthor=S.+W.+Landvatterauthor=J.+E.+Stricklerauthor=M.+M.+McLaughlinauthor=I.+R.+Siemensauthor=S.+M.+Fisherauthor=G.+P.+Liviauthor=J.+R.+Whiteauthor=J.+L.+Adamsauthor=P.+R.+Young&title=A+protein+kinase+involved+in+the+regulation+of+inflammatory+cytokine+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DLaydon%26aufirst%3DJ.%2BT.%26aulast%3DMcDonnell%26aufirst%3DP.%2BC.%26aulast%3DGallagher%26aufirst%3DT.%2BF.%26aulast%3DKimar%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DMcNulty%26aufirst%3DD.%26aulast%3DBlumenthal%26aufirst%3DM.%2BJ.%26aulast%3DHeys%26aufirst%3DJ.%2BR.%26aulast%3DLandvatter%26aufirst%3DS.%2BW.%26aulast%3DStrickler%26aufirst%3DJ.%2BE.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26aulast%3DSiemens%26aufirst%3DI.%2BR.%26aulast%3DFisher%26aufirst%3DS.%2BM.%26aulast%3DLivi%26aufirst%3DG.%2BP.%26aulast%3DWhite%26aufirst%3DJ.%2BR.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26atitle%3DA%2520protein%2520kinase%2520involved%2520in%2520the%2520regulation%2520of%2520inflammatory%2520cytokine%2520biosynthesis%26jtitle%3DNature%26date%3D1994%26volume%3D372%26spage%3D739%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="note"><p class="first last">For example,</p></div><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pettus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herberich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saris, C. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmait, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span> </span><span class="NLM_article-title">Discovery and Evaluation of 7-Alkyl-1,5-bis-aryl-pyrazolopyridinones as Highly Potent, Selective, and Orally Efficacious Inhibitors of p38α Mitogen-Activated Protein Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2973</span><span class="NLM_x">–</span> <span class="NLM_lpage">2985</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100095x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2973-2985&author=L.+H.+Pettusauthor=R.+P.+Wurzauthor=S.+Xuauthor=B.+Herberichauthor=B.+Henkleauthor=Q.+Liuauthor=H.+J.+McBrideauthor=S.+Muauthor=M.+H.+Plantauthor=C.+J.+M.+Sarisauthor=L.+Shermanauthor=L.+M.+Wongauthor=S.+Chmaitauthor=M.+R.+Leeauthor=C.+Mohrauthor=F.+Hsiehauthor=A.+S.+Tasker&title=Discovery+and+Evaluation+of+7-Alkyl-1%2C5-bis-aryl-pyrazolopyridinones+as+Highly+Potent%2C+Selective%2C+and+Orally+Efficacious+Inhibitors+of+p38%CE%B1+Mitogen-Activated+Protein+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1021%2Fjm100095x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100095x%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMcBride%26aufirst%3DH.%2BJ.%26aulast%3DMu%26aufirst%3DS.%26aulast%3DPlant%26aufirst%3DM.%2BH.%26aulast%3DSaris%26aufirst%3DC.%2BJ.%2BM.%26aulast%3DSherman%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DL.%2BM.%26aulast%3DChmait%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26atitle%3DDiscovery%2520and%2520Evaluation%2520of%25207-Alkyl-1%252C5-bis-aryl-pyrazolopyridinones%2520as%2520Highly%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Efficacious%2520Inhibitors%2520of%2520p38%25CE%25B1%2520Mitogen-Activated%2520Protein%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2973%26epage%3D2985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durley, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepperle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucker, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerome, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrufo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Promo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickory, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blevis-Bal, R.</span><span> </span><span class="NLM_article-title">Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5852</span><span class="NLM_x">–</span> <span class="NLM_lpage">5856</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5852-5856&author=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+B.+Monahanauthor=T.+L.+Boehmauthor=J.+K.+Walkerauthor=B.+Devadasauthor=R.+C.+Durleyauthor=R.+Kurumbailauthor=H.+Shiehauthor=L.+Xingauthor=M.+Hepperleauthor=P.+V.+Ruckerauthor=K.+D.+Jeromeauthor=A.+G.+Bensonauthor=L.+D.+Marrufoauthor=H.+M.+Madsenauthor=J.+Hitchcockauthor=T.+J.+Owenauthor=L.+Christieauthor=M.+A.+Promoauthor=B.+S.+Hickoryauthor=E.+Alviraauthor=W.+Naingauthor=R.+Blevis-Bal&title=Discovery+of+N-substituted+pyridinones+as+potent+and+selective+inhibitors+of+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DDurley%26aufirst%3DR.%2BC.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DHepperle%26aufirst%3DM.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DJerome%26aufirst%3DK.%2BD.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DHitchcock%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DT.%2BJ.%26aulast%3DChristie%26aufirst%3DL.%26aulast%3DPromo%26aufirst%3DM.%2BA.%26aulast%3DHickory%26aufirst%3DB.%2BS.%26aulast%3DAlvira%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DBlevis-Bal%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520N-substituted%2520pyridinones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520p38%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5852%26epage%3D5856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Herberich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, G.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosfeld, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span> </span><span class="NLM_article-title">Discovery of Highly Selective and Potent p38 Inhibitors Based on a Phthalazine Scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6271</span><span class="NLM_x">–</span> <span class="NLM_lpage">6279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8005417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6271-6279&author=B.+Herberichauthor=G.-Q.+Caoauthor=P.+P.+Chakrabartiauthor=J.+R.+Falseyauthor=L.+Pettusauthor=R.+M.+Rzasaauthor=A.+B.+Reedauthor=A.+Reicheltauthor=K.+Shamauthor=M.+Thamanauthor=R.+P.+Wurzauthor=S.+Xuauthor=D.+Zhangauthor=F.+Hsiehauthor=M.+R.+Leeauthor=R.+Syedauthor=V.+Liauthor=D.+Grosfeldauthor=M.+H.+Plantauthor=B.+Henkleauthor=L.+Shermanauthor=S.+Middletonauthor=L.+M.+Wongauthor=A.+S.+Tasker&title=Discovery+of+Highly+Selective+and+Potent+p38+Inhibitors+Based+on+a+Phthalazine+Scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1021%2Fjm8005417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8005417%26sid%3Dliteratum%253Aachs%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DG.-Q.%26aulast%3DChakrabarti%26aufirst%3DP.%2BP.%26aulast%3DFalsey%26aufirst%3DJ.%2BR.%26aulast%3DPettus%26aufirst%3DL.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DSham%26aufirst%3DK.%26aulast%3DThaman%26aufirst%3DM.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DSyed%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DGrosfeld%26aufirst%3DD.%26aulast%3DPlant%26aufirst%3DM.%2BH.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DSherman%26aufirst%3DL.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DL.%2BM.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26atitle%3DDiscovery%2520of%2520Highly%2520Selective%2520and%2520Potent%2520p38%2520Inhibitors%2520Based%2520on%2520a%2520Phthalazine%2520Scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6271%26epage%3D6279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Natarajan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levorse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vora, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvetovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carballo-Jane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, D. M.</span><span> </span><span class="NLM_article-title">p38 MAP kinase inhibitors. Discovery of an orally bioavailable and highly efficacious compound based on the 7-amino-naphthyridone scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5468</span><span class="NLM_x">–</span> <span class="NLM_lpage">5471</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5468-5471&author=S.+R.+Natarajanauthor=L.+Liuauthor=M.+Levorseauthor=J.+E.+Thompsonauthor=E.+A.+O%E2%80%99Neillauthor=S.+J.+O%E2%80%99Keefeauthor=K.+A.+Voraauthor=R.+Cvetovichauthor=J.+Y.+Chungauthor=E.+Carballo-Janeauthor=D.+M.+Visco&title=p38+MAP+kinase+inhibitors.+Discovery+of+an+orally+bioavailable+and+highly+efficacious+compound+based+on+the+7-amino-naphthyridone+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNatarajan%26aufirst%3DS.%2BR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLevorse%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DS.%2BJ.%26aulast%3DVora%26aufirst%3DK.%2BA.%26aulast%3DCvetovich%26aufirst%3DR.%26aulast%3DChung%26aufirst%3DJ.%2BY.%26aulast%3DCarballo-Jane%26aufirst%3DE.%26aulast%3DVisco%26aufirst%3DD.%2BM.%26atitle%3Dp38%2520MAP%2520kinase%2520inhibitors.%2520Discovery%2520of%2520an%2520orally%2520bioavailable%2520and%2520highly%2520efficacious%2520compound%2520based%2520on%2520the%25207-amino-naphthyridone%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5468%26epage%3D5471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audoly, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberia, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braganza, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carty, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortina, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuperman, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaLiberte, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naiman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peese, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trebino, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramov, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volberg, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4339</span><span class="NLM_x">–</span> <span class="NLM_lpage">4344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4339-4344&author=K.+F.+McClureauthor=M.+A.+Letavicauthor=A.+S.+Kalgutkarauthor=C.+A.+Gabelauthor=L.+Audolyauthor=J.+T.+Barberiaauthor=J.+F.+Braganzaauthor=D.+Carterauthor=T.+J.+Cartyauthor=S.+R.+Cortinaauthor=M.+A.+Dombroskiauthor=K.+M.+Donahueauthor=N.+C.+Elliottauthor=C.+P.+Gibbonsauthor=C.+K.+Jordanauthor=A.+V.+Kupermanauthor=J.+M.+Labasiauthor=R.+E.+LaLiberteauthor=J.+M.+McCoyauthor=B.+M.+Naimanauthor=K.+L.+Nelsonauthor=H.+T.+Nguyenauthor=K.+M.+Peeseauthor=F.+J.+Sweeneyauthor=T.+J.+Taylorauthor=C.+E.+Trebinoauthor=Y.+A.+Abramovauthor=E.+R.+Lairdauthor=W.+A.+Volbergauthor=J.+Zhouauthor=J.+Bachauthor=F.+Lombardo&title=Structure%E2%88%92activity+relationships+of+triazolopyridine+oxazole+p38+inhibitors%3A+identification+of+candidates+for+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26aulast%3DAudoly%26aufirst%3DL.%26aulast%3DBarberia%26aufirst%3DJ.%2BT.%26aulast%3DBraganza%26aufirst%3DJ.%2BF.%26aulast%3DCarter%26aufirst%3DD.%26aulast%3DCarty%26aufirst%3DT.%2BJ.%26aulast%3DCortina%26aufirst%3DS.%2BR.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DDonahue%26aufirst%3DK.%2BM.%26aulast%3DElliott%26aufirst%3DN.%2BC.%26aulast%3DGibbons%26aufirst%3DC.%2BP.%26aulast%3DJordan%26aufirst%3DC.%2BK.%26aulast%3DKuperman%26aufirst%3DA.%2BV.%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DLaLiberte%26aufirst%3DR.%2BE.%26aulast%3DMcCoy%26aufirst%3DJ.%2BM.%26aulast%3DNaiman%26aufirst%3DB.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DPeese%26aufirst%3DK.%2BM.%26aulast%3DSweeney%26aufirst%3DF.%2BJ.%26aulast%3DTaylor%26aufirst%3DT.%2BJ.%26aulast%3DTrebino%26aufirst%3DC.%2BE.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DLaird%26aufirst%3DE.%2BR.%26aulast%3DVolberg%26aufirst%3DW.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DBach%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DF.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520triazolopyridine%2520oxazole%2520p38%2520inhibitors%253A%2520identification%2520of%2520candidates%2520for%2520clinical%2520development%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4339%26epage%3D4344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcintyre, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6261</span><span class="NLM_x">–</span> <span class="NLM_lpage">6270</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503594" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6261-6270&author=C.+Liuauthor=S.+T.+Wrobleskiauthor=J.+Linauthor=K.+M.+Gilloolyauthor=K.+Mcintyreauthor=S.+Pittauthor=D.+R.+Shenauthor=D.+J.+Shusterauthor=H.+Zhangauthor=A.+M.+Doweykoauthor=J.+S.+Sackauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=5-Cyanopyrimidine+Derivatives+as+a+Novel+Class+of+Potent%2C+Selective%2C+and+Orally+Active+Inhibitors+of+p38%CE%B1+MAP+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=10.1021%2Fjm0503594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503594%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DMcintyre%26aufirst%3DK.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3D5-Cyanopyrimidine%2520Derivatives%2520as%2520a%2520Novel%2520Class%2520of%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Active%2520Inhibitors%2520of%2520p38%25CE%25B1%2520MAP%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6261%26epage%3D6270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Padova, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucklin, G.</span><span> </span><span class="NLM_article-title">Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3595</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3595-99&author=L.+Reveszauthor=E.+Blumauthor=F.+E.+Di+Padovaauthor=T.+Buhlauthor=R.+Feifelauthor=H.+Gramauthor=P.+Hiestandauthor=U.+Manningauthor=G.+Rucklin&title=Novel+p38+inhibitors+with+potent+oral+efficacy+in+several+models+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DBlum%26aufirst%3DE.%26aulast%3DDi%2BPadova%26aufirst%3DF.%2BE.%26aulast%3DBuhl%26aufirst%3DT.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DManning%26aufirst%3DU.%26aulast%3DRucklin%26aufirst%3DG.%26atitle%3DNovel%2520p38%2520inhibitors%2520with%2520potent%2520oral%2520efficacy%2520in%2520several%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3595%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Trejo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arzeno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalrymple, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunten, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafargue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovejoy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire-Moar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcintosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villasenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Lu</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4702</span><span class="NLM_x">–</span> <span class="NLM_lpage">4713</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0301787" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4702-4713&author=A.+Trejoauthor=H.+Arzenoauthor=M.+Brownerauthor=S.+Chandaauthor=S.+Chengauthor=D.+D.+Comerauthor=S.+A.+Dalrympleauthor=P.+Duntenauthor=J.+Lafargueauthor=B.+Lovejoyauthor=J.+Freire-Moarauthor=J.+Limauthor=J.+Mcintoshauthor=J.+Millerauthor=E.+Pappauthor=D.+Reuterauthor=R.+Robertsauthor=J.+Saundersauthor=K.+Songauthor=A.+Villasenorauthor=S.+D.+Warrenauthor=M.+Welchauthor=P.+Wellerauthor=P.+E.+Whiteleyauthor=Lu+Zengauthor=D.+M.+Goldstein&title=Design+and+synthesis+of+4-azaindoles+as+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2h&amp;dbid=16384&amp;doi=10.1021%2Fjm0301787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0301787%26sid%3Dliteratum%253Aachs%26aulast%3DTrejo%26aufirst%3DA.%26aulast%3DArzeno%26aufirst%3DH.%26aulast%3DBrowner%26aufirst%3DM.%26aulast%3DChanda%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DComer%26aufirst%3DD.%2BD.%26aulast%3DDalrymple%26aufirst%3DS.%2BA.%26aulast%3DDunten%26aufirst%3DP.%26aulast%3DLafargue%26aufirst%3DJ.%26aulast%3DLovejoy%26aufirst%3DB.%26aulast%3DFreire-Moar%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DMcintosh%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DJ.%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DReuter%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DR.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DVillasenor%26aufirst%3DA.%26aulast%3DWarren%26aufirst%3DS.%2BD.%26aulast%3DWelch%26aufirst%3DM.%26aulast%3DWeller%26aufirst%3DP.%26aulast%3DWhiteley%26aufirst%3DP.%2BE.%26aulast%3DZeng%26aufirst%3DLu%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%25204-azaindoles%2520as%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4702%26epage%3D4713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavender, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olini, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahmy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siekierka, J. J.</span><span> </span><span class="NLM_article-title">Imidazopyrimidines, potent inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=347-350&author=K.+C.+Rupertauthor=J.+R.+Henryauthor=J.+H.+Doddauthor=S.+A.+Wadsworthauthor=D.+E.+Cavenderauthor=G.+C.+Oliniauthor=B.+Fahmyauthor=J.+J.+Siekierka&title=Imidazopyrimidines%2C+potent+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHenry%26aufirst%3DJ.%2BR.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DWadsworth%26aufirst%3DS.%2BA.%26aulast%3DCavender%26aufirst%3DD.%2BE.%26aulast%3DOlini%26aufirst%3DG.%2BC.%26aulast%3DFahmy%26aufirst%3DB.%26aulast%3DSiekierka%26aufirst%3DJ.%2BJ.%26atitle%3DImidazopyrimidines%252C%2520potent%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D347%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitfelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span> </span><span class="NLM_article-title">Pyrazole urea-based inhibitors of p38 MAP kinase: From lead compound to clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2994</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020057r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2j&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2994-3008&author=J.+Reganauthor=S.+Breitfelderauthor=P.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=B.+Klausauthor=J.+Madwedauthor=M.+Moriakauthor=N.+Mossauthor=C.+Pargellisauthor=S.+Pavauthor=A.+Protoauthor=A.+Swinamerauthor=L.+Tongauthor=C.+Torcellini&title=Pyrazole+urea-based+inhibitors+of+p38+MAP+kinase%3A+From+lead+compound+to+clinical+candidate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2jR"><div class="casContent"><span class="casTitleNuber">2j</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate</span></div><div class="casAuthors">Regan, John; Breitfelder, Steffen; Cirillo, Pier; Gilmore, Thomas; Graham, Anne G.; Hickey, Eugene; Klaus, Bernhard; Madwed, Jeffrey; Moriak, Monica; Moss, Neil; Pargellis, Chris; Pav, Sue; Proto, Alfred; Swinamer, Alan; Tong, Liang; Torcellini, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2994-3008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on a series of N-pyrazole, N'-aryl ureas and their mode of binding to p38 mitogen activated protein kinase.  Importantly, a key binding domain that is distinct from the ATP (ATP) binding site is exposed when the conserved activation loop, consisting in part of Asp168-Phe169-Gly170, adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.  We describe the correlation of the structure-activity relationships and crystallog. structures of these inhibitors with p38.  In addn., we incorporated another binding pharmacophore that forms a hydrogen bond at the ATP binding site.  This modification affords significant improvements in binding, cellular, and in vivo potencies resulting in the selection of Compd. 45 (BIRB 796) as a clin. candidate for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotOOfLV3xRbVg90H21EOLACvtfcHk0lhWevoDKKoUzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D&md5=e473f514179c8fe24ab3efccc292b6c6</span></div><a href="/servlet/linkout?suffix=cit2j&amp;dbid=16384&amp;doi=10.1021%2Fjm020057r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020057r%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DBreitfelder%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKlaus%26aufirst%3DB.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DTorcellini%26aufirst%3DC.%26atitle%3DPyrazole%2520urea-based%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%253A%2520From%2520lead%2520compound%2520to%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2994%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Choy, E. H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayi, G. S.</span><span> </span><span class="NLM_article-title">Cytokine Pathway and Joint Inflammation in Rheumatoid Arthritis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1056%2FNEJM200103223441207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=11259725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisFyrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=907-916&author=E.+H.+S.+Choyauthor=G.+S.+Panayi&title=Cytokine+Pathway+and+Joint+Inflammation+in+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine pathways and joint inflammation in rheumatoid arthritis</span></div><div class="casAuthors">Choy, Ernest H. S.; Panayi, Gabriel S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">907-916</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review with 79 refs.  Although the cause of rheumatoid arthritis is still unclear, the improved understanding of the pathogenesis of the disease has opened the door to innovative therapies.  By targeting mols. that are directly involved in the pathogenesis of rheumatoid arthritis, these therapies may be more efficacious and specific and less toxic in the short and long term than std. therapies.  Radiol. evidence suggests that these new therapies, such as anticytokine therapy, may slow disease progression.  Finally, the success of anticytokine therapy will also provide valuable insights into the initiation and progression of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8KnAs8wt9tbVg90H21EOLACvtfcHk0lhD1zgxQLWdZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisFyrur8%253D&md5=407ee2bc06a307c241e60f048e5f4a95</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1056%2FNEJM200103223441207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200103223441207%26sid%3Dliteratum%253Aachs%26aulast%3DChoy%26aufirst%3DE.%2BH.%2BS.%26aulast%3DPanayi%26aufirst%3DG.%2BS.%26atitle%3DCytokine%2520Pathway%2520and%2520Joint%2520Inflammation%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D907%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Foster, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souness, J. E.</span><span> </span><span class="NLM_article-title">Potential of p38 inhibitors in the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=12937622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=488-497&author=M.+L.+Fosterauthor=F.+Halleyauthor=J.+E.+Souness&title=Potential+of+p38+inhibitors+in+the+treatment+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Potential of p38 inhibitors in the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Foster, Martyn L.; Halley, Frank; Souness, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">488-497</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review, with 64 refs.  Rheumatoid arthritis (RA) is a chronic debilitating disease estd. to afflict 1-3% of the world population.  Although palliative treatments (nonsteroidal anti-inflammatory drugs or NSAIDs) are widely prescribed, there are currently only a few treatments that can modify the insidious progression of the disease (disease-modifying antirheumatic drugs or DMARDs), which frequently leads to phys. incapacitation and, on occasion, death.  Proinflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) are implicated in the disease onset and in the progression of bone and joint destruction that characterizes chronic RA.  P38 is an intracellular mitogen/stress-activated protein kinase (MAPK/SAPK) that regulates both the release and the actions of TNF-α and IL-1β.  Inhibition of p38 kinase is thus an important potential target for novel DMARDs.  Following the pioneering work conducted at SmithKline Beecham and elucidation of the roles of p38 with potent and selective inhibitors such as SB-203580, many pharmaceutical companies have embarked upon p38 synthetic programs, as indicated by the ever-increasing no. of patents in this domain.  At Aventis, a rapid parallel synthesis project led to the identification of RPR-200765A, a potent and selective p38 inhibitor of the lipopolysaccharide-induced release of TNF-α in vitro in mononuclear phagocytes and in vivo in the rat.  It also reduces disease incidence and progression in the rat streptococcal cell wall arthritis model when administered orally in either a prophylactic or a therapeutic dosing regimen.  Development of p38 inhibitors has been slow, probably because of toxicol. problems, which might explain why only two oral p38 inhibitors, SB-242235 and VX-745, have advanced into clin. development.  In the present article, the preclin. data exemplified in studies on RPR-200765A indicating why p38 inhibitors are attracting so much attention as potential novel anti-RA drugs are reviewed.  Current information on the different structural classes of p38 inhibitors is presented and possible reasons for the delays in their development are critically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPsDRV9bCN37Vg90H21EOLACvtfcHk0lhD1zgxQLWdZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFKktg%253D%253D&md5=b634b7ab2f3e8fd6747c4889e324f3a3</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DM.%2BL.%26aulast%3DHalley%26aufirst%3DF.%26aulast%3DSouness%26aufirst%3DJ.%2BE.%26atitle%3DPotential%2520of%2520p38%2520inhibitors%2520in%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2000%26volume%3D13%26spage%3D488%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Feldmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maini, R. N.</span><span> </span><span class="NLM_article-title">Role of cytokines in rheumatoid arthritis</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1146%2Fannurev.immunol.14.1.397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=8717520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADyaK28XitlCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1996&pages=397-440&author=M.+Feldmannauthor=F.+M.+Brennanauthor=R.+N.+Maini&title=Role+of+cytokines+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Role of cytokines in rheumatoid arthritis</span></div><div class="casAuthors">Feldmann, Marc; Brennan, Fionula M.; Maini, Ravinder N.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">397-440</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with 226 refs.  Anal. of cytokine mRNA and protein in rheumatoid arthritis tissue revealed that many proinflammatory cytokines such as TNFα, IL-1, IL-6, GM-CSF, and chemokines such as IL-8 are abundant in all patients regardless of therapy.  This is compensated to some degree by the increased prodn. of anti-inflammatory cytokines such as IL-10 and TGFβ and cytokine inhibitors such as IL-1ra and sol. TNF-R.  However, this upregulation in homeostatic regulatory mechanisms is not sufficient as these are unable to neutralize all the TNFα and IL-1 produced.  In rheumatoid joint cell cultures that spontaneously produce IL-1, TNFα was the major dominant regulator of IL-1.  Subsequently, other proinflammatory cytokines were also inhibited if TNFα was neutralized, leading to the new concept that the proinflammatory cytokines were linked in a network with TNFα at its apex.  This led to the hypothesis that TNFα was of major importance in rheumatoid arthritis and was a therapeutic target.  This hypothesis has been successfully tested in animal models, of, for example, collagen-induced arthritis, and these studies have provided the rationale for clin. trials of anti-TNFα therapy in patients with long-standing rheumatoid arthritis.  Several clin. trials using a chimeric anti-TNFα antibody have shown marked clin. benefit, verifying the hypothesis that TNFα is of major importance in rheumatoid arthritis.  Retreatment studies have also shown benefit in repeated relapses, indicating that the disease remains TNFα dependent.  Overall these studies demonstrate that anal. of cytokine expression and regulation may yield effective therapeutic targets in inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHja_UMVsQ8rVg90H21EOLACvtfcHk0liQd_R4vUAaFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitlCgtb4%253D&md5=bcffdb544e217ca525bef31af6d0fc44</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.14.1.397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.14.1.397%26sid%3Dliteratum%253Aachs%26aulast%3DFeldmann%26aufirst%3DM.%26aulast%3DBrennan%26aufirst%3DF.%2BM.%26aulast%3DMaini%26aufirst%3DR.%2BN.%26atitle%3DRole%2520of%2520cytokines%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1996%26volume%3D14%26spage%3D397%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">Inflammatory cytokines: Interleukin-1 and Tumor Necrosis Factor as Effector Molecules in Autoimmune Diseases</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1016%2FS0952-7915%2805%2980018-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=1665333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=941-948&author=C.+A.+Dinarello&title=Inflammatory+cytokines%3A+Interleukin-1+and+Tumor+Necrosis+Factor+as+Effector+Molecules+in+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory cytokines:  interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases</span></div><div class="casAuthors">Dinarello, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">941-8</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    </div><div class="casAbstract">The nature of the events that ppt. autoimmune diseases varies.  Interleukin-1 and tumor necrosis factor do not ppt. autoimmune diseases but rather act as effector mols.  They induce eicosanoid and NO synthesis, stimulate collagenases and collagen synthesis, and trigger the genes for other cytokines, namely interleukin-2, interleukin-6 and interleukin-8.  The ability to block interleukin-1 with the receptor antagonist, and tumor necrosis factor with sol. receptors, has given investigators specific tools to test the role of these two cytokines in the pathol. processes of autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhF6Z-Gd_1RrVg90H21EOLACvtfcHk0liQd_R4vUAaFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D&md5=9124ac01336892ed242ed4583f14b4c6</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2805%2980018-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252805%252980018-4%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DInflammatory%2520cytokines%253A%2520Interleukin-1%2520and%2520Tumor%2520Necrosis%2520Factor%2520as%2520Effector%2520Molecules%2520in%2520Autoimmune%2520Diseases%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1991%26volume%3D3%26spage%3D941%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jarvis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulds, D.</span><span> </span><span class="NLM_article-title">Etanercept: a review of its use in rheumatoid arthritis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=945-966&author=B.+Jarvisauthor=D.+Faulds&title=Etanercept%3A+a+review+of+its+use+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DB.%26aulast%3DFaulds%26aufirst%3DD.%26atitle%3DEtanercept%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520rheumatoid%2520arthritis%26jtitle%3DDrugs%26date%3D1999%26volume%3D57%26spage%3D945%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rutgeerts, P. J.</span><span> </span><span class="NLM_article-title">Review article: efficacy of infliximab in Crohn’s disease—induction and maintenance of remission</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1046%2Fj.1365-2036.1999.00025.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=10597334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADyaK1MXmsl2iu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=9-15&issue=Suppl+4&author=P.+J.+Rutgeerts&title=Review+article%3A+efficacy+of+infliximab+in+Crohn%E2%80%99s+disease%E2%80%94induction+and+maintenance+of+remission"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of infliximab in Crohn's disease - induction and maintenance of remission</span></div><div class="casAuthors">Rutgeerts, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 10 refs.  The primary goals of treating patients with Crohn's disease are to induce a clin. remission, maintain the remission, and prevent assocd. complications.  Various treatment regimens for patients with Crohn's disease induce a response and remission; however, most prove ineffective for maintenance of the clin. effect.  A therapeutic agent that can induce and maintain remission, while promoting the restoration of intestinal mucosa, would prove to be most beneficial in such a patient population.  Several studies with infliximab have clin. demonstrated that the antitumor necrosis factor-alpha therapy rapidly reduced the signs and symptoms in patients with moderate-to-severe Crohn's disease.  In acute studies with the chimeric monoclonal antibody, clin. benefit was assocd. with healing and redn. of inflammation in the bowel mucosal tissue.  In a maintenance study, retreatment with infliximab maintained remission of the active disease.  Addnl., treatment with the lowest infusion dose of infliximab (5 mg/kg) provided a high degree of clin. benefit with a long-term outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ee9AqW66hrVg90H21EOLACvtfcHk0lgUN7denSrlJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsl2iu7g%253D&md5=54b81dd3efe43048450b9bfbaf002ac4</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2036.1999.00025.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2036.1999.00025.x%26sid%3Dliteratum%253Aachs%26aulast%3DRutgeerts%26aufirst%3DP.%2BJ.%26atitle%3DReview%2520article%253A%2520efficacy%2520of%2520infliximab%2520in%2520Crohn%25E2%2580%2599s%2520disease%25E2%2580%2594induction%2520and%2520maintenance%2520of%2520remission%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D1999%26volume%3D13%26issue%3DSuppl%25204%26spage%3D9%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sweeney, S. E.</span><span> </span><span class="NLM_article-title">The as-yet unfulfilled promise of p38 MAPK inhibitors</span> <span class="citation_source-journal">Nature Rev. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1038%2Fnrrheum.2009.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=19710669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGrtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=475-477&author=S.+E.+Sweeney&title=The+as-yet+unfulfilled+promise+of+p38+MAPK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The as-yet unfulfilled promise of p38 MAPK inhibitors</span></div><div class="casAuthors">Sweeney, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Rheumatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">475-477</span>CODEN:
                <span class="NLM_cas:coden">NRRACB</span>;
        ISSN:<span class="NLM_cas:issn">1759-4790</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There has been a continued pursuit of new targets for cost effective, oral treatments for rheumatoid arthritis (RA).  In fact, numerous inhibitors of signal transduction pathways have been designed.  One target for such inhibition is the p38 mitogen-activated protein kinase signaling cascade which possesses a role in inflammation by mediating the cellular response to stress, pathogens, and cytokines.  Many p38 inhibitors have already been developed and tested, however, their efficacy in RA has been disappointing.  Despite their decreased toxicity, response to these agents continues to be inadequate or poorly sustained.  They do not seem to be effective treatments for RA, and will probably not be pursued clin.  Still, the search continues for small-mol. inhibitors that will reach the efficacy and safety of the biol. agents currently applied to treat RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomQkzhab8S_rVg90H21EOLACvtfcHk0lgUN7denSrlJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGrtrvF&md5=fe4d4b673ab8c8c958bfc77a3d797923</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2009.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2009.171%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DS.%2BE.%26atitle%3DThe%2520as-yet%2520unfulfilled%2520promise%2520of%2520p38%2520MAPK%2520inhibitors%26jtitle%3DNature%2520Rev.%2520Rheumatol.%26date%3D2009%26volume%3D5%26spage%3D475%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karcher, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Successful structure-based design of recent p38 MAP kinase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F156802609789007363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=19689372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=655-676&author=S.+C.+Karcherauthor=S.+A.+Laufer&title=Successful+structure-based+design+of+recent+p38+MAP+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Successful structure-based design of recent p38 MAP kinase inhibitors</span></div><div class="casAuthors">Karcher, Solveigh C.; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">655-676</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Inflammation is a complex immune response to cellular and tissue damage caused by phys., chem., immunol., or microbial stimuli.  Prior to the successful launch of the anti-cytokine biologist, therapeutic approaches for the treatment of chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease were assocd. with severe side effects.  Although biol. agents have revolutionized the treatment of inflammatory disorders, the high costs and inconvenient dosing regimens would greatly benefit from novel safe and effective orally active inhibitors of tumor necrosis factor (TNF) α and interleukin (IL) 1β.  The clin. benefit of anti-cytokine therapy and the central role of the p38 mitogen-activated protein (MAP) kinase in up-regulation of proinflammatory cytokines such as IL-1β and TNF-α suggest that p38 MAP kinase is a promising target for antiinflammatory therapy.  Since 1993 an immense no. of inhibitors of p38 MAP kinase have been characterized.  To date, aside from the well known pyridinylimidazoles, multiple novel scaffolds have been identified, but only a small no. have advanced into clin. phase II studies, probably due to high toxicity and poor selectivity.  To gain safe drug profiles, high potency, marginal CYP450 (cytochrome P 450) interaction and toxicity, as well as high levels of selectivity would be desirable.  This review will summarize current knowledge on p38 MAP kinase inhibitors and will critically discuss proceedings and strategies toward achieving selectivity and potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1YpMV6vHn37Vg90H21EOLACvtfcHk0lgUN7denSrlJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjK&md5=597b42a2f0a0cb61db7aa0146450796b</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.2174%2F156802609789007363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789007363%26sid%3Dliteratum%253Aachs%26aulast%3DKarcher%26aufirst%3DS.%2BC.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DSuccessful%2520structure-based%2520design%2520of%2520recent%2520p38%2520MAP%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D655%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pettus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span> </span><span class="NLM_article-title">Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006−2008</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F156802608786264245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=18991731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWgtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1452-1467&author=L.+H.+Pettusauthor=R.+P.+Wurz&title=Small+molecule+p38+MAP+kinase+inhibitors+for+the+treatment+of+inflammatory+diseases%3A+novel+structures+and+developments+during+2006%E2%88%922008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006-2008</span></div><div class="casAuthors">Pettus, Liping H.; Wurz, Ryan P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1452-1467</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The p38 mitogen-activated protein (MAP) kinase plays a central role in inflammation.  It has been the subject of extensive efforts in both basic research and drug discovery for the treatment of inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis, where aberrant cytokine signaling is the driver of the disease.  This article reviews the patent and journal publication activities during 2006-2008 describing novel small mol. p38α inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKQu_KXhrvHrVg90H21EOLACvtfcHk0lgUN7denSrlJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWgtrfJ&md5=65fa3e72c52323dcd378421dd577a1b4</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.2174%2F156802608786264245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608786264245%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26atitle%3DSmall%2520molecule%2520p38%2520MAP%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%253A%2520novel%2520structures%2520and%2520developments%2520during%25202006%25E2%2588%25922008%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1452%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, T.</span><span> </span><span class="NLM_article-title">Pathway to the clinic: Inhibition of p38 MAP kinase. A review of ten chemotypes selected for development</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1017-1029&author=D.+M.+Goldsteinauthor=T.+Gabriel&title=Pathway+to+the+clinic%3A+Inhibition+of+p38+MAP+kinase.+A+review+of+ten+chemotypes+selected+for+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Pathway to the clinic: Inhibition of P38 MAP kinase. A review of ten chemotypes selected for development</span></div><div class="casAuthors">Goldstein, David M.; Gabriel, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  P38 mitogen activated protein (MAP) kinase remains the most compelling therapeutic target for oral drug intervention for a wide range of autoimmune disorders based on the central role this enzyme plays in inflammatory cell signaling.  Efforts to discover inhibitors of p38 suitable for clin. investigation have continued to escalate in part due to the incredible diversity of unique chemotypes reported to inhibit the enzyme.  Since 1993, at least seventeen p38 inhibitors have been reported to have entered into clin. trials.  Next generation inhibitors have been disclosed with improved potency for p38 and enhanced selectivity vs. other protein kinases.  Over the last three years, there have been multiple reports of cytokine suppression in humans following oral administration of p38 inhibitors.  These results, in addn. to proof of concept studies in rheumatoid patients, have established p38 inhibition as an avenue for the future management of pro-inflammatory cytokine based diseases.  This review describes the discovery at Roche of novel p38 inhibitors which have advanced into clin. trials.  The pharmacol. of the Roche compds. is then compared with eight chem. distinct p38 inhibitors known to have entered clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrve3HIFcxtSrVg90H21EOLACvtfcHk0lhFH2TPhAAT4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK&md5=a4acd0c62b42c1f2eb4dafd8f8b60306</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.2174%2F1568026054985939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985939%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGabriel%26aufirst%3DT.%26atitle%3DPathway%2520to%2520the%2520clinic%253A%2520Inhibition%2520of%2520p38%2520MAP%2520kinase.%2520A%2520review%2520of%2520ten%2520chemotypes%2520selected%2520for%2520development%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1017%26epage%3D1029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span> </span><span class="NLM_article-title">Structural comparison of p38 inhibitor−protein complexes: a review of recent p38 inhibitors having unique binding interactions</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1005-1016&author=S.+T.+Wrobleskiauthor=A.+M.+Doweyko&title=Structural+comparison+of+p38+inhibitor%E2%88%92protein+complexes%3A+a+review+of+recent+p38+inhibitors+having+unique+binding+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Structural comparison of p38 inhibitor-protein complexes: A review of recent p38 inhibitors having unique binding interactions</span></div><div class="casAuthors">Wrobleski, Stephen T.; Doweyko, Arthur M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1005-1016</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Small mol. inhibition of protein kinases in the treatment of significant diseases such as cancer, Alzheimer's disease, diabetes, and rheumatoid arthritis has attracted significant attention over the past two decades and has clearly become one of the most significant challenges for drug discovery in the 21st century.  While the recent identification of 518 different kinases in the human genome has offered a wealth of opportunities for drug intervention in the treatment of these diseases, it has also created a daunting challenge with respect to selective kinase inhibition as a viable strategy in target-based drug design.  Over the past decade, the design and development of a small mol. that selectively inhibits the p38 mitogen activated protein (MAP) kinase has clearly emerged as one.  This review will focus on the comparison of the x-ray crystal structures and binding models of the most recent p38 inhibitor-enzyme complexes and the identification of the structural elements and interactions that may be important in providing inhibitor potency and selectivity toward the p38 MAP kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTUmGGtEwCPbVg90H21EOLACvtfcHk0lhFH2TPhAAT4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbJ&md5=5add0d628abece6a2e15675e575cd97e</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.2174%2F1568026054985894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985894%26sid%3Dliteratum%253Aachs%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26atitle%3DStructural%2520comparison%2520of%2520p38%2520inhibitor%25E2%2588%2592protein%2520complexes%253A%2520a%2520review%2520of%2520recent%2520p38%2520inhibitors%2520having%2520unique%2520binding%2520interactions%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1005%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Natarajan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. B.</span><span> </span><span class="NLM_article-title">P38 MAP kinase inhibitors: Evolution of imidazole-based and pyrido-pyrimidin-2-one lead classes</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=987-1003&author=S.+R.+Natarajanauthor=J.+B.+Doherty&title=P38+MAP+kinase+inhibitors%3A+Evolution+of+imidazole-based+and+pyrido-pyrimidin-2-one+lead+classes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5f</span><div class="casTitle"><span class="NLM_cas:atitle">P38 MAP kinase inhibitors: Evolution of imidazole-based and pyrido-pyrimidin-2-one lead classes</span></div><div class="casAuthors">Natarajan, Swaminathan R.; Doherty, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">987-1003</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The initial disclosure of tri-substituted imidazole-based drug mols. such as 1 for inhibition of p38 MAP kinase by SmithKline Beecham (SB) sparked an effort in this area at Merck and other pharmaceutical research establishments.  Although analogs in this class have shown good inhibitory properties against p38 MAP kinase, their selectivity profile were modest and left much room for improvement.  Attempts to discover newer compds. with improved selectivity over the prototypical SB compd. 203580 (1), led to the discovery of a new sub-class of p38 inhibitors typified by compd. 18 at Merck.  Although this benchmark compd. was potent, highly selective and orally efficacious it was burdened with compd. related adverse effects in dogs that has delayed further development.  In 1999, a new class of p38 inhibitors represented by clin. candidate VX-745 (26), was disclosed by Vertex Pharmaceuticals.  This compd. displayed unprecedented selectivity due to its unique mode of binding to the active site in p38 MAP kinase.  Inspired by the exquisite selectivity profile of VX-745 [26] a scaffold re-design was initiated at Merck which resulted in the discovery of the quinazolinone, pyrimido-pyrimidone, pyrido-pyrimidone, quinolinone and naphthyridinone based p38 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt25e5Z6oNSLVg90H21EOLACvtfcHk0lhFH2TPhAAT4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbI&md5=37aceda30385bb1a23ce8355d65348f4</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.2174%2F1568026054985876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985876%26sid%3Dliteratum%253Aachs%26aulast%3DNatarajan%26aufirst%3DS.%2BR.%26aulast%3DDoherty%26aufirst%3DJ.%2BB.%26atitle%3DP38%2520MAP%2520kinase%2520inhibitors%253A%2520Evolution%2520of%2520imidazole-based%2520and%2520pyrido-pyrimidin-2-one%2520lead%2520classes%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D987%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Hynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Small molecule p38 inhibitors: novel structural features and advances from 2002−2005</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=967-985&author=J.+Hynesauthor=K.+Leftheris&title=Small+molecule+p38+inhibitors%3A+novel+structural+features+and+advances+from+2002%E2%88%922005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5g</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule p38 inhibitors: Novel structural features and advances from 2002-2005</span></div><div class="casAuthors">Hynes, John, Jr.; Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">967-985</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The discovery and development of selective, efficacious, and safe small mol. p38 mitogen-activated protein kinase inhibitors for the treatment of inflammatory diseases remains the focus of many pharmaceutical research programs.  Advances in small mol. p38 inhibitor design in potency and oral efficacy have been accelerated with the large no. of available inhibitor-enzyme x-ray structures.  These advances have allowed for the discovery of diverse sets of inhibitors with the opportunity to map inhibitor interactions and design selective inhibitors.  This review covers recent compd. disclosures in the patent and published literature over the last three years.  Many disclosures represent new chemotypes as well as creative modifications of known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXWto2uZjwJrVg90H21EOLACvtfcHk0lgudoaVE1acNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP&md5=e8a3966e7f270b6171b95f306d3fc341</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.2174%2F1568026054985920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985920%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DSmall%2520molecule%2520p38%2520inhibitors%253A%2520novel%2520structural%2520features%2520and%2520advances%2520from%25202002%25E2%2588%25922005%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D967%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Diller, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, A.</span><span> </span><span class="NLM_article-title">The discovery of novel chemotypes of p38 kinase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=953-965&author=D.+J.+Dillerauthor=T.+H.+Linauthor=A.+Metzger&title=The+discovery+of+novel+chemotypes+of+p38+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5hR"><div class="casContent"><span class="casTitleNuber">5h</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of novel chemotypes of p38 kinase inhibitors</span></div><div class="casAuthors">Diller, David J.; Lin, Tsung H.; Metzger, Axel</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">953-965</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the late 1970s and the early 1980s the initial p38 chemotype, the triaryl imidazoles, was discovered as an off-target effect during the development of cyclooxygenase and 5-lipoxygenase inhibitors long before the identity of the p38 kinase was known.  During the last 10 years a no. of novel p38 chemotypes were discovered via high throughput screening.  More recently, the first series of p38 inhibitors discovered by x-ray crystallog. and virtual screening was announced.  Finally, throughout the life span of p38 drug discovery programs significant medicinal chem. effort has continually been placed on the design of new inhibitors from known chemotypes using mol. modeling, protein crystallog., hybrid design and simply sound intuition.  Indeed, the search for p38 kinase inhibitors offers an excellent historical perspective as to how technol. changes that have taken place in the pharmaceutical industry over the last decade, have affected the ways in which new leads are discovered and advanced.  It is the intent of this review to highlight the discoveries of novel p38 chemotypes, emphasizing where possible the key technologies used in the discoveries and the knowledge gained from each discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdKiiRZXrOlbVg90H21EOLACvtfcHk0lgudoaVE1acNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbO&md5=18943c61fb02525de469d293d1451e71</span></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=10.2174%2F1568026054985948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985948%26sid%3Dliteratum%253Aachs%26aulast%3DDiller%26aufirst%3DD.%2BJ.%26aulast%3DLin%26aufirst%3DT.%2BH.%26aulast%3DMetzger%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520novel%2520chemotypes%2520of%2520p38%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D953%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Bolós, J.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of p38 mitogen-activated protein kinase inhibitors</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=857-868&author=J.+Bol%C3%B3s&title=Structure%E2%88%92activity+relationships+of+p38+mitogen-activated+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBol%25C3%25B3s%26aufirst%3DJ.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibitors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D857%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, N.</span><span> </span><span class="NLM_article-title">p38 MAP kinase inhibitors: Mmany are made, but few are chosen</span> <span class="citation_source-journal">Curr. Opin Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=421-430&issue=4&author=C.+Dominguezauthor=D.+A.+Powersauthor=N.+Tamayo&title=p38+MAP+kinase+inhibitors%3A+Mmany+are+made%2C+but+few+are+chosen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DPowers%26aufirst%3DD.%2BA.%26aulast%3DTamayo%26aufirst%3DN.%26atitle%3Dp38%2520MAP%2520kinase%2520inhibitors%253A%2520Mmany%2520are%2520made%252C%2520but%2520few%2520are%2520chosen%26jtitle%3DCurr.%2520Opin%2520Drug%2520Discovery%2520Dev.%26date%3D2005%26volume%3D8%26issue%3D4%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ding, C.</span><span> </span><span class="NLM_article-title">Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1020</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1020-1025&issue=11&author=C.+Ding&title=Drug+evaluation%3A+VX-702%2C+a+MAP+kinase+inhibitor+for+rheumatoid+arthritis+and+acute+coronary+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26atitle%3DDrug%2520evaluation%253A%2520VX-702%252C%2520a%2520MAP%2520kinase%2520inhibitor%2520for%2520rheumatoid%2520arthritis%2520and%2520acute%2520coronary%2520syndrome%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D7%26issue%3D11%26spage%3D1020%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soth, M. J.</span><span> </span><span class="NLM_article-title">Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2353</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9012906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2345-2353&author=D.+M.+Goldsteinauthor=A.+Kuglstatterauthor=Y.+Louauthor=M.+J.+Soth&title=Selective+p38%CE%B1+Inhibitors+Clinically+Evaluated+for+the+Treatment+of+Chronic+Inflammatory+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm9012906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012906%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DSoth%26aufirst%3DM.%2BJ.%26atitle%3DSelective%2520p38%25CE%25B1%2520Inhibitors%2520Clinically%2520Evaluated%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Inflammatory%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2345%26epage%3D2353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabbagh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phippard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suttmann, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Porto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. R.</span><span> </span><span class="NLM_article-title">Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1124%2Fjpet.108.139006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=18776065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=610-619&issue=3&author=R.+J.+Hillauthor=K.+Dabbaghauthor=D.+Phippardauthor=C.+Liauthor=R.+T.+Suttmannauthor=M+Welchauthor=E.+Pappauthor=K.+W.+Songauthor=K.-C.+Changauthor=D.+Leafferauthor=Y.-N.+Kimauthor=R.+T.+Robertsauthor=T.+S.+Zabkaauthor=D.+Audauthor=J.+Dal+Portoauthor=A.+M.+Manningauthor=S.+L.+Pengauthor=D.+M.+Goldsteinauthor=B.+R.+Wong&title=Pamapimod%2C+a+novel+p38+mitogen-activated+protein+kinase+inhibitor%3A+preclinical+analysis+of+efficacy+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity</span></div><div class="casAuthors">Hill, Ronald J.; Dabbagh, Karim; Phippard, Deborah; Li, Ching; Suttmann, Rebecca T.; Welch, Mary; Papp, Eva; Song, Kyung W.; Chang, Kung-ching; Leaffer, David; Kim, Yong-Nam; Roberts, Richard T.; Zabka, Tanja S.; Aud, Dee; Dal Porto, Joseph; Manning, Anthony M.; Peng, Stanford L.; Goldstein, David M.; Wong, Brian R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">610-619</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P38α is a protein kinase that regulates the expression of inflammatory cytokines, suggesting a role in the pathogenesis of diseases such as rheumatoid arthritis (RA) or systemic lupus erythematosus.  Here, we describe the preclin. pharmacol. of pamapimod, a novel p38 mitogen-activated protein kinase inhibitor.  Pamapimod inhibited p38α and p38β enzymic activity, with IC50 values of 0.014±0.002 and 0.48±0.04 μM, resp.  There was no activity against p38δ or p38γ isoforms.  When profiled across 350 kinases, pamapimod bound only to four kinases in addn. to p38.  Cellular potency was assessed using phosphorylation of heat shock protein-27 and c-Jun as selective readouts for p38 and c-Jun NH2-terminal kinase (JNK), resp.  Pamapimod inhibited p38 (IC50, 0.06 μM), but inhibition of JNK was not detected.  Pamapimod also inhibited lipopolysaccharide (LPS)-stimulated tumor necrosis factor (TNF) α prodn. by monocytes, interleukin (IL)-1β prodn. in human whole blood, and spontaneous TNFα prodn. by synovial explants from RA patients.  LPS- and TNFα-stimulated prodn. of TNFα and IL-6 in rodents also was inhibited by pamapimod.  In murine collagen-induced arthritis, pamapimod reduced clin. signs of inflammation and bone loss at 50 mg/kg or greater.  In a rat model of hyperalgesia, pamapimod increased tolerance to pressure in a dose-dependent manner, suggesting an important role of p38 in pain assocd. with inflammation.  Finally, an analog of pamapimod that has equiv. potency and selectivity inhibited renal disease in lupus-prone MRL/lpr mice.  Our study demonstrates that pamapimod is a potent, selective inhibitor of p38α with the ability to inhibit the signs and symptoms of RA and other autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoImm011NnzW7Vg90H21EOLACvtfcHk0lig7PF8eP4llA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtL3F&md5=9311aa6b1a51544ac755d1cc77cdd92f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.139006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.139006%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DDabbagh%26aufirst%3DK.%26aulast%3DPhippard%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSuttmann%26aufirst%3DR.%2BT.%26aulast%3DWelch%26aufirst%3DM%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DSong%26aufirst%3DK.%2BW.%26aulast%3DChang%26aufirst%3DK.-C.%26aulast%3DLeaffer%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DY.-N.%26aulast%3DRoberts%26aufirst%3DR.%2BT.%26aulast%3DZabka%26aufirst%3DT.%2BS.%26aulast%3DAud%26aufirst%3DD.%26aulast%3DDal%2BPorto%26aufirst%3DJ.%26aulast%3DManning%26aufirst%3DA.%2BM.%26aulast%3DPeng%26aufirst%3DS.%2BL.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DWong%26aufirst%3DB.%2BR.%26atitle%3DPamapimod%252C%2520a%2520novel%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibitor%253A%2520preclinical%2520analysis%2520of%2520efficacy%2520and%2520selectivity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26issue%3D3%26spage%3D610%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capolino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroe, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-tert-Butyl-2-<i>p</i>-tolyl-2<i>H</i>-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph-thalen-1-yl]urea (BIRB 796)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">4676</span><span class="NLM_x">–</span> <span class="NLM_lpage">4686</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030121k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4676-4686&issue=22&author=J.+Reganauthor=A.+Capolinoauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=R.+R.+Kroeauthor=J.+Madwedauthor=M.+Moriakauthor=R.+Nelsonauthor=C.+A.+Pargellisauthor=A.+Swinamerauthor=C.+Torcelliniauthor=M.+Tsangauthor=N.+Moss&title=Structure%E2%88%92Activity+Relationships+of+the+p38%CE%B1+MAP+Kinase+Inhibitor+1-%285-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl%29-3-%5B4-%282-morpholin-4-yl-ethoxy%29naph-thalen-1-yl%5Durea+%28BIRB+796%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm030121k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030121k%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DCapolino%26aufirst%3DA.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKroe%26aufirst%3DR.%2BR.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTorcellini%26aufirst%3DC.%26aulast%3DTsang%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DStructure%25E2%2588%2592Activity%2520Relationships%2520of%2520the%2520p38%25CE%25B1%2520MAP%2520Kinase%2520Inhibitor%25201-%25285-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl%2529-3-%255B4-%25282-morpholin-4-yl-ethoxy%2529naph-thalen-1-yl%255Durea%2520%2528BIRB%2520796%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D22%26spage%3D4676%26epage%3D4686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Nikas, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drosos, A. A.</span><span> </span><span class="NLM_article-title">SCIO-469 (Scios Inc.)</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1205-1212&issue=11&author=S.+N.+Nikasauthor=A.+A.+Drosos&title=SCIO-469+%28Scios+Inc.%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNikas%26aufirst%3DS.%2BN.%26aulast%3DDrosos%26aufirst%3DA.%2BA.%26atitle%3DSCIO-469%2520%2528Scios%2520Inc.%2529%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D5%26issue%3D11%26spage%3D1205%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Xing, Li</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadus, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span> </span><span class="NLM_article-title">Structure Bioinformatics-Based Prediction of Exceptional Selectivity of p38 MAP Kinase Inhibitor PH-797804</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6402</span><span class="NLM_x">–</span> <span class="NLM_lpage">6411</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi900655f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6402-6411&author=Li+Xingauthor=H.+S.+Shiehauthor=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+K.+Walkerauthor=B.+Devadasauthor=H.+R.+Hopeauthor=R.+P.+Comptonauthor=J.+F.+Schindlerauthor=J.+L.+Hirschauthor=A.+G.+Bensonauthor=R.+G.+Kurumbailauthor=R.+A.+Stegemanauthor=J.+M.+Williamsauthor=R.+M.+Broadusauthor=Z.+Waldenauthor=J.+B.+Monahan&title=Structure+Bioinformatics-Based+Prediction+of+Exceptional+Selectivity+of+p38+MAP+Kinase+Inhibitor+PH-797804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi900655f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900655f%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DLi%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DCompton%26aufirst%3DR.%2BP.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DBroadus%26aufirst%3DR.%2BM.%26aulast%3DWalden%26aufirst%3DZ.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DStructure%2520Bioinformatics-Based%2520Prediction%2520of%2520Exceptional%2520Selectivity%2520of%2520p38%2520MAP%2520Kinase%2520Inhibitor%2520PH-797804%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D6402%26epage%3D6411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hynes, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokross, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-<i>f</i>][1,2,4]triazine p38α Mitogen-Activated Protein Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4-16&author=J.+Hynesauthor=A.+J.+Dyckmanauthor=S.+Linauthor=S.+Wrobleskiauthor=H.+Wuauthor=K.+M.+Gilloolyauthor=S.+B.+Kannerauthor=H.+Lonialauthor=D.+Looauthor=K.+W.+McIntyreauthor=S.+Pittauthor=D.+R.+Shenauthor=D.+J.+Shusterauthor=X.+Yangauthor=R.+Zhangauthor=K.+Behniaauthor=H.+Zhangauthor=P.+H.+Maratheauthor=A.+M.+Doweykoauthor=J.+S.+Tokarskiauthor=J.+S.+Sackauthor=M.+Pokrossauthor=S.+E.+Kieferauthor=J.+A.+Newittauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Design%2C+Synthesis%2C+and+Anti-inflammatory+Properties+of+Orally+Active+4-%28Phenylamino%29-pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+p38%CE%B1+Mitogen-Activated+Protein+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm7009414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009414%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DWrobleski%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DLonial%26aufirst%3DH.%26aulast%3DLoo%26aufirst%3DD.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DPokross%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Anti-inflammatory%2520Properties%2520of%2520Orally%2520Active%25204-%2528Phenylamino%2529-pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520p38%25CE%25B1%2520Mitogen-Activated%2520Protein%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredup, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of new pyrrolo[2,1-<i>f</i>][1,2,4]triazines as potent p38α MAP kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2739</span><span class="NLM_x">–</span> <span class="NLM_lpage">2744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2739-2744&author=S.+T.+Wrobleskiauthor=S.+Linauthor=J.+Hynesauthor=H.+Wuauthor=S.+Pittauthor=D.+R.+Shenauthor=R.+Zhangauthor=K.+M.+Gilloolyauthor=D.+J.+Shusterauthor=K.+W.+McIntyreauthor=A.+M.+Doweykoauthor=K.+F.+Kishauthor=J.+A.+Tredupauthor=G.+J.+Dukeauthor=J.+S.+Sackauthor=M.+McKinnonauthor=J.+Doddauthor=J.+C.+Barrishauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Synthesis+and+SAR+of+new+pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+as+potent+p38%CE%B1+MAP+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DKish%26aufirst%3DK.%2BF.%26aulast%3DTredup%26aufirst%3DJ.%2BA.%26aulast%3DDuke%26aufirst%3DG.%2BJ.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520new%2520pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520as%2520potent%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2739%26epage%3D2744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Cambanis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobre, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niculescu-Duvaz, I.</span><span> </span><span class="NLM_article-title">Potential anticancer agents. V. Aromatic nitrogen mustards related to 3-[<i>N</i>,<i>N</i>-bis(2-chloroethyl)amino]-4-methylbenzoic acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00301a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1969&pages=161-164&author=A.+Cambanisauthor=V.+Dobreauthor=I.+Niculescu-Duvaz&title=Potential+anticancer+agents.+V.+Aromatic+nitrogen+mustards+related+to+3-%5BN%2CN-bis%282-chloroethyl%29amino%5D-4-methylbenzoic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm00301a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00301a043%26sid%3Dliteratum%253Aachs%26aulast%3DCambanis%26aufirst%3DA.%26aulast%3DDobre%26aufirst%3DV.%26aulast%3DNiculescu-Duvaz%26aufirst%3DI.%26atitle%3DPotential%2520anticancer%2520agents.%2520V.%2520Aromatic%2520nitrogen%2520mustards%2520related%2520to%25203-%255BN%252CN-bis%25282-chloroethyl%2529amino%255D-4-methylbenzoic%2520acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1969%26volume%3D12%26spage%3D161%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">PDB deposition number: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MVM">3MVM</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d','cit1e','cit1f'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e','cit2f','cit2g','cit2h','cit2i','cit2j'],'ref3':['cit3a','cit3b','cit3c','cit3d'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e','cit5f','cit5g','cit5h','cit5i','cit5j'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 41 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niklas M.  Walter</span>, <span class="hlFld-ContribAuthor ">Heike K.  Wentsch</span>, <span class="hlFld-ContribAuthor ">Mike  Bührmann</span>, <span class="hlFld-ContribAuthor ">Silke M.  Bauer</span>, <span class="hlFld-ContribAuthor ">Eva  Döring</span>, <span class="hlFld-ContribAuthor ">Svenja  Mayer-Wrangowski</span>, <span class="hlFld-ContribAuthor ">Adrian  Sievers-Engler</span>, <span class="hlFld-ContribAuthor ">Nicole  Willemsen-Seegers</span>, <span class="hlFld-ContribAuthor ">Guido  Zaman</span>, <span class="hlFld-ContribAuthor ">Rogier  Buijsman</span>, <span class="hlFld-ContribAuthor ">Michael  Lämmerhofer</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>, and <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Type I1/2 p38α MAP Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged Target Residence Time by Interfering with the R-Spine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (19)
                                     , 8027-8054. <a href="https://doi.org/10.1021/acs.jmedchem.7b00745" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00745%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BType%252BI1%25252F2%252Bp38%2525CE%2525B1%252BMAP%252BKinase%252BInhibitors%252Bwith%252BExcellent%252BSelectivity%25252C%252BHigh%252BPotency%25252C%252Band%252BProlonged%252BTarget%252BResidence%252BTime%252Bby%252BInterfering%252Bwith%252Bthe%252BR-Spine%26aulast%3DWalter%26aufirst%3DNiklas%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19052017%26date%3D07092017%26date%3D12102017%26date%3D23082017%26volume%3D60%26issue%3D19%26spage%3D8027%26epage%3D8054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>  . </span><span class="cited-content_cbyCitation_article-title">The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8712-8756. <a href="https://doi.org/10.1021/acs.jmedchem.6b00472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252B%2525E2%252580%25259CCyclopropyl%252BFragment%2525E2%252580%25259D%252Bis%252Ba%252BVersatile%252BPlayer%252Bthat%252BFrequently%252BAppears%252Bin%252BPreclinical%25252FClinical%252BDrug%252BMolecules%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D30032016%26date%3D30062016%26date%3D13102016%26date%3D14062016%26volume%3D59%26issue%3D19%26spage%3D8712%26epage%3D8756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mario  Fiore</span>, <span class="hlFld-ContribAuthor ">Stefano  Forli</span>, and <span class="hlFld-ContribAuthor ">Fabrizio  Manetti</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 3609-3634. <a href="https://doi.org/10.1021/acs.jmedchem.5b01457" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01457%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BMitogen-Activated%252BProtein%252BKinase-Activated%252BProtein%252BKinase%252B2%252B%252528MAPKAPK2%25252C%252BMK2%252529%25253A%252BMedicinal%252BChemistry%252BEfforts%252BTo%252BLead%252BSmall%252BMolecule%252BInhibitors%252Bto%252BClinical%252BTrials%26aulast%3DFiore%26aufirst%3DMario%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D18092015%26date%3D09112015%26date%3D28042016%26date%3D26102015%26volume%3D59%26issue%3D8%26spage%3D3609%26epage%3D3634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunjian  Liu</span>, <span class="hlFld-ContribAuthor ">James  Lin</span>, <span class="hlFld-ContribAuthor ">John  Hynes</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>, <span class="hlFld-ContribAuthor ">Shuqun  Lin</span>, <span class="hlFld-ContribAuthor ">T. G. Murali  Dhar</span>, <span class="hlFld-ContribAuthor ">Vivekananda M.  Vrudhula</span>, <span class="hlFld-ContribAuthor ">Jung-Hui  Sun</span>, <span class="hlFld-ContribAuthor ">Sam  Chao</span>, <span class="hlFld-ContribAuthor ">Rulin  Zhao</span>, <span class="hlFld-ContribAuthor ">Bei  Wang</span>, <span class="hlFld-ContribAuthor ">Bang-Chi  Chen</span>, <span class="hlFld-ContribAuthor ">Gerry  Everlof</span>, <span class="hlFld-ContribAuthor ">Christoph  Gesenberg</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Taylor</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, and <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (19)
                                     , 7775-7784. <a href="https://doi.org/10.1021/acs.jmedchem.5b00839" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00839</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00839%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528%2525284-%2525285-%252528Cyclopropylcarbamoyl%252529-2-methylphenylamino%252529-5-methylpyrrolo%25255B1%25252C2-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine-6-carbonyl%252529%252528propyl%252529carbamoyloxy%252529methyl-2-%2525284-%252528phosphonooxy%252529phenyl%252529acetate%2525C2%2525A0%252528BMS-751324%252529%25252C%252Ba%252BClinical%252BProdrug%252Bof%252Bp38%2525CE%2525B1%252BMAP%252BKinase%252BInhibitor%26aulast%3DLiu%26aufirst%3DChunjian%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D01062015%26date%3D22092015%26date%3D08102015%26date%3D11092015%26volume%3D58%26issue%3D19%26spage%3D7775%26epage%3D7784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ángela  González-de-Castro</span>, <span class="hlFld-ContribAuthor ">Howard  Broughton</span>, <span class="hlFld-ContribAuthor ">José A.  Martínez-Pérez</span>, and <span class="hlFld-ContribAuthor ">Juan F.  Espinosa</span>  . </span><span class="cited-content_cbyCitation_article-title">Conformational Features of Secondary N-Cyclopropyl Amides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (8)
                                     , 3914-3920. <a href="https://doi.org/10.1021/acs.joc.5b00236" title="DOI URL">https://doi.org/10.1021/acs.joc.5b00236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b00236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b00236%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConformational%252BFeatures%252Bof%252BSecondary%252BN-Cyclopropyl%252BAmides%26aulast%3DGonz%25C3%25A1lez-de-Castro%26aufirst%3D%25C3%2581ngela%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D01022015%26date%3D08042015%26date%3D17042015%26date%3D24032015%26volume%3D80%26issue%3D8%26spage%3D3914%26epage%3D3920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Unzue</span>, <span class="hlFld-ContribAuthor ">Jing  Dong</span>, <span class="hlFld-ContribAuthor ">Karine  Lafleur</span>, <span class="hlFld-ContribAuthor ">Hongtao  Zhao</span>, <span class="hlFld-ContribAuthor ">Emilie  Frugier</span>, <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>, and <span class="hlFld-ContribAuthor ">Cristina  Nevado</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrrolo[3,2-b]quinoxaline Derivatives as Types I1/2 and II Eph Tyrosine Kinase Inhibitors: Structure-Based Design, Synthesis, and in Vivo Validation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (15)
                                     , 6834-6844. <a href="https://doi.org/10.1021/jm5009242" title="DOI URL">https://doi.org/10.1021/jm5009242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5009242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5009242%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrrolo%25255B3%25252C2-b%25255Dquinoxaline%252BDerivatives%252Bas%252BTypes%252BI1%25252F2%252Band%252BII%252BEph%252BTyrosine%252BKinase%252BInhibitors%25253A%252BStructure-Based%252BDesign%25252C%252BSynthesis%25252C%252Band%252Bin%252BVivo%252BValidation%26aulast%3DUnzue%26aufirst%3DAndrea%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18062014%26date%3D30072014%26date%3D14082014%26volume%3D57%26issue%3D15%26spage%3D6834%26epage%3D6844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xitao  Li</span>, <span class="hlFld-ContribAuthor ">Yingying  Zuo</span>, <span class="hlFld-ContribAuthor ">Guanghui  Tang</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueying  Wang</span>, <span class="hlFld-ContribAuthor ">Tianlin  Guo</span>, <span class="hlFld-ContribAuthor ">Mengying  Xia</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>, and <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 2,5-Diaminopyrimidine Covalent Irreversible Inhibitors of Bruton’s Tyrosine Kinase with in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5112-5128. <a href="https://doi.org/10.1021/jm4017762" title="DOI URL">https://doi.org/10.1021/jm4017762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4017762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4017762%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B2%25252C5-Diaminopyrimidine%252BCovalent%252BIrreversible%252BInhibitors%252Bof%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252Bwith%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DLi%26aufirst%3DXitao%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16112013%26date%3D10062014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5112%26epage%3D5128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toru  Asano</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Chiyoshi  Kasahara</span>, <span class="hlFld-ContribAuthor ">Hirokazu  Kubota</span>, <span class="hlFld-ContribAuthor ">Toru  Kontani</span>, <span class="hlFld-ContribAuthor ">Yu  Harayama</span>, <span class="hlFld-ContribAuthor ">Kazuki  Ohno</span>, <span class="hlFld-ContribAuthor ">Hidekazu  Mizuhara</span>, <span class="hlFld-ContribAuthor ">Masaharu  Yokomoto</span>, <span class="hlFld-ContribAuthor ">Keiji  Misumi</span>, <span class="hlFld-ContribAuthor ">Tomohiko  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Mitsuaki  Ohta</span>, and <span class="hlFld-ContribAuthor ">Makoto  Takeuchi.</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification, Synthesis, and Biological Evaluation of 6-[(6R)-2-(4-Fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a Potent p38 MAP Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7772-7785. <a href="https://doi.org/10.1021/jm3008008" title="DOI URL">https://doi.org/10.1021/jm3008008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3008008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3008008%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252B6-%25255B%2525286R%252529-2-%2525284-Fluorophenyl%252529-6-%252528hydroxymethyl%252529-4%25252C5%25252C6%25252C7-tetrahydropyrazolo%25255B1%25252C5-a%25255Dpyrimidin-3-yl%25255D-2-%2525282-methylphenyl%252529pyridazin-3%2525282H%252529-one%252B%252528AS1940477%252529%25252C%252Ba%252BPotent%252Bp38%252BMAP%252BKinase%252BInhibitor%26aulast%3DAsano%26aufirst%3DToru%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07062012%26date%3D31082012%26date%3D13092012%26date%3D20082012%26volume%3D55%26issue%3D17%26spage%3D7772%26epage%3D7785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathrin E.  Martz</span>, <span class="hlFld-ContribAuthor ">Angelika  Dorn</span>, <span class="hlFld-ContribAuthor ">Benjamin  Baur</span>, <span class="hlFld-ContribAuthor ">Verena  Schattel</span>, <span class="hlFld-ContribAuthor ">Márcia I.  Goettert</span>, <span class="hlFld-ContribAuthor ">Svenja C.  Mayer-Wrangowski</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>, and <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting the Hinge Glycine Flip and the Activation Loop: Novel Approach to Potent p38α Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7862-7874. <a href="https://doi.org/10.1021/jm300951u" title="DOI URL">https://doi.org/10.1021/jm300951u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300951u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300951u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252BHinge%252BGlycine%252BFlip%252Band%252Bthe%252BActivation%252BLoop%25253A%252BNovel%252BApproach%252Bto%252BPotent%252Bp38%2525CE%2525B1%252BInhibitors%26aulast%3DMartz%26aufirst%3DKathrin%2BE.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D04072012%26date%3D29082012%26date%3D13092012%26date%3D16082012%26volume%3D55%26issue%3D17%26spage%3D7862%26epage%3D7874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eslam M.H.  Ali</span>, <span class="hlFld-ContribAuthor ">Mohammed S.  Abdel-Maksoud</span>, <span class="hlFld-ContribAuthor ">Rasha Mohamed  Hassan</span>, <span class="hlFld-ContribAuthor ">Karim I.  Mersal</span>, <span class="hlFld-ContribAuthor ">Usama M.  Ammar</span>, <span class="hlFld-ContribAuthor ">Choi  Se-In</span>, <span class="hlFld-ContribAuthor ">Han  He-Soo</span>, <span class="hlFld-ContribAuthor ">Hee-Kwon  Kim</span>, <span class="hlFld-ContribAuthor ">Anna  Lee</span>, <span class="hlFld-ContribAuthor ">Kyung-Tae  Lee</span>, <span class="hlFld-ContribAuthor ">Chang-Hyun  Oh</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>31 </em>, 115969. <a href="https://doi.org/10.1016/j.bmc.2020.115969" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115969%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banti-inflammatory%252Bactivity%252Bof%252Bimidazol-5-yl%252Bpyridine%252Bderivatives%252Bas%252Bp38%2525CE%2525B1%25252FMAPK14%252Binhibitor%26aulast%3DAli%26aufirst%3DEslam%2BM.H.%26date%3D2021%26volume%3D31%26spage%3D115969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jesurajan  Jebamani</span>, <span class="hlFld-ContribAuthor ">Shubha  Pranesh</span>, <span class="hlFld-ContribAuthor ">Jayadev  Shivalingappa</span>, <span class="hlFld-ContribAuthor ">Manjunatha  Narayanarao</span>, <span class="hlFld-ContribAuthor ">Mussuvir  Pasha</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activities of novel pyrrolo[1,2-d][1,2,4]triazin-1(2H)-one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2021,</strong> <em> </em>, 1-14. <a href="https://doi.org/10.1080/00397911.2020.1859117" title="DOI URL">https://doi.org/10.1080/00397911.2020.1859117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2020.1859117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2020.1859117%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bnovel%252Bpyrrolo%25255B1%25252C2-d%25255D%25255B1%25252C2%25252C4%25255Dtriazin-1%2525282H%252529-one%252Bderivatives%26aulast%3DJebamani%26aufirst%3DJesurajan%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.M.  Ivanov</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00062-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00062-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00062-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00062-7%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C2%25252C4-Triazines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DIvanov%26aufirst%3DS.M.%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3Dvol.%252010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Lalli</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems With One Bridgehead (Ring Junction) Nitrogen Atom: Two Extra Heteroatoms 0:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14939-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14939-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14939-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14939-X%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%252BWith%252BOne%252BBridgehead%252B%252528Ring%252BJunction%252529%252BNitrogen%252BAtom%25253A%252BTwo%252BExtra%252BHeteroatoms%252B0%25253A2%26aulast%3DLalli%26aufirst%3DClaudia%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Kaieda</span>, <span class="hlFld-ContribAuthor ">Masashi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Hiromi  Fukuda</span>, <span class="hlFld-ContribAuthor ">Rei  Okamoto</span>, <span class="hlFld-ContribAuthor ">Shinji  Morimoto</span>, <span class="hlFld-ContribAuthor ">Masayuki  Gotoh</span>, <span class="hlFld-ContribAuthor ">Takahiro  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Yuri  Hori</span>, <span class="hlFld-ContribAuthor ">Satoko  Unno</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Toshimasa  Tanaka</span>, <span class="hlFld-ContribAuthor ">Sachiko  Itono</span>, <span class="hlFld-ContribAuthor ">Terufumi  Takagi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Sugimoto</span>, <span class="hlFld-ContribAuthor ">Kengo  Okada</span>, <span class="hlFld-ContribAuthor ">Weston  Lane</span>, <span class="hlFld-ContribAuthor ">Bi‐Ching  Sang</span>, <span class="hlFld-ContribAuthor ">Kumar  Saikatendu</span>, <span class="hlFld-ContribAuthor ">Shinichiro  Matsunaga</span>, <span class="hlFld-ContribAuthor ">Seiji  Miwatashi</span>. </span><span class="cited-content_cbyCitation_article-title">Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐
              b
              ]Pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 2. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (24)
                                     , 2093-2101. <a href="https://doi.org/10.1002/cmdc.201900373" title="DOI URL">https://doi.org/10.1002/cmdc.201900373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900373%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructure%2525E2%252580%252590Based%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BImidazo%25255B4%25252C5%2525E2%252580%252590%252Bb%252B%25255DPyridin%2525E2%252580%2525902%2525E2%252580%252590one%2525E2%252580%252590Based%252Bp38%252BMAP%252BKinase%252BInhibitors%25253A%252BPart%2525E2%252580%2525852%26aulast%3DKaieda%26aufirst%3DAkira%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D24%26spage%3D2093%26epage%3D2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Astolfi</span>, <span class="hlFld-ContribAuthor ">Mark  Kudolo</span>, <span class="hlFld-ContribAuthor ">Jose  Brea</span>, <span class="hlFld-ContribAuthor ">Giorgia  Manni</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Manfroni</span>, <span class="hlFld-ContribAuthor ">Deborah  Palazzotti</span>, <span class="hlFld-ContribAuthor ">Stefano  Sabatini</span>, <span class="hlFld-ContribAuthor ">Federica  Cecchetti</span>, <span class="hlFld-ContribAuthor ">Tommaso  Felicetti</span>, <span class="hlFld-ContribAuthor ">Rolando  Cannalire</span>, <span class="hlFld-ContribAuthor ">Serena  Massari</span>, <span class="hlFld-ContribAuthor ">Oriana  Tabarrini</span>, <span class="hlFld-ContribAuthor ">Maria Isabel  Loza</span>, <span class="hlFld-ContribAuthor ">Francesca  Fallarino</span>, <span class="hlFld-ContribAuthor ">Violetta  Cecchetti</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Maria Letizia  Barreca</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111624. <a href="https://doi.org/10.1016/j.ejmech.2019.111624" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111624%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Bp38%2525CE%2525B1%252BMAPK%252Binhibitors%252Bthrough%252Ba%252Bfunnel%252Blike%252Bworkflow%252Bcombining%252Bin%252Bsilico%252Bscreening%252Band%252Bin%2525C2%2525A0vitro%252Bvalidation%26aulast%3DAstolfi%26aufirst%3DAndrea%26date%3D2019%26volume%3D182%26spage%3D111624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Kaieda</span>, <span class="hlFld-ContribAuthor ">Masashi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Hiromi  Fukuda</span>, <span class="hlFld-ContribAuthor ">Rei  Okamoto</span>, <span class="hlFld-ContribAuthor ">Shinji  Morimoto</span>, <span class="hlFld-ContribAuthor ">Masayuki  Gotoh</span>, <span class="hlFld-ContribAuthor ">Takahiro  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Yuri  Hori</span>, <span class="hlFld-ContribAuthor ">Satoko  Unno</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Toshimasa  Tanaka</span>, <span class="hlFld-ContribAuthor ">Sachiko  Itono</span>, <span class="hlFld-ContribAuthor ">Terufumi  Takagi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Sugimoto</span>, <span class="hlFld-ContribAuthor ">Kengo  Okada</span>, <span class="hlFld-ContribAuthor ">Gyorgy  Snell</span>, <span class="hlFld-ContribAuthor ">Ryan  Bertsch</span>, <span class="hlFld-ContribAuthor ">Jasmine  Nguyen</span>, <span class="hlFld-ContribAuthor ">Bi‐Ching  Sang</span>, <span class="hlFld-ContribAuthor ">Seiji  Miwatashi</span>. </span><span class="cited-content_cbyCitation_article-title">Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐
              b
              ]pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 1. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (10)
                                     , 1022-1030. <a href="https://doi.org/10.1002/cmdc.201900129" title="DOI URL">https://doi.org/10.1002/cmdc.201900129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900129%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructure%2525E2%252580%252590Based%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BImidazo%25255B4%25252C5%2525E2%252580%252590%252Bb%252B%25255Dpyridin%2525E2%252580%2525902%2525E2%252580%252590one%2525E2%252580%252590Based%252Bp38%252BMAP%252BKinase%252BInhibitors%25253A%252BPart%252B1%26aulast%3DKaieda%26aufirst%3DAkira%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D10%26spage%3D1022%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Marín-Ocampo</span>, <span class="hlFld-ContribAuthor ">Luz Angela  Veloza</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Abonia</span>, <span class="hlFld-ContribAuthor ">Juan C.  Sepúlveda-Arias</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-inflammatory activity of triazine derivatives: A systematic review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 435-447. <a href="https://doi.org/10.1016/j.ejmech.2018.11.027" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnti-inflammatory%252Bactivity%252Bof%252Btriazine%252Bderivatives%25253A%252BA%252Bsystematic%252Breview%26aulast%3DMar%25C3%25ADn-Ocampo%26aufirst%3DLaura%26date%3D2019%26volume%3D162%26spage%3D435%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Long-Chih  Hwang</span>, <span class="hlFld-ContribAuthor ">Shiun-Yau  Yang</span>, <span class="hlFld-ContribAuthor ">Chung-Lin  Chuang</span>, <span class="hlFld-ContribAuthor ">Gene-Hsiang  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">An Optimized Synthesis, Molecular Structure and Characterization of Benzylic Derivatives of 1,2,4-Triazin-3,5(2H,4H)-dione. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (11)
                                     , 1924. <a href="https://doi.org/10.3390/molecules22111924" title="DOI URL">https://doi.org/10.3390/molecules22111924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22111924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22111924%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAn%252BOptimized%252BSynthesis%25252C%252BMolecular%252BStructure%252Band%252BCharacterization%252Bof%252BBenzylic%252BDerivatives%252Bof%252B1%25252C2%25252C4-Triazin-3%25252C5%2525282H%25252C4H%252529-dione%26aulast%3DHwang%26aufirst%3DLong-Chih%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D11%26spage%3D1924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramkumar  Menon</span>, <span class="hlFld-ContribAuthor ">John  Papaconstantinou</span>. </span><span class="cited-content_cbyCitation_article-title">p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2016,</strong> <em>20 </em>
                                    (12)
                                     , 1397-1412. <a href="https://doi.org/10.1080/14728222.2016.1216980" title="DOI URL">https://doi.org/10.1080/14728222.2016.1216980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2016.1216980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2016.1216980%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3Dp38%252BMitogen%252Bactivated%252Bprotein%252Bkinase%252B%252528MAPK%252529%25253A%252Ba%252Bnew%252Btherapeutic%252Btarget%252Bfor%252Breducing%252Bthe%252Brisk%252Bof%252Badverse%252Bpregnancy%252Boutcomes%26aulast%3DMenon%26aufirst%3DRamkumar%26date%3D2016%26date%3D2016%26volume%3D20%26issue%3D12%26spage%3D1397%26epage%3D1412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beata  Żołnowska</span>, <span class="hlFld-ContribAuthor ">Jarosław  Sławiński</span>, <span class="hlFld-ContribAuthor ">Aneta  Pogorzelska</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Szafrański</span>, <span class="hlFld-ContribAuthor ">Anna  Kawiak</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Stasiłojć</span>, <span class="hlFld-ContribAuthor ">Mariusz  Belka</span>, <span class="hlFld-ContribAuthor ">Szymon  Ulenberg</span>, <span class="hlFld-ContribAuthor ">Tomasz  Bączek</span>, <span class="hlFld-ContribAuthor ">Jarosław  Chojnacki</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 5-Substituted 2-(Aylmethylthio)-4-chloro-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides: Synthesis, Molecular Structure, Anticancer Activity, Apoptosis-Inducing Activity and Metabolic Stability. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (6)
                                     , 808. <a href="https://doi.org/10.3390/molecules21060808" title="DOI URL">https://doi.org/10.3390/molecules21060808</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21060808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21060808%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNovel%252B5-Substituted%252B2-%252528Aylmethylthio%252529-4-chloro-N-%2525285-aryl-1%25252C2%25252C4-triazin-3-yl%252529benzenesulfonamides%25253A%252BSynthesis%25252C%252BMolecular%252BStructure%25252C%252BAnticancer%252BActivity%25252C%252BApoptosis-Inducing%252BActivity%252Band%252BMetabolic%252BStability%26aulast%3D%25C5%25BBo%25C5%2582nowska%26aufirst%3DBeata%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D6%26spage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amany M.  Ghanim</span>, <span class="hlFld-ContribAuthor ">David W.  Knight</span>, <span class="hlFld-ContribAuthor ">Nermine A.  Osman</span>, <span class="hlFld-ContribAuthor ">Hanan A.  Abdel-Fattah</span>, <span class="hlFld-ContribAuthor ">Azza M.  Kadry</span>. </span><span class="cited-content_cbyCitation_article-title">New methods for the selective alkylation of 3-thioxo-1,2,4-triazin-5-ones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (21)
                                     , 2215-2218. <a href="https://doi.org/10.1016/j.tetlet.2016.03.065" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.03.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.03.065%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DNew%252Bmethods%252Bfor%252Bthe%252Bselective%252Balkylation%252Bof%252B3-thioxo-1%25252C2%25252C4-triazin-5-ones%26aulast%3DGhanim%26aufirst%3DAmany%2BM.%26date%3D2016%26volume%3D57%26issue%3D21%26spage%3D2215%26epage%3D2218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Unzue</span>, <span class="hlFld-ContribAuthor ">Karine  Lafleur</span>, <span class="hlFld-ContribAuthor ">Hongtao  Zhao</span>, <span class="hlFld-ContribAuthor ">Ting  Zhou</span>, <span class="hlFld-ContribAuthor ">Jing  Dong</span>, <span class="hlFld-ContribAuthor ">Peter  Kolb</span>, <span class="hlFld-ContribAuthor ">Johanna  Liebl</span>, <span class="hlFld-ContribAuthor ">Stefan  Zahler</span>, <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>, <span class="hlFld-ContribAuthor ">Cristina  Nevado</span>. </span><span class="cited-content_cbyCitation_article-title">Three stories on Eph kinase inhibitors: From in silico discovery to in vivo validation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>112 </em>, 347-366. <a href="https://doi.org/10.1016/j.ejmech.2016.01.057" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.01.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.01.057%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThree%252Bstories%252Bon%252BEph%252Bkinase%252Binhibitors%25253A%252BFrom%252Bin%252Bsilico%252Bdiscovery%252Bto%252Bin%2525C2%2525A0vivo%252Bvalidation%26aulast%3DUnzue%26aufirst%3DAndrea%26date%3D2016%26volume%3D112%26spage%3D347%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana  Hernández-Flórez</span>, <span class="hlFld-ContribAuthor ">Lara  Valor</span>. </span><span class="cited-content_cbyCitation_article-title">Los inhibidores de las proteínas-cinasas en enfermedades autoinmunes e inflamatorias: presente y futuro de nuevas dianas terapéuticas. </span><span class="cited-content_cbyCitation_journal-name">Reumatología Clínica</span><span> <strong>2016,</strong> <em>12 </em>
                                    (2)
                                     , 91-99. <a href="https://doi.org/10.1016/j.reuma.2015.06.004" title="DOI URL">https://doi.org/10.1016/j.reuma.2015.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.reuma.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.reuma.2015.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DReumatolog%25C3%25ADa%2520Cl%25C3%25ADnica%26atitle%3DLos%252Binhibidores%252Bde%252Blas%252Bprote%2525C3%2525ADnas-cinasas%252Ben%252Benfermedades%252Bautoinmunes%252Be%252Binflamatorias%25253A%252Bpresente%252By%252Bfuturo%252Bde%252Bnuevas%252Bdianas%252Bterap%2525C3%2525A9uticas%26aulast%3DHern%25C3%25A1ndez-Fl%25C3%25B3rez%26aufirst%3DDiana%26date%3D2016%26volume%3D12%26issue%3D2%26spage%3D91%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana  Hernández-Flórez</span>, <span class="hlFld-ContribAuthor ">Lara  Valor</span>. </span><span class="cited-content_cbyCitation_article-title">Protein-kinase Inhibitors: A New Treatment Pathway for Autoimmune and Inflammatory Diseases?. </span><span class="cited-content_cbyCitation_journal-name">Reumatología Clínica (English Edition)</span><span> <strong>2016,</strong> <em>12 </em>
                                    (2)
                                     , 91-99. <a href="https://doi.org/10.1016/j.reumae.2015.06.003" title="DOI URL">https://doi.org/10.1016/j.reumae.2015.06.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.reumae.2015.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.reumae.2015.06.003%26sid%3Dliteratum%253Aachs%26jtitle%3DReumatolog%25C3%25ADa%2520Cl%25C3%25ADnica%2520%2528English%2520Edition%2529%26atitle%3DProtein-kinase%252BInhibitors%25253A%252BA%252BNew%252BTreatment%252BPathway%252Bfor%252BAutoimmune%252Band%252BInflammatory%252BDiseases%25253F%26aulast%3DHern%25C3%25A1ndez-Fl%25C3%25B3rez%26aufirst%3DDiana%26date%3D2016%26volume%3D12%26issue%3D2%26spage%3D91%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samra  Sardar</span>, <span class="hlFld-ContribAuthor ">Åsa  Andersson</span>. </span><span class="cited-content_cbyCitation_article-title">Old and new therapeutics for Rheumatoid Arthritis:
              in vivo
              models and drug development. </span><span class="cited-content_cbyCitation_journal-name">Immunopharmacology and Immunotoxicology</span><span> <strong>2016,</strong> <em>38 </em>
                                    (1)
                                     , 2-13. <a href="https://doi.org/10.3109/08923973.2015.1125917" title="DOI URL">https://doi.org/10.3109/08923973.2015.1125917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/08923973.2015.1125917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F08923973.2015.1125917%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunopharmacology%2520and%2520Immunotoxicology%26atitle%3DOld%252Band%252Bnew%252Btherapeutics%252Bfor%252BRheumatoid%252BArthritis%25253A%252Bin%252Bvivo%252Bmodels%252Band%252Bdrug%252Bdevelopment%26aulast%3DSardar%26aufirst%3DSamra%26date%3D2016%26date%3D2016%26volume%3D38%26issue%3D1%26spage%3D2%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamed  Emami</span>, <span class="hlFld-ContribAuthor ">Esad  Vucic</span>, <span class="hlFld-ContribAuthor ">Sharath  Subramanian</span>, <span class="hlFld-ContribAuthor ">Amr  Abdelbaky</span>, <span class="hlFld-ContribAuthor ">Zahi A.  Fayad</span>, <span class="hlFld-ContribAuthor ">Shuyan  Du</span>, <span class="hlFld-ContribAuthor ">Eli  Roth</span>, <span class="hlFld-ContribAuthor ">Christie M.  Ballantyne</span>, <span class="hlFld-ContribAuthor ">Emile R.  Mohler</span>, <span class="hlFld-ContribAuthor ">Michael E.  Farkouh</span>, <span class="hlFld-ContribAuthor ">Joonyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Matthew  Farmer</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Alexander  Ehlgen</span>, <span class="hlFld-ContribAuthor ">Thomas H.  Langenickel</span>, <span class="hlFld-ContribAuthor ">Linda  Velasquez</span>, <span class="hlFld-ContribAuthor ">Wendy  Hayes</span>, <span class="hlFld-ContribAuthor ">Ahmed  Tawakol</span>. </span><span class="cited-content_cbyCitation_article-title">The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: A multicenter FDG-PET trial. </span><span class="cited-content_cbyCitation_journal-name">Atherosclerosis</span><span> <strong>2015,</strong> <em>240 </em>
                                    (2)
                                     , 490-496. <a href="https://doi.org/10.1016/j.atherosclerosis.2015.03.039" title="DOI URL">https://doi.org/10.1016/j.atherosclerosis.2015.03.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.atherosclerosis.2015.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.atherosclerosis.2015.03.039%26sid%3Dliteratum%253Aachs%26jtitle%3DAtherosclerosis%26atitle%3DThe%252Beffect%252Bof%252BBMS-582949%25252C%252Ba%252BP38%252Bmitogen-activated%252Bprotein%252Bkinase%252B%252528P38%252BMAPK%252529%252Binhibitor%252Bon%252Barterial%252Binflammation%25253A%252BA%252Bmulticenter%252BFDG-PET%252Btrial%26aulast%3DEmami%26aufirst%3DHamed%26date%3D2015%26volume%3D240%26issue%3D2%26spage%3D490%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Mingzhang  Gao</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of carbon-11-labeled 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine derivatives as new potential PET tracers for imaging of p38α mitogen-activated protein kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3700-3705. <a href="https://doi.org/10.1016/j.bmcl.2014.07.017" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.07.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.07.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bcarbon-11-labeled%252B4-%252528phenylamino%252529-pyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252Bderivatives%252Bas%252Bnew%252Bpotential%252BPET%252Btracers%252Bfor%252Bimaging%252Bof%252Bp38%2525CE%2525B1%252Bmitogen-activated%252Bprotein%252Bkinase%26aulast%3DWang%26aufirst%3DMin%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3700%26epage%3D3705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefanie  Bühler</span>, <span class="hlFld-ContribAuthor ">Stefan A  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">p38 MAPK inhibitors: a patent review (2012 – 2013). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (5)
                                     , 535-554. <a href="https://doi.org/10.1517/13543776.2014.894977" title="DOI URL">https://doi.org/10.1517/13543776.2014.894977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.894977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.894977%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3Dp38%252BMAPK%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282012%252B%2525E2%252580%252593%252B2013%252529%26aulast%3DB%25C3%25BChler%26aufirst%3DStefanie%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D5%26spage%3D535%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianyang  Chen</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Yanhong  Chen</span>, <span class="hlFld-ContribAuthor ">Qian  He</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(ii)-catalyzed cascade approach for the synthesis of pyrrolo[2,1-f][1,2,4]triazine-fused isoquinolines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (22)
                                     , 11168. <a href="https://doi.org/10.1039/c3ra47324d" title="DOI URL">https://doi.org/10.1039/c3ra47324d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra47324d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra47324d%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCopper%252528ii%252529-catalyzed%252Bcascade%252Bapproach%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine-fused%252Bisoquinolines%26aulast%3DChen%26aufirst%3DJianyang%26date%3D2014%26volume%3D4%26issue%3D22%26spage%3D11168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Nigel W.  Moriarty</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Echols</span>, <span class="hlFld-ContribAuthor ">Thomas C.  Terwilliger</span>, <span class="hlFld-ContribAuthor ">Eric T.  Baldwin</span>, <span class="hlFld-ContribAuthor ">Matt  Pokross</span>, <span class="hlFld-ContribAuthor ">Shana  Posy</span>, <span class="hlFld-ContribAuthor ">Paul D.  Adams</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand placement based on prior structures: the guided ligand-replacement method. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section D Biological Crystallography</span><span> <strong>2014,</strong> <em>70 </em>
                                    (1)
                                     , 134-143. <a href="https://doi.org/10.1107/S1399004713030071" title="DOI URL">https://doi.org/10.1107/S1399004713030071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S1399004713030071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS1399004713030071%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520D%2520Biological%2520Crystallography%26atitle%3DLigand%252Bplacement%252Bbased%252Bon%252Bprior%252Bstructures%25253A%252Bthe%252Bguided%252Bligand-replacement%252Bmethod%26aulast%3DKlei%26aufirst%3DHerbert%2BE.%26date%3D2014%26date%3D2013%26volume%3D70%26issue%3D1%26spage%3D134%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanyan  Yang</span>, <span class="hlFld-ContribAuthor ">Seung Cheol  Kim</span>, <span class="hlFld-ContribAuthor ">Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Young-Su  Yi</span>, <span class="hlFld-ContribAuthor ">Man Hee  Rhee</span>, <span class="hlFld-ContribAuthor ">Gi-Ho  Sung</span>, <span class="hlFld-ContribAuthor ">Byong Chul  Yoo</span>, <span class="hlFld-ContribAuthor ">Jae Youl  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Roles of p38 Mitogen-Activated Protein Kinase in Macrophage-Mediated Inflammatory Responses. </span><span class="cited-content_cbyCitation_journal-name">Mediators of Inflammation</span><span> <strong>2014,</strong> <em>2014 </em>, 1-13. <a href="https://doi.org/10.1155/2014/352371" title="DOI URL">https://doi.org/10.1155/2014/352371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2014/352371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2014%2F352371%26sid%3Dliteratum%253Aachs%26jtitle%3DMediators%2520of%2520Inflammation%26atitle%3DFunctional%252BRoles%252Bof%252Bp38%252BMitogen-Activated%252BProtein%252BKinase%252Bin%252BMacrophage-Mediated%252BInflammatory%252BResponses%26aulast%3DYang%26aufirst%3DYanyan%26date%3D2014%26volume%3D2014%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>, <span class="hlFld-ContribAuthor ">Shuqun  Lin</span>, <span class="hlFld-ContribAuthor ">T.G.  Murali Dhar</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, <span class="hlFld-ContribAuthor ">Tianle  Li</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Fan</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Kish</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kiefer</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">John A.  Newitt</span>, <span class="hlFld-ContribAuthor ">Mark R.  Witmer</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (14)
                                     , 4120-4126. <a href="https://doi.org/10.1016/j.bmcl.2013.05.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bidentification%252Bof%252Bnovel%252Bp38%2525CE%2525B1%252Bisoform%252Bselective%252Bkinase%252Binhibitors%252Bhaving%252Ban%252Bunprecedented%252Bp38%2525CE%2525B1%252Bbinding%252Bmode%26aulast%3DWrobleski%26aufirst%3DStephen%2BT.%26date%3D2013%26volume%3D23%26issue%3D14%26spage%3D4120%26epage%3D4126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunjian  Liu</span>, <span class="hlFld-ContribAuthor ">James  Lin</span>, <span class="hlFld-ContribAuthor ">Gerry  Everlof</span>, <span class="hlFld-ContribAuthor ">Christoph  Gesenberg</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Mary  Malley</span>, <span class="hlFld-ContribAuthor ">Michael A.  Galella</span>, <span class="hlFld-ContribAuthor ">Murray  Mckinnon</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS-582949, a clinical p38α inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (10)
                                     , 3028-3033. <a href="https://doi.org/10.1016/j.bmcl.2013.03.022" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bcarbamoylmethylene%252Blinked%252Bprodrugs%252Bof%252BBMS-582949%25252C%252Ba%252Bclinical%252Bp38%2525CE%2525B1%252Binhibitor%26aulast%3DLiu%26aufirst%3DChunjian%26date%3D2013%26volume%3D23%26issue%3D10%26spage%3D3028%26epage%3D3033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erine A.  Kupetsky</span>, <span class="hlFld-ContribAuthor ">Alicia R.  Mathers</span>, <span class="hlFld-ContribAuthor ">Laura K.  Ferris</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-cytokine therapy in the treatment of psoriasis. </span><span class="cited-content_cbyCitation_journal-name">Cytokine</span><span> <strong>2013,</strong> <em>61 </em>
                                    (3)
                                     , 704-712. <a href="https://doi.org/10.1016/j.cyto.2012.12.027" title="DOI URL">https://doi.org/10.1016/j.cyto.2012.12.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cyto.2012.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cyto.2012.12.027%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%26atitle%3DAnti-cytokine%252Btherapy%252Bin%252Bthe%252Btreatment%252Bof%252Bpsoriasis%26aulast%3DKupetsky%26aufirst%3DErine%2BA.%26date%3D2013%26volume%3D61%26issue%3D3%26spage%3D704%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Verica  Paunovic</span>, <span class="hlFld-ContribAuthor ">Margaret M.  Harnett</span>. </span><span class="cited-content_cbyCitation_article-title">Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Drugs</span><span> <strong>2013,</strong> <em>73 </em>
                                    (2)
                                     , 101-115. <a href="https://doi.org/10.1007/s40265-013-0014-6" title="DOI URL">https://doi.org/10.1007/s40265-013-0014-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40265-013-0014-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40265-013-0014-6%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%26atitle%3DMitogen-Activated%252BProtein%252BKinases%252Bas%252BTherapeutic%252BTargets%252Bfor%252BRheumatoid%252BArthritis%26aulast%3DPaunovic%26aufirst%3DVerica%26date%3D2013%26date%3D2013%26volume%3D73%26issue%3D2%26spage%3D101%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Bamborough</span>. </span><span class="cited-content_cbyCitation_article-title">System-based drug discovery within the human kinome. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2012,</strong> <em>7 </em>
                                    (11)
                                     , 1053-1070. <a href="https://doi.org/10.1517/17460441.2012.724056" title="DOI URL">https://doi.org/10.1517/17460441.2012.724056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2012.724056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2012.724056%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DSystem-based%252Bdrug%252Bdiscovery%252Bwithin%252Bthe%252Bhuman%252Bkinome%26aulast%3DBamborough%26aufirst%3DPaul%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D11%26spage%3D1053%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johann E.  Gudjonsson</span>, <span class="hlFld-ContribAuthor ">Andrew  Johnston</span>, <span class="hlFld-ContribAuthor ">Charles N.  Ellis</span>. </span><span class="cited-content_cbyCitation_article-title">Novel systemic drugs under investigation for the treatment of psoriasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Academy of Dermatology</span><span> <strong>2012,</strong> <em>67 </em>
                                    (1)
                                     , 139-147. <a href="https://doi.org/10.1016/j.jaad.2011.06.037" title="DOI URL">https://doi.org/10.1016/j.jaad.2011.06.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jaad.2011.06.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jaad.2011.06.037%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Academy%2520of%2520Dermatology%26atitle%3DNovel%252Bsystemic%252Bdrugs%252Bunder%252Binvestigation%252Bfor%252Bthe%252Btreatment%252Bof%252Bpsoriasis%26aulast%3DGudjonsson%26aufirst%3DJohann%2BE.%26date%3D2012%26volume%3D67%26issue%3D1%26spage%3D139%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dearg S.  Brown</span>, <span class="hlFld-ContribAuthor ">John G.  Cumming</span>, <span class="hlFld-ContribAuthor ">Paul  Bethel</span>, <span class="hlFld-ContribAuthor ">Jonathan  Finlayson</span>, <span class="hlFld-ContribAuthor ">Stefan  Gerhardt</span>, <span class="hlFld-ContribAuthor ">Ian  Nash</span>, <span class="hlFld-ContribAuthor ">Richard A.  Pauptit</span>, <span class="hlFld-ContribAuthor ">Kurt G.  Pike</span>, <span class="hlFld-ContribAuthor ">Alan  Reid</span>, <span class="hlFld-ContribAuthor ">Wendy  Snelson</span>, <span class="hlFld-ContribAuthor ">Steve  Swallow</span>, <span class="hlFld-ContribAuthor ">Caroline  Thompson</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (12)
                                     , 3879-3883. <a href="https://doi.org/10.1016/j.bmcl.2012.04.116" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.04.116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.04.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.04.116%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252BN-cyclopropyl-4-methyl-3-%25255B6-%2525284-methylpiperazin-1-yl%252529-4-oxoquinazolin-3%2525284H%252529-yl%25255Dbenzamide%252B%252528AZD6703%252529%25252C%252Ba%252Bclinical%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bdiseases%26aulast%3DBrown%26aufirst%3DDearg%2BS.%26date%3D2012%26volume%3D22%26issue%3D12%26spage%3D3879%26epage%3D3883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Fischer</span>, <span class="hlFld-ContribAuthor ">Solveigh C  Koeberle</span>, <span class="hlFld-ContribAuthor ">Stefan A  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">p38α mitogen-activated protein kinase inhibitors, a patent review (2005 – 2011). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2011,</strong> <em>21 </em>
                                    (12)
                                     , 1843-1866. <a href="https://doi.org/10.1517/13543776.2011.636737" title="DOI URL">https://doi.org/10.1517/13543776.2011.636737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2011.636737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2011.636737%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3Dp38%2525CE%2525B1%252Bmitogen-activated%252Bprotein%252Bkinase%252Binhibitors%25252C%252Ba%252Bpatent%252Breview%252B%2525282005%252B%2525E2%252580%252593%252B2011%252529%26aulast%3DFischer%26aufirst%3DStefan%26date%3D2011%26date%3D2011%26volume%3D21%26issue%3D12%26spage%3D1843%26epage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, <span class="hlFld-ContribAuthor ">Tianle  Li</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Gillooly</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kiefer</span>, <span class="hlFld-ContribAuthor ">John A.  Newitt</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (15)
                                     , 4633-4637. <a href="https://doi.org/10.1016/j.bmcl.2011.05.091" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.05.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.05.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.05.091%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252BC6-ketones%252Bas%252Bpotent%25252C%252Borally%252Bactive%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%252Binhibitors%26aulast%3DDyckman%26aufirst%3DAlaric%2BJ.%26date%3D2011%26volume%3D21%26issue%3D15%26spage%3D4633%26epage%3D4637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of reported clinical p38α MAP kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0015.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Our previously disclosed p38α MAP kinase inhibitors <b>1a</b> and <b>1b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0016.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) <i>N</i>-ethyl-3-amino-4-methylbenzamide (<b>3a</b>) or <i>N</i>-cyclopropyl-3-amino-4-methylbenzamide (<b>3b</b>), DMF, rt, overnight, 80% yield; (b) NaOH, THF, 50 °C to reflux, 94−100% yield; (c) R<sup>1</sup>NH<sub>2</sub>, coupling reagents such as EDC, HOBT, and BOP.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) (i) MeOH, 4 N HCl in 1,4-dioxane, rt, 16 h, (ii) KOH, 50 °C, 3 h, 71−99% yields; (b) 1N HCl, reflux, 6.5 h, 95% yield; (c) R<sup>2</sup>NH<sub>2</sub>, coupling reagents such as EDC, HATU, and BOP.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystallographic structure of <b>7k</b> bound to p38α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystallographic structure of <b>7v</b> bound to p38α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>7k</b> in the rat adjuvant arthritis model (qd dosing). Vehicle: PEG 300.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>7k</b> in the rat adjuvant arthritis model (bid dosing). Vehicle: PEG 300.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/medium/jm-2010-00540x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>7k</b> vs <b>1a</b> in the rat adjuvant arthritis model (qd dosing). Vehicle: PEG 300.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm100540x/production/images/large/jm-2010-00540x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100540x&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 15 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schieven, G. L.</span><span> </span><span class="NLM_article-title">The biology of p38 kinase: A central role in inflammation</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=921-928&author=G.+L.+Schieven&title=The+biology+of+p38+kinase%3A+A+central+role+in+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of p38 kinase: A central role in inflammation</span></div><div class="casAuthors">Schieven, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">921-928</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The p38 kinase plays a central role in inflammation, and it has been the subject of extensive efforts in both basic research and drug discovery.  This review summarizes the biol. of the p38 kinase with a focus on its role in inflammation.  The p38 kinase regulates the prodn. of key inflammatory mediators, including TNFα, IL-1β, and COX-2.  In addn., p38 also acts downstream of cytokines such as TNFα, mediating some of their effects.  The potential efficacy of p38 inhibitors may thus be greater than would be expected from the inhibition of the mediators alone.  Inhibitors of p38 kinase are currently in development for the treatment of rheumatoid arthritis.  The biol. processes regulated by p38 kinase suggest a wide variety of addnl. potential indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMrGjukF3_1bVg90H21EOLACvtfcHk0lgiMG5HNiBMWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrnF&md5=477b596143660343b98e6748c0c36430</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.2174%2F1568026054985902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985902%26sid%3Dliteratum%253Aachs%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26atitle%3DThe%2520biology%2520of%2520p38%2520kinase%253A%2520A%2520central%2520role%2520in%2520inflammation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D921%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Saklatvala, J.</span><span> </span><span class="NLM_article-title">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1016%2Fj.coph.2004.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=15251131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=372-377&author=J.+Saklatvala&title=The+p38+MAP+kinase+pathway+as+a+therapeutic+target+in+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span></div><div class="casAuthors">Saklatvala, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The p38 MAPK signalling pathway plays an important role in inflammation and other physiol. processes.  Specific inhibitors of p38 α and β MAPK block prodn. of the major inflammatory cytokines (i.e. tumor necrosis factor-α and interleukin-1) and other proteins (e.g. cyclooxygenase-2), and are anti-inflammatory in animal models of disease.  A major function of the pathway is post-transcriptional control of inflammatory gene expression.  Many of the mRNAs are unstable (or untranslatable) because of AU-rich elements in the 3'untranslated region.  Signalling in the p38 pathway counteracts these and stabilizes the mRNAs by preventing their otherwise rapid de-adenylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpglO4EVBhJ-LVg90H21EOLACvtfcHk0lgiMG5HNiBMWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D&md5=5678936250f1dbc9c27707bd7edf6108</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DSaklatvala%26aufirst%3DJ.%26atitle%3DThe%2520p38%2520MAP%2520kinase%2520pathway%2520as%2520a%2520therapeutic%2520target%2520in%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2004%26volume%3D4%26spage%3D372%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">P38 MAP Kinases: Key Signaling Molecules as Therapeutic Targets for Inflammatory Diseases</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=717-726&author=S.+Kumarauthor=J.+Borhmauthor=J.+C.+Lee&title=P38+MAP+Kinases%3A+Key+Signaling+Molecules+as+Therapeutic+Targets+for+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DBorhm%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DP38%2520MAP%2520Kinases%253A%2520Key%2520Signaling%2520Molecules%2520as%2520Therapeutic%2520Targets%2520for%2520Inflammatory%2520Diseases%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D717%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badge, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1016%2FS0079-6468%2808%2970091-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=11774793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVGntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=1-60&author=J.+L.+Adamsauthor=A.+M.+Badgeauthor=S.+Kumarauthor=J.+C.+Lee&title=p38+MAP+kinase%3A+molecular+target+for+the+inhibition+of+pro-inflammatory+cytokines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines</span></div><div class="casAuthors">Adams, Jerry L.; Badger, Alison M.; Kumar, Sanjay; Lee, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-60</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 286 refs.  Topics discussed include the discovery of p38 kinase; the relationship of p38 to the MAP kinases; the p38 kinase family; upstream activators; downstream substrates; medicinal chem. preceding the discovery of p38; p38 structure-activity relationships; the structural basis of kinase selectivity; the pharmacol. of p38 inhibitors; and preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob8EiblMQiarVg90H21EOLACvtfcHk0lg7h2QG4m1ULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVGntbw%253D&md5=fb9d63787dfe16059715b6a68afa41a3</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2808%2970091-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252808%252970091-2%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DBadge%26aufirst%3DA.%2BM.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3Dp38%2520MAP%2520kinase%253A%2520molecular%2520target%2520for%2520the%2520inhibition%2520of%2520pro-inflammatory%2520cytokines%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D38%26spage%3D1%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, Z.</span><span> </span><span class="NLM_article-title">p38 MAPK signaling cascades in inflammatory disease</span> <span class="citation_source-journal">Mol. Med. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1016%2FS1357-4310%2899%2901544-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=10498912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVWiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=439-447&author=E.+Herlaarauthor=Z.+Brown&title=p38+MAPK+signaling+cascades+in+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1eR"><div class="casContent"><span class="casTitleNuber">1e</span><div class="casTitle"><span class="NLM_cas:atitle">p38 MAPK signalling cascades in inflammatory disease</span></div><div class="casAuthors">Herlaar, E.; Brown, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Today</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">439-447</span>CODEN:
                <span class="NLM_cas:coden">MMTOFK</span>;
        ISSN:<span class="NLM_cas:issn">1357-4310</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 44 refs.  Inflammatory mediators released during acute and chronic diseases activate multiple intracellular signaling cascades including the mitogen-activated protein kinase (MAPK) signal transduction pathway, which plays a significant role in the recruitment of leukocytes to sites of inflammation.  Stimulation of leukocytes by pro-inflammatory cytokines is known to result in the activation of the MAPK isoform p38.  However, the functional consequences of p38 MAPK activation during leukocyte recruitment, including adhesion, migration and effector functions such as oxidative burst and degranulation, are only just beginning to be elucidated.  Specific p38 inhibitors aimed at reducing the prodn. of inflammatory mediators are now being developed, and might in the future provide more effective treatment for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIhoJ67g0sRrVg90H21EOLACvtfcHk0lg7h2QG4m1ULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVWiu7g%253D&md5=3bf8c8ba39b01b5a3188d75b06107709</span></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1016%2FS1357-4310%2899%2901544-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-4310%252899%252901544-0%26sid%3Dliteratum%253Aachs%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DZ.%26atitle%3Dp38%2520MAPK%2520signaling%2520cascades%2520in%2520inflammatory%2520disease%26jtitle%3DMol.%2520Med.%2520Today%26date%3D1999%26volume%3D5%26spage%3D439%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laydon, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenthal, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heys, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landvatter, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemens, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livi, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span> </span><span class="NLM_article-title">A protein kinase involved in the regulation of inflammatory cytokine biosynthesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=739-745&author=J.+C.+Leeauthor=J.+T.+Laydonauthor=P.+C.+McDonnellauthor=T.+F.+Gallagherauthor=S.+Kimarauthor=D.+Greenauthor=D.+McNultyauthor=M.+J.+Blumenthalauthor=J.+R.+Heysauthor=S.+W.+Landvatterauthor=J.+E.+Stricklerauthor=M.+M.+McLaughlinauthor=I.+R.+Siemensauthor=S.+M.+Fisherauthor=G.+P.+Liviauthor=J.+R.+Whiteauthor=J.+L.+Adamsauthor=P.+R.+Young&title=A+protein+kinase+involved+in+the+regulation+of+inflammatory+cytokine+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DLaydon%26aufirst%3DJ.%2BT.%26aulast%3DMcDonnell%26aufirst%3DP.%2BC.%26aulast%3DGallagher%26aufirst%3DT.%2BF.%26aulast%3DKimar%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DMcNulty%26aufirst%3DD.%26aulast%3DBlumenthal%26aufirst%3DM.%2BJ.%26aulast%3DHeys%26aufirst%3DJ.%2BR.%26aulast%3DLandvatter%26aufirst%3DS.%2BW.%26aulast%3DStrickler%26aufirst%3DJ.%2BE.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26aulast%3DSiemens%26aufirst%3DI.%2BR.%26aulast%3DFisher%26aufirst%3DS.%2BM.%26aulast%3DLivi%26aufirst%3DG.%2BP.%26aulast%3DWhite%26aufirst%3DJ.%2BR.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26atitle%3DA%2520protein%2520kinase%2520involved%2520in%2520the%2520regulation%2520of%2520inflammatory%2520cytokine%2520biosynthesis%26jtitle%3DNature%26date%3D1994%26volume%3D372%26spage%3D739%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="note"><p class="first last">For example,</p></div><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pettus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herberich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saris, C. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmait, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span> </span><span class="NLM_article-title">Discovery and Evaluation of 7-Alkyl-1,5-bis-aryl-pyrazolopyridinones as Highly Potent, Selective, and Orally Efficacious Inhibitors of p38α Mitogen-Activated Protein Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2973</span><span class="NLM_x">–</span> <span class="NLM_lpage">2985</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100095x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2973-2985&author=L.+H.+Pettusauthor=R.+P.+Wurzauthor=S.+Xuauthor=B.+Herberichauthor=B.+Henkleauthor=Q.+Liuauthor=H.+J.+McBrideauthor=S.+Muauthor=M.+H.+Plantauthor=C.+J.+M.+Sarisauthor=L.+Shermanauthor=L.+M.+Wongauthor=S.+Chmaitauthor=M.+R.+Leeauthor=C.+Mohrauthor=F.+Hsiehauthor=A.+S.+Tasker&title=Discovery+and+Evaluation+of+7-Alkyl-1%2C5-bis-aryl-pyrazolopyridinones+as+Highly+Potent%2C+Selective%2C+and+Orally+Efficacious+Inhibitors+of+p38%CE%B1+Mitogen-Activated+Protein+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1021%2Fjm100095x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100095x%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMcBride%26aufirst%3DH.%2BJ.%26aulast%3DMu%26aufirst%3DS.%26aulast%3DPlant%26aufirst%3DM.%2BH.%26aulast%3DSaris%26aufirst%3DC.%2BJ.%2BM.%26aulast%3DSherman%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DL.%2BM.%26aulast%3DChmait%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26atitle%3DDiscovery%2520and%2520Evaluation%2520of%25207-Alkyl-1%252C5-bis-aryl-pyrazolopyridinones%2520as%2520Highly%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Efficacious%2520Inhibitors%2520of%2520p38%25CE%25B1%2520Mitogen-Activated%2520Protein%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2973%26epage%3D2985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durley, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepperle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucker, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerome, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrufo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Promo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickory, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blevis-Bal, R.</span><span> </span><span class="NLM_article-title">Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5852</span><span class="NLM_x">–</span> <span class="NLM_lpage">5856</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5852-5856&author=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+B.+Monahanauthor=T.+L.+Boehmauthor=J.+K.+Walkerauthor=B.+Devadasauthor=R.+C.+Durleyauthor=R.+Kurumbailauthor=H.+Shiehauthor=L.+Xingauthor=M.+Hepperleauthor=P.+V.+Ruckerauthor=K.+D.+Jeromeauthor=A.+G.+Bensonauthor=L.+D.+Marrufoauthor=H.+M.+Madsenauthor=J.+Hitchcockauthor=T.+J.+Owenauthor=L.+Christieauthor=M.+A.+Promoauthor=B.+S.+Hickoryauthor=E.+Alviraauthor=W.+Naingauthor=R.+Blevis-Bal&title=Discovery+of+N-substituted+pyridinones+as+potent+and+selective+inhibitors+of+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DDurley%26aufirst%3DR.%2BC.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DHepperle%26aufirst%3DM.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DJerome%26aufirst%3DK.%2BD.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DHitchcock%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DT.%2BJ.%26aulast%3DChristie%26aufirst%3DL.%26aulast%3DPromo%26aufirst%3DM.%2BA.%26aulast%3DHickory%26aufirst%3DB.%2BS.%26aulast%3DAlvira%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DBlevis-Bal%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520N-substituted%2520pyridinones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520p38%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5852%26epage%3D5856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Herberich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, G.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosfeld, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span> </span><span class="NLM_article-title">Discovery of Highly Selective and Potent p38 Inhibitors Based on a Phthalazine Scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6271</span><span class="NLM_x">–</span> <span class="NLM_lpage">6279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8005417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6271-6279&author=B.+Herberichauthor=G.-Q.+Caoauthor=P.+P.+Chakrabartiauthor=J.+R.+Falseyauthor=L.+Pettusauthor=R.+M.+Rzasaauthor=A.+B.+Reedauthor=A.+Reicheltauthor=K.+Shamauthor=M.+Thamanauthor=R.+P.+Wurzauthor=S.+Xuauthor=D.+Zhangauthor=F.+Hsiehauthor=M.+R.+Leeauthor=R.+Syedauthor=V.+Liauthor=D.+Grosfeldauthor=M.+H.+Plantauthor=B.+Henkleauthor=L.+Shermanauthor=S.+Middletonauthor=L.+M.+Wongauthor=A.+S.+Tasker&title=Discovery+of+Highly+Selective+and+Potent+p38+Inhibitors+Based+on+a+Phthalazine+Scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1021%2Fjm8005417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8005417%26sid%3Dliteratum%253Aachs%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DG.-Q.%26aulast%3DChakrabarti%26aufirst%3DP.%2BP.%26aulast%3DFalsey%26aufirst%3DJ.%2BR.%26aulast%3DPettus%26aufirst%3DL.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DSham%26aufirst%3DK.%26aulast%3DThaman%26aufirst%3DM.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DSyed%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DGrosfeld%26aufirst%3DD.%26aulast%3DPlant%26aufirst%3DM.%2BH.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DSherman%26aufirst%3DL.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DL.%2BM.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26atitle%3DDiscovery%2520of%2520Highly%2520Selective%2520and%2520Potent%2520p38%2520Inhibitors%2520Based%2520on%2520a%2520Phthalazine%2520Scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6271%26epage%3D6279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Natarajan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levorse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vora, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvetovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carballo-Jane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, D. M.</span><span> </span><span class="NLM_article-title">p38 MAP kinase inhibitors. Discovery of an orally bioavailable and highly efficacious compound based on the 7-amino-naphthyridone scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5468</span><span class="NLM_x">–</span> <span class="NLM_lpage">5471</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5468-5471&author=S.+R.+Natarajanauthor=L.+Liuauthor=M.+Levorseauthor=J.+E.+Thompsonauthor=E.+A.+O%E2%80%99Neillauthor=S.+J.+O%E2%80%99Keefeauthor=K.+A.+Voraauthor=R.+Cvetovichauthor=J.+Y.+Chungauthor=E.+Carballo-Janeauthor=D.+M.+Visco&title=p38+MAP+kinase+inhibitors.+Discovery+of+an+orally+bioavailable+and+highly+efficacious+compound+based+on+the+7-amino-naphthyridone+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNatarajan%26aufirst%3DS.%2BR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLevorse%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DS.%2BJ.%26aulast%3DVora%26aufirst%3DK.%2BA.%26aulast%3DCvetovich%26aufirst%3DR.%26aulast%3DChung%26aufirst%3DJ.%2BY.%26aulast%3DCarballo-Jane%26aufirst%3DE.%26aulast%3DVisco%26aufirst%3DD.%2BM.%26atitle%3Dp38%2520MAP%2520kinase%2520inhibitors.%2520Discovery%2520of%2520an%2520orally%2520bioavailable%2520and%2520highly%2520efficacious%2520compound%2520based%2520on%2520the%25207-amino-naphthyridone%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5468%26epage%3D5471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audoly, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberia, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braganza, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carty, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortina, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuperman, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaLiberte, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naiman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peese, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trebino, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramov, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volberg, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4339</span><span class="NLM_x">–</span> <span class="NLM_lpage">4344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4339-4344&author=K.+F.+McClureauthor=M.+A.+Letavicauthor=A.+S.+Kalgutkarauthor=C.+A.+Gabelauthor=L.+Audolyauthor=J.+T.+Barberiaauthor=J.+F.+Braganzaauthor=D.+Carterauthor=T.+J.+Cartyauthor=S.+R.+Cortinaauthor=M.+A.+Dombroskiauthor=K.+M.+Donahueauthor=N.+C.+Elliottauthor=C.+P.+Gibbonsauthor=C.+K.+Jordanauthor=A.+V.+Kupermanauthor=J.+M.+Labasiauthor=R.+E.+LaLiberteauthor=J.+M.+McCoyauthor=B.+M.+Naimanauthor=K.+L.+Nelsonauthor=H.+T.+Nguyenauthor=K.+M.+Peeseauthor=F.+J.+Sweeneyauthor=T.+J.+Taylorauthor=C.+E.+Trebinoauthor=Y.+A.+Abramovauthor=E.+R.+Lairdauthor=W.+A.+Volbergauthor=J.+Zhouauthor=J.+Bachauthor=F.+Lombardo&title=Structure%E2%88%92activity+relationships+of+triazolopyridine+oxazole+p38+inhibitors%3A+identification+of+candidates+for+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26aulast%3DAudoly%26aufirst%3DL.%26aulast%3DBarberia%26aufirst%3DJ.%2BT.%26aulast%3DBraganza%26aufirst%3DJ.%2BF.%26aulast%3DCarter%26aufirst%3DD.%26aulast%3DCarty%26aufirst%3DT.%2BJ.%26aulast%3DCortina%26aufirst%3DS.%2BR.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DDonahue%26aufirst%3DK.%2BM.%26aulast%3DElliott%26aufirst%3DN.%2BC.%26aulast%3DGibbons%26aufirst%3DC.%2BP.%26aulast%3DJordan%26aufirst%3DC.%2BK.%26aulast%3DKuperman%26aufirst%3DA.%2BV.%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DLaLiberte%26aufirst%3DR.%2BE.%26aulast%3DMcCoy%26aufirst%3DJ.%2BM.%26aulast%3DNaiman%26aufirst%3DB.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DPeese%26aufirst%3DK.%2BM.%26aulast%3DSweeney%26aufirst%3DF.%2BJ.%26aulast%3DTaylor%26aufirst%3DT.%2BJ.%26aulast%3DTrebino%26aufirst%3DC.%2BE.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DLaird%26aufirst%3DE.%2BR.%26aulast%3DVolberg%26aufirst%3DW.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DBach%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DF.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520triazolopyridine%2520oxazole%2520p38%2520inhibitors%253A%2520identification%2520of%2520candidates%2520for%2520clinical%2520development%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4339%26epage%3D4344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcintyre, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6261</span><span class="NLM_x">–</span> <span class="NLM_lpage">6270</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503594" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6261-6270&author=C.+Liuauthor=S.+T.+Wrobleskiauthor=J.+Linauthor=K.+M.+Gilloolyauthor=K.+Mcintyreauthor=S.+Pittauthor=D.+R.+Shenauthor=D.+J.+Shusterauthor=H.+Zhangauthor=A.+M.+Doweykoauthor=J.+S.+Sackauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=5-Cyanopyrimidine+Derivatives+as+a+Novel+Class+of+Potent%2C+Selective%2C+and+Orally+Active+Inhibitors+of+p38%CE%B1+MAP+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=10.1021%2Fjm0503594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503594%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DMcintyre%26aufirst%3DK.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3D5-Cyanopyrimidine%2520Derivatives%2520as%2520a%2520Novel%2520Class%2520of%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Active%2520Inhibitors%2520of%2520p38%25CE%25B1%2520MAP%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6261%26epage%3D6270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Padova, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucklin, G.</span><span> </span><span class="NLM_article-title">Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3595</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3595-99&author=L.+Reveszauthor=E.+Blumauthor=F.+E.+Di+Padovaauthor=T.+Buhlauthor=R.+Feifelauthor=H.+Gramauthor=P.+Hiestandauthor=U.+Manningauthor=G.+Rucklin&title=Novel+p38+inhibitors+with+potent+oral+efficacy+in+several+models+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DBlum%26aufirst%3DE.%26aulast%3DDi%2BPadova%26aufirst%3DF.%2BE.%26aulast%3DBuhl%26aufirst%3DT.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DManning%26aufirst%3DU.%26aulast%3DRucklin%26aufirst%3DG.%26atitle%3DNovel%2520p38%2520inhibitors%2520with%2520potent%2520oral%2520efficacy%2520in%2520several%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3595%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Trejo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arzeno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalrymple, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunten, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafargue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovejoy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire-Moar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcintosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villasenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Lu</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4702</span><span class="NLM_x">–</span> <span class="NLM_lpage">4713</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0301787" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4702-4713&author=A.+Trejoauthor=H.+Arzenoauthor=M.+Brownerauthor=S.+Chandaauthor=S.+Chengauthor=D.+D.+Comerauthor=S.+A.+Dalrympleauthor=P.+Duntenauthor=J.+Lafargueauthor=B.+Lovejoyauthor=J.+Freire-Moarauthor=J.+Limauthor=J.+Mcintoshauthor=J.+Millerauthor=E.+Pappauthor=D.+Reuterauthor=R.+Robertsauthor=J.+Saundersauthor=K.+Songauthor=A.+Villasenorauthor=S.+D.+Warrenauthor=M.+Welchauthor=P.+Wellerauthor=P.+E.+Whiteleyauthor=Lu+Zengauthor=D.+M.+Goldstein&title=Design+and+synthesis+of+4-azaindoles+as+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2h&amp;dbid=16384&amp;doi=10.1021%2Fjm0301787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0301787%26sid%3Dliteratum%253Aachs%26aulast%3DTrejo%26aufirst%3DA.%26aulast%3DArzeno%26aufirst%3DH.%26aulast%3DBrowner%26aufirst%3DM.%26aulast%3DChanda%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DComer%26aufirst%3DD.%2BD.%26aulast%3DDalrymple%26aufirst%3DS.%2BA.%26aulast%3DDunten%26aufirst%3DP.%26aulast%3DLafargue%26aufirst%3DJ.%26aulast%3DLovejoy%26aufirst%3DB.%26aulast%3DFreire-Moar%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DMcintosh%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DJ.%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DReuter%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DR.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DVillasenor%26aufirst%3DA.%26aulast%3DWarren%26aufirst%3DS.%2BD.%26aulast%3DWelch%26aufirst%3DM.%26aulast%3DWeller%26aufirst%3DP.%26aulast%3DWhiteley%26aufirst%3DP.%2BE.%26aulast%3DZeng%26aufirst%3DLu%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%25204-azaindoles%2520as%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4702%26epage%3D4713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavender, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olini, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahmy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siekierka, J. J.</span><span> </span><span class="NLM_article-title">Imidazopyrimidines, potent inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=347-350&author=K.+C.+Rupertauthor=J.+R.+Henryauthor=J.+H.+Doddauthor=S.+A.+Wadsworthauthor=D.+E.+Cavenderauthor=G.+C.+Oliniauthor=B.+Fahmyauthor=J.+J.+Siekierka&title=Imidazopyrimidines%2C+potent+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHenry%26aufirst%3DJ.%2BR.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DWadsworth%26aufirst%3DS.%2BA.%26aulast%3DCavender%26aufirst%3DD.%2BE.%26aulast%3DOlini%26aufirst%3DG.%2BC.%26aulast%3DFahmy%26aufirst%3DB.%26aulast%3DSiekierka%26aufirst%3DJ.%2BJ.%26atitle%3DImidazopyrimidines%252C%2520potent%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D347%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitfelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span> </span><span class="NLM_article-title">Pyrazole urea-based inhibitors of p38 MAP kinase: From lead compound to clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2994</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020057r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2j&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2994-3008&author=J.+Reganauthor=S.+Breitfelderauthor=P.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=B.+Klausauthor=J.+Madwedauthor=M.+Moriakauthor=N.+Mossauthor=C.+Pargellisauthor=S.+Pavauthor=A.+Protoauthor=A.+Swinamerauthor=L.+Tongauthor=C.+Torcellini&title=Pyrazole+urea-based+inhibitors+of+p38+MAP+kinase%3A+From+lead+compound+to+clinical+candidate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2jR"><div class="casContent"><span class="casTitleNuber">2j</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate</span></div><div class="casAuthors">Regan, John; Breitfelder, Steffen; Cirillo, Pier; Gilmore, Thomas; Graham, Anne G.; Hickey, Eugene; Klaus, Bernhard; Madwed, Jeffrey; Moriak, Monica; Moss, Neil; Pargellis, Chris; Pav, Sue; Proto, Alfred; Swinamer, Alan; Tong, Liang; Torcellini, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2994-3008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on a series of N-pyrazole, N'-aryl ureas and their mode of binding to p38 mitogen activated protein kinase.  Importantly, a key binding domain that is distinct from the ATP (ATP) binding site is exposed when the conserved activation loop, consisting in part of Asp168-Phe169-Gly170, adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.  We describe the correlation of the structure-activity relationships and crystallog. structures of these inhibitors with p38.  In addn., we incorporated another binding pharmacophore that forms a hydrogen bond at the ATP binding site.  This modification affords significant improvements in binding, cellular, and in vivo potencies resulting in the selection of Compd. 45 (BIRB 796) as a clin. candidate for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotOOfLV3xRbVg90H21EOLACvtfcHk0lhzz7fAfv6X3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D&md5=e473f514179c8fe24ab3efccc292b6c6</span></div><a href="/servlet/linkout?suffix=cit2j&amp;dbid=16384&amp;doi=10.1021%2Fjm020057r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020057r%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DBreitfelder%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKlaus%26aufirst%3DB.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DTorcellini%26aufirst%3DC.%26atitle%3DPyrazole%2520urea-based%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%253A%2520From%2520lead%2520compound%2520to%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2994%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Choy, E. H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayi, G. S.</span><span> </span><span class="NLM_article-title">Cytokine Pathway and Joint Inflammation in Rheumatoid Arthritis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1056%2FNEJM200103223441207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=11259725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisFyrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=907-916&author=E.+H.+S.+Choyauthor=G.+S.+Panayi&title=Cytokine+Pathway+and+Joint+Inflammation+in+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine pathways and joint inflammation in rheumatoid arthritis</span></div><div class="casAuthors">Choy, Ernest H. S.; Panayi, Gabriel S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">907-916</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review with 79 refs.  Although the cause of rheumatoid arthritis is still unclear, the improved understanding of the pathogenesis of the disease has opened the door to innovative therapies.  By targeting mols. that are directly involved in the pathogenesis of rheumatoid arthritis, these therapies may be more efficacious and specific and less toxic in the short and long term than std. therapies.  Radiol. evidence suggests that these new therapies, such as anticytokine therapy, may slow disease progression.  Finally, the success of anticytokine therapy will also provide valuable insights into the initiation and progression of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8KnAs8wt9tbVg90H21EOLACvtfcHk0lhzz7fAfv6X3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisFyrur8%253D&md5=407ee2bc06a307c241e60f048e5f4a95</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1056%2FNEJM200103223441207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200103223441207%26sid%3Dliteratum%253Aachs%26aulast%3DChoy%26aufirst%3DE.%2BH.%2BS.%26aulast%3DPanayi%26aufirst%3DG.%2BS.%26atitle%3DCytokine%2520Pathway%2520and%2520Joint%2520Inflammation%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D907%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Foster, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souness, J. E.</span><span> </span><span class="NLM_article-title">Potential of p38 inhibitors in the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=12937622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=488-497&author=M.+L.+Fosterauthor=F.+Halleyauthor=J.+E.+Souness&title=Potential+of+p38+inhibitors+in+the+treatment+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Potential of p38 inhibitors in the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Foster, Martyn L.; Halley, Frank; Souness, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">488-497</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review, with 64 refs.  Rheumatoid arthritis (RA) is a chronic debilitating disease estd. to afflict 1-3% of the world population.  Although palliative treatments (nonsteroidal anti-inflammatory drugs or NSAIDs) are widely prescribed, there are currently only a few treatments that can modify the insidious progression of the disease (disease-modifying antirheumatic drugs or DMARDs), which frequently leads to phys. incapacitation and, on occasion, death.  Proinflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) are implicated in the disease onset and in the progression of bone and joint destruction that characterizes chronic RA.  P38 is an intracellular mitogen/stress-activated protein kinase (MAPK/SAPK) that regulates both the release and the actions of TNF-α and IL-1β.  Inhibition of p38 kinase is thus an important potential target for novel DMARDs.  Following the pioneering work conducted at SmithKline Beecham and elucidation of the roles of p38 with potent and selective inhibitors such as SB-203580, many pharmaceutical companies have embarked upon p38 synthetic programs, as indicated by the ever-increasing no. of patents in this domain.  At Aventis, a rapid parallel synthesis project led to the identification of RPR-200765A, a potent and selective p38 inhibitor of the lipopolysaccharide-induced release of TNF-α in vitro in mononuclear phagocytes and in vivo in the rat.  It also reduces disease incidence and progression in the rat streptococcal cell wall arthritis model when administered orally in either a prophylactic or a therapeutic dosing regimen.  Development of p38 inhibitors has been slow, probably because of toxicol. problems, which might explain why only two oral p38 inhibitors, SB-242235 and VX-745, have advanced into clin. development.  In the present article, the preclin. data exemplified in studies on RPR-200765A indicating why p38 inhibitors are attracting so much attention as potential novel anti-RA drugs are reviewed.  Current information on the different structural classes of p38 inhibitors is presented and possible reasons for the delays in their development are critically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPsDRV9bCN37Vg90H21EOLACvtfcHk0lhzz7fAfv6X3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFKktg%253D%253D&md5=b634b7ab2f3e8fd6747c4889e324f3a3</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DM.%2BL.%26aulast%3DHalley%26aufirst%3DF.%26aulast%3DSouness%26aufirst%3DJ.%2BE.%26atitle%3DPotential%2520of%2520p38%2520inhibitors%2520in%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2000%26volume%3D13%26spage%3D488%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Feldmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maini, R. N.</span><span> </span><span class="NLM_article-title">Role of cytokines in rheumatoid arthritis</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1146%2Fannurev.immunol.14.1.397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=8717520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADyaK28XitlCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1996&pages=397-440&author=M.+Feldmannauthor=F.+M.+Brennanauthor=R.+N.+Maini&title=Role+of+cytokines+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Role of cytokines in rheumatoid arthritis</span></div><div class="casAuthors">Feldmann, Marc; Brennan, Fionula M.; Maini, Ravinder N.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">397-440</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with 226 refs.  Anal. of cytokine mRNA and protein in rheumatoid arthritis tissue revealed that many proinflammatory cytokines such as TNFα, IL-1, IL-6, GM-CSF, and chemokines such as IL-8 are abundant in all patients regardless of therapy.  This is compensated to some degree by the increased prodn. of anti-inflammatory cytokines such as IL-10 and TGFβ and cytokine inhibitors such as IL-1ra and sol. TNF-R.  However, this upregulation in homeostatic regulatory mechanisms is not sufficient as these are unable to neutralize all the TNFα and IL-1 produced.  In rheumatoid joint cell cultures that spontaneously produce IL-1, TNFα was the major dominant regulator of IL-1.  Subsequently, other proinflammatory cytokines were also inhibited if TNFα was neutralized, leading to the new concept that the proinflammatory cytokines were linked in a network with TNFα at its apex.  This led to the hypothesis that TNFα was of major importance in rheumatoid arthritis and was a therapeutic target.  This hypothesis has been successfully tested in animal models, of, for example, collagen-induced arthritis, and these studies have provided the rationale for clin. trials of anti-TNFα therapy in patients with long-standing rheumatoid arthritis.  Several clin. trials using a chimeric anti-TNFα antibody have shown marked clin. benefit, verifying the hypothesis that TNFα is of major importance in rheumatoid arthritis.  Retreatment studies have also shown benefit in repeated relapses, indicating that the disease remains TNFα dependent.  Overall these studies demonstrate that anal. of cytokine expression and regulation may yield effective therapeutic targets in inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHja_UMVsQ8rVg90H21EOLACvtfcHk0lhx94VJhWOx1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitlCgtb4%253D&md5=bcffdb544e217ca525bef31af6d0fc44</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.14.1.397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.14.1.397%26sid%3Dliteratum%253Aachs%26aulast%3DFeldmann%26aufirst%3DM.%26aulast%3DBrennan%26aufirst%3DF.%2BM.%26aulast%3DMaini%26aufirst%3DR.%2BN.%26atitle%3DRole%2520of%2520cytokines%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1996%26volume%3D14%26spage%3D397%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">Inflammatory cytokines: Interleukin-1 and Tumor Necrosis Factor as Effector Molecules in Autoimmune Diseases</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1016%2FS0952-7915%2805%2980018-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=1665333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=941-948&author=C.+A.+Dinarello&title=Inflammatory+cytokines%3A+Interleukin-1+and+Tumor+Necrosis+Factor+as+Effector+Molecules+in+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory cytokines:  interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases</span></div><div class="casAuthors">Dinarello, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">941-8</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    </div><div class="casAbstract">The nature of the events that ppt. autoimmune diseases varies.  Interleukin-1 and tumor necrosis factor do not ppt. autoimmune diseases but rather act as effector mols.  They induce eicosanoid and NO synthesis, stimulate collagenases and collagen synthesis, and trigger the genes for other cytokines, namely interleukin-2, interleukin-6 and interleukin-8.  The ability to block interleukin-1 with the receptor antagonist, and tumor necrosis factor with sol. receptors, has given investigators specific tools to test the role of these two cytokines in the pathol. processes of autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhF6Z-Gd_1RrVg90H21EOLACvtfcHk0lhx94VJhWOx1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D&md5=9124ac01336892ed242ed4583f14b4c6</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2805%2980018-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252805%252980018-4%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DInflammatory%2520cytokines%253A%2520Interleukin-1%2520and%2520Tumor%2520Necrosis%2520Factor%2520as%2520Effector%2520Molecules%2520in%2520Autoimmune%2520Diseases%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1991%26volume%3D3%26spage%3D941%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jarvis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulds, D.</span><span> </span><span class="NLM_article-title">Etanercept: a review of its use in rheumatoid arthritis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=945-966&author=B.+Jarvisauthor=D.+Faulds&title=Etanercept%3A+a+review+of+its+use+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DB.%26aulast%3DFaulds%26aufirst%3DD.%26atitle%3DEtanercept%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520rheumatoid%2520arthritis%26jtitle%3DDrugs%26date%3D1999%26volume%3D57%26spage%3D945%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rutgeerts, P. J.</span><span> </span><span class="NLM_article-title">Review article: efficacy of infliximab in Crohn’s disease—induction and maintenance of remission</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1046%2Fj.1365-2036.1999.00025.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=10597334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADyaK1MXmsl2iu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=9-15&issue=Suppl+4&author=P.+J.+Rutgeerts&title=Review+article%3A+efficacy+of+infliximab+in+Crohn%E2%80%99s+disease%E2%80%94induction+and+maintenance+of+remission"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of infliximab in Crohn's disease - induction and maintenance of remission</span></div><div class="casAuthors">Rutgeerts, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 10 refs.  The primary goals of treating patients with Crohn's disease are to induce a clin. remission, maintain the remission, and prevent assocd. complications.  Various treatment regimens for patients with Crohn's disease induce a response and remission; however, most prove ineffective for maintenance of the clin. effect.  A therapeutic agent that can induce and maintain remission, while promoting the restoration of intestinal mucosa, would prove to be most beneficial in such a patient population.  Several studies with infliximab have clin. demonstrated that the antitumor necrosis factor-alpha therapy rapidly reduced the signs and symptoms in patients with moderate-to-severe Crohn's disease.  In acute studies with the chimeric monoclonal antibody, clin. benefit was assocd. with healing and redn. of inflammation in the bowel mucosal tissue.  In a maintenance study, retreatment with infliximab maintained remission of the active disease.  Addnl., treatment with the lowest infusion dose of infliximab (5 mg/kg) provided a high degree of clin. benefit with a long-term outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ee9AqW66hrVg90H21EOLACvtfcHk0lhx94VJhWOx1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsl2iu7g%253D&md5=54b81dd3efe43048450b9bfbaf002ac4</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2036.1999.00025.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2036.1999.00025.x%26sid%3Dliteratum%253Aachs%26aulast%3DRutgeerts%26aufirst%3DP.%2BJ.%26atitle%3DReview%2520article%253A%2520efficacy%2520of%2520infliximab%2520in%2520Crohn%25E2%2580%2599s%2520disease%25E2%2580%2594induction%2520and%2520maintenance%2520of%2520remission%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D1999%26volume%3D13%26issue%3DSuppl%25204%26spage%3D9%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sweeney, S. E.</span><span> </span><span class="NLM_article-title">The as-yet unfulfilled promise of p38 MAPK inhibitors</span> <span class="citation_source-journal">Nature Rev. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1038%2Fnrrheum.2009.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=19710669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGrtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=475-477&author=S.+E.+Sweeney&title=The+as-yet+unfulfilled+promise+of+p38+MAPK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The as-yet unfulfilled promise of p38 MAPK inhibitors</span></div><div class="casAuthors">Sweeney, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Rheumatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">475-477</span>CODEN:
                <span class="NLM_cas:coden">NRRACB</span>;
        ISSN:<span class="NLM_cas:issn">1759-4790</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There has been a continued pursuit of new targets for cost effective, oral treatments for rheumatoid arthritis (RA).  In fact, numerous inhibitors of signal transduction pathways have been designed.  One target for such inhibition is the p38 mitogen-activated protein kinase signaling cascade which possesses a role in inflammation by mediating the cellular response to stress, pathogens, and cytokines.  Many p38 inhibitors have already been developed and tested, however, their efficacy in RA has been disappointing.  Despite their decreased toxicity, response to these agents continues to be inadequate or poorly sustained.  They do not seem to be effective treatments for RA, and will probably not be pursued clin.  Still, the search continues for small-mol. inhibitors that will reach the efficacy and safety of the biol. agents currently applied to treat RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomQkzhab8S_rVg90H21EOLACvtfcHk0lhx94VJhWOx1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGrtrvF&md5=fe4d4b673ab8c8c958bfc77a3d797923</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2009.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2009.171%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DS.%2BE.%26atitle%3DThe%2520as-yet%2520unfulfilled%2520promise%2520of%2520p38%2520MAPK%2520inhibitors%26jtitle%3DNature%2520Rev.%2520Rheumatol.%26date%3D2009%26volume%3D5%26spage%3D475%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karcher, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Successful structure-based design of recent p38 MAP kinase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F156802609789007363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=19689372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=655-676&author=S.+C.+Karcherauthor=S.+A.+Laufer&title=Successful+structure-based+design+of+recent+p38+MAP+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Successful structure-based design of recent p38 MAP kinase inhibitors</span></div><div class="casAuthors">Karcher, Solveigh C.; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">655-676</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Inflammation is a complex immune response to cellular and tissue damage caused by phys., chem., immunol., or microbial stimuli.  Prior to the successful launch of the anti-cytokine biologist, therapeutic approaches for the treatment of chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease were assocd. with severe side effects.  Although biol. agents have revolutionized the treatment of inflammatory disorders, the high costs and inconvenient dosing regimens would greatly benefit from novel safe and effective orally active inhibitors of tumor necrosis factor (TNF) α and interleukin (IL) 1β.  The clin. benefit of anti-cytokine therapy and the central role of the p38 mitogen-activated protein (MAP) kinase in up-regulation of proinflammatory cytokines such as IL-1β and TNF-α suggest that p38 MAP kinase is a promising target for antiinflammatory therapy.  Since 1993 an immense no. of inhibitors of p38 MAP kinase have been characterized.  To date, aside from the well known pyridinylimidazoles, multiple novel scaffolds have been identified, but only a small no. have advanced into clin. phase II studies, probably due to high toxicity and poor selectivity.  To gain safe drug profiles, high potency, marginal CYP450 (cytochrome P 450) interaction and toxicity, as well as high levels of selectivity would be desirable.  This review will summarize current knowledge on p38 MAP kinase inhibitors and will critically discuss proceedings and strategies toward achieving selectivity and potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1YpMV6vHn37Vg90H21EOLACvtfcHk0liiJr8EgmNq9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjK&md5=597b42a2f0a0cb61db7aa0146450796b</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.2174%2F156802609789007363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789007363%26sid%3Dliteratum%253Aachs%26aulast%3DKarcher%26aufirst%3DS.%2BC.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DSuccessful%2520structure-based%2520design%2520of%2520recent%2520p38%2520MAP%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D655%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pettus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span> </span><span class="NLM_article-title">Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006−2008</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F156802608786264245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=18991731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWgtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1452-1467&author=L.+H.+Pettusauthor=R.+P.+Wurz&title=Small+molecule+p38+MAP+kinase+inhibitors+for+the+treatment+of+inflammatory+diseases%3A+novel+structures+and+developments+during+2006%E2%88%922008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006-2008</span></div><div class="casAuthors">Pettus, Liping H.; Wurz, Ryan P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1452-1467</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The p38 mitogen-activated protein (MAP) kinase plays a central role in inflammation.  It has been the subject of extensive efforts in both basic research and drug discovery for the treatment of inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis, where aberrant cytokine signaling is the driver of the disease.  This article reviews the patent and journal publication activities during 2006-2008 describing novel small mol. p38α inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKQu_KXhrvHrVg90H21EOLACvtfcHk0liiJr8EgmNq9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWgtrfJ&md5=65fa3e72c52323dcd378421dd577a1b4</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.2174%2F156802608786264245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608786264245%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26atitle%3DSmall%2520molecule%2520p38%2520MAP%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%253A%2520novel%2520structures%2520and%2520developments%2520during%25202006%25E2%2588%25922008%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1452%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, T.</span><span> </span><span class="NLM_article-title">Pathway to the clinic: Inhibition of p38 MAP kinase. A review of ten chemotypes selected for development</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1017-1029&author=D.+M.+Goldsteinauthor=T.+Gabriel&title=Pathway+to+the+clinic%3A+Inhibition+of+p38+MAP+kinase.+A+review+of+ten+chemotypes+selected+for+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Pathway to the clinic: Inhibition of P38 MAP kinase. A review of ten chemotypes selected for development</span></div><div class="casAuthors">Goldstein, David M.; Gabriel, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  P38 mitogen activated protein (MAP) kinase remains the most compelling therapeutic target for oral drug intervention for a wide range of autoimmune disorders based on the central role this enzyme plays in inflammatory cell signaling.  Efforts to discover inhibitors of p38 suitable for clin. investigation have continued to escalate in part due to the incredible diversity of unique chemotypes reported to inhibit the enzyme.  Since 1993, at least seventeen p38 inhibitors have been reported to have entered into clin. trials.  Next generation inhibitors have been disclosed with improved potency for p38 and enhanced selectivity vs. other protein kinases.  Over the last three years, there have been multiple reports of cytokine suppression in humans following oral administration of p38 inhibitors.  These results, in addn. to proof of concept studies in rheumatoid patients, have established p38 inhibition as an avenue for the future management of pro-inflammatory cytokine based diseases.  This review describes the discovery at Roche of novel p38 inhibitors which have advanced into clin. trials.  The pharmacol. of the Roche compds. is then compared with eight chem. distinct p38 inhibitors known to have entered clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrve3HIFcxtSrVg90H21EOLACvtfcHk0liiJr8EgmNq9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK&md5=a4acd0c62b42c1f2eb4dafd8f8b60306</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.2174%2F1568026054985939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985939%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGabriel%26aufirst%3DT.%26atitle%3DPathway%2520to%2520the%2520clinic%253A%2520Inhibition%2520of%2520p38%2520MAP%2520kinase.%2520A%2520review%2520of%2520ten%2520chemotypes%2520selected%2520for%2520development%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1017%26epage%3D1029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span> </span><span class="NLM_article-title">Structural comparison of p38 inhibitor−protein complexes: a review of recent p38 inhibitors having unique binding interactions</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1005-1016&author=S.+T.+Wrobleskiauthor=A.+M.+Doweyko&title=Structural+comparison+of+p38+inhibitor%E2%88%92protein+complexes%3A+a+review+of+recent+p38+inhibitors+having+unique+binding+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Structural comparison of p38 inhibitor-protein complexes: A review of recent p38 inhibitors having unique binding interactions</span></div><div class="casAuthors">Wrobleski, Stephen T.; Doweyko, Arthur M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1005-1016</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Small mol. inhibition of protein kinases in the treatment of significant diseases such as cancer, Alzheimer's disease, diabetes, and rheumatoid arthritis has attracted significant attention over the past two decades and has clearly become one of the most significant challenges for drug discovery in the 21st century.  While the recent identification of 518 different kinases in the human genome has offered a wealth of opportunities for drug intervention in the treatment of these diseases, it has also created a daunting challenge with respect to selective kinase inhibition as a viable strategy in target-based drug design.  Over the past decade, the design and development of a small mol. that selectively inhibits the p38 mitogen activated protein (MAP) kinase has clearly emerged as one.  This review will focus on the comparison of the x-ray crystal structures and binding models of the most recent p38 inhibitor-enzyme complexes and the identification of the structural elements and interactions that may be important in providing inhibitor potency and selectivity toward the p38 MAP kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTUmGGtEwCPbVg90H21EOLACvtfcHk0liiJr8EgmNq9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbJ&md5=5add0d628abece6a2e15675e575cd97e</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.2174%2F1568026054985894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985894%26sid%3Dliteratum%253Aachs%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26atitle%3DStructural%2520comparison%2520of%2520p38%2520inhibitor%25E2%2588%2592protein%2520complexes%253A%2520a%2520review%2520of%2520recent%2520p38%2520inhibitors%2520having%2520unique%2520binding%2520interactions%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1005%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Natarajan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. B.</span><span> </span><span class="NLM_article-title">P38 MAP kinase inhibitors: Evolution of imidazole-based and pyrido-pyrimidin-2-one lead classes</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=987-1003&author=S.+R.+Natarajanauthor=J.+B.+Doherty&title=P38+MAP+kinase+inhibitors%3A+Evolution+of+imidazole-based+and+pyrido-pyrimidin-2-one+lead+classes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5f</span><div class="casTitle"><span class="NLM_cas:atitle">P38 MAP kinase inhibitors: Evolution of imidazole-based and pyrido-pyrimidin-2-one lead classes</span></div><div class="casAuthors">Natarajan, Swaminathan R.; Doherty, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">987-1003</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The initial disclosure of tri-substituted imidazole-based drug mols. such as 1 for inhibition of p38 MAP kinase by SmithKline Beecham (SB) sparked an effort in this area at Merck and other pharmaceutical research establishments.  Although analogs in this class have shown good inhibitory properties against p38 MAP kinase, their selectivity profile were modest and left much room for improvement.  Attempts to discover newer compds. with improved selectivity over the prototypical SB compd. 203580 (1), led to the discovery of a new sub-class of p38 inhibitors typified by compd. 18 at Merck.  Although this benchmark compd. was potent, highly selective and orally efficacious it was burdened with compd. related adverse effects in dogs that has delayed further development.  In 1999, a new class of p38 inhibitors represented by clin. candidate VX-745 (26), was disclosed by Vertex Pharmaceuticals.  This compd. displayed unprecedented selectivity due to its unique mode of binding to the active site in p38 MAP kinase.  Inspired by the exquisite selectivity profile of VX-745 [26] a scaffold re-design was initiated at Merck which resulted in the discovery of the quinazolinone, pyrimido-pyrimidone, pyrido-pyrimidone, quinolinone and naphthyridinone based p38 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt25e5Z6oNSLVg90H21EOLACvtfcHk0li2nDROHYrd_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbI&md5=37aceda30385bb1a23ce8355d65348f4</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.2174%2F1568026054985876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985876%26sid%3Dliteratum%253Aachs%26aulast%3DNatarajan%26aufirst%3DS.%2BR.%26aulast%3DDoherty%26aufirst%3DJ.%2BB.%26atitle%3DP38%2520MAP%2520kinase%2520inhibitors%253A%2520Evolution%2520of%2520imidazole-based%2520and%2520pyrido-pyrimidin-2-one%2520lead%2520classes%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D987%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Hynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Small molecule p38 inhibitors: novel structural features and advances from 2002−2005</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=967-985&author=J.+Hynesauthor=K.+Leftheris&title=Small+molecule+p38+inhibitors%3A+novel+structural+features+and+advances+from+2002%E2%88%922005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5g</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule p38 inhibitors: Novel structural features and advances from 2002-2005</span></div><div class="casAuthors">Hynes, John, Jr.; Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">967-985</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The discovery and development of selective, efficacious, and safe small mol. p38 mitogen-activated protein kinase inhibitors for the treatment of inflammatory diseases remains the focus of many pharmaceutical research programs.  Advances in small mol. p38 inhibitor design in potency and oral efficacy have been accelerated with the large no. of available inhibitor-enzyme x-ray structures.  These advances have allowed for the discovery of diverse sets of inhibitors with the opportunity to map inhibitor interactions and design selective inhibitors.  This review covers recent compd. disclosures in the patent and published literature over the last three years.  Many disclosures represent new chemotypes as well as creative modifications of known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXWto2uZjwJrVg90H21EOLACvtfcHk0li2nDROHYrd_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP&md5=e8a3966e7f270b6171b95f306d3fc341</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.2174%2F1568026054985920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985920%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DSmall%2520molecule%2520p38%2520inhibitors%253A%2520novel%2520structural%2520features%2520and%2520advances%2520from%25202002%25E2%2588%25922005%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D967%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Diller, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, A.</span><span> </span><span class="NLM_article-title">The discovery of novel chemotypes of p38 kinase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.2174%2F1568026054985948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=16178740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=953-965&author=D.+J.+Dillerauthor=T.+H.+Linauthor=A.+Metzger&title=The+discovery+of+novel+chemotypes+of+p38+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5hR"><div class="casContent"><span class="casTitleNuber">5h</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of novel chemotypes of p38 kinase inhibitors</span></div><div class="casAuthors">Diller, David J.; Lin, Tsung H.; Metzger, Axel</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">953-965</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the late 1970s and the early 1980s the initial p38 chemotype, the triaryl imidazoles, was discovered as an off-target effect during the development of cyclooxygenase and 5-lipoxygenase inhibitors long before the identity of the p38 kinase was known.  During the last 10 years a no. of novel p38 chemotypes were discovered via high throughput screening.  More recently, the first series of p38 inhibitors discovered by x-ray crystallog. and virtual screening was announced.  Finally, throughout the life span of p38 drug discovery programs significant medicinal chem. effort has continually been placed on the design of new inhibitors from known chemotypes using mol. modeling, protein crystallog., hybrid design and simply sound intuition.  Indeed, the search for p38 kinase inhibitors offers an excellent historical perspective as to how technol. changes that have taken place in the pharmaceutical industry over the last decade, have affected the ways in which new leads are discovered and advanced.  It is the intent of this review to highlight the discoveries of novel p38 chemotypes, emphasizing where possible the key technologies used in the discoveries and the knowledge gained from each discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdKiiRZXrOlbVg90H21EOLACvtfcHk0li2nDROHYrd_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbO&md5=18943c61fb02525de469d293d1451e71</span></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=10.2174%2F1568026054985948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985948%26sid%3Dliteratum%253Aachs%26aulast%3DDiller%26aufirst%3DD.%2BJ.%26aulast%3DLin%26aufirst%3DT.%2BH.%26aulast%3DMetzger%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520novel%2520chemotypes%2520of%2520p38%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D953%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Bolós, J.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of p38 mitogen-activated protein kinase inhibitors</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=857-868&author=J.+Bol%C3%B3s&title=Structure%E2%88%92activity+relationships+of+p38+mitogen-activated+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBol%25C3%25B3s%26aufirst%3DJ.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibitors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D857%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, N.</span><span> </span><span class="NLM_article-title">p38 MAP kinase inhibitors: Mmany are made, but few are chosen</span> <span class="citation_source-journal">Curr. Opin Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=421-430&issue=4&author=C.+Dominguezauthor=D.+A.+Powersauthor=N.+Tamayo&title=p38+MAP+kinase+inhibitors%3A+Mmany+are+made%2C+but+few+are+chosen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DPowers%26aufirst%3DD.%2BA.%26aulast%3DTamayo%26aufirst%3DN.%26atitle%3Dp38%2520MAP%2520kinase%2520inhibitors%253A%2520Mmany%2520are%2520made%252C%2520but%2520few%2520are%2520chosen%26jtitle%3DCurr.%2520Opin%2520Drug%2520Discovery%2520Dev.%26date%3D2005%26volume%3D8%26issue%3D4%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ding, C.</span><span> </span><span class="NLM_article-title">Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1020</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1020-1025&issue=11&author=C.+Ding&title=Drug+evaluation%3A+VX-702%2C+a+MAP+kinase+inhibitor+for+rheumatoid+arthritis+and+acute+coronary+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26atitle%3DDrug%2520evaluation%253A%2520VX-702%252C%2520a%2520MAP%2520kinase%2520inhibitor%2520for%2520rheumatoid%2520arthritis%2520and%2520acute%2520coronary%2520syndrome%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D7%26issue%3D11%26spage%3D1020%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soth, M. J.</span><span> </span><span class="NLM_article-title">Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2353</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9012906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2345-2353&author=D.+M.+Goldsteinauthor=A.+Kuglstatterauthor=Y.+Louauthor=M.+J.+Soth&title=Selective+p38%CE%B1+Inhibitors+Clinically+Evaluated+for+the+Treatment+of+Chronic+Inflammatory+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm9012906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012906%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DSoth%26aufirst%3DM.%2BJ.%26atitle%3DSelective%2520p38%25CE%25B1%2520Inhibitors%2520Clinically%2520Evaluated%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Inflammatory%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2345%26epage%3D2353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabbagh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phippard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suttmann, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Porto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. R.</span><span> </span><span class="NLM_article-title">Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100540x&amp;key=10.1124%2Fjpet.108.139006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100540x&amp;key=18776065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100540x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=610-619&issue=3&author=R.+J.+Hillauthor=K.+Dabbaghauthor=D.+Phippardauthor=C.+Liauthor=R.+T.+Suttmannauthor=M+Welchauthor=E.+Pappauthor=K.+W.+Songauthor=K.-C.+Changauthor=D.+Leafferauthor=Y.-N.+Kimauthor=R.+T.+Robertsauthor=T.+S.+Zabkaauthor=D.+Audauthor=J.+Dal+Portoauthor=A.+M.+Manningauthor=S.+L.+Pengauthor=D.+M.+Goldsteinauthor=B.+R.+Wong&title=Pamapimod%2C+a+novel+p38+mitogen-activated+protein+kinase+inhibitor%3A+preclinical+analysis+of+efficacy+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity</span></div><div class="casAuthors">Hill, Ronald J.; Dabbagh, Karim; Phippard, Deborah; Li, Ching; Suttmann, Rebecca T.; Welch, Mary; Papp, Eva; Song, Kyung W.; Chang, Kung-ching; Leaffer, David; Kim, Yong-Nam; Roberts, Richard T.; Zabka, Tanja S.; Aud, Dee; Dal Porto, Joseph; Manning, Anthony M.; Peng, Stanford L.; Goldstein, David M.; Wong, Brian R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">610-619</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P38α is a protein kinase that regulates the expression of inflammatory cytokines, suggesting a role in the pathogenesis of diseases such as rheumatoid arthritis (RA) or systemic lupus erythematosus.  Here, we describe the preclin. pharmacol. of pamapimod, a novel p38 mitogen-activated protein kinase inhibitor.  Pamapimod inhibited p38α and p38β enzymic activity, with IC50 values of 0.014±0.002 and 0.48±0.04 μM, resp.  There was no activity against p38δ or p38γ isoforms.  When profiled across 350 kinases, pamapimod bound only to four kinases in addn. to p38.  Cellular potency was assessed using phosphorylation of heat shock protein-27 and c-Jun as selective readouts for p38 and c-Jun NH2-terminal kinase (JNK), resp.  Pamapimod inhibited p38 (IC50, 0.06 μM), but inhibition of JNK was not detected.  Pamapimod also inhibited lipopolysaccharide (LPS)-stimulated tumor necrosis factor (TNF) α prodn. by monocytes, interleukin (IL)-1β prodn. in human whole blood, and spontaneous TNFα prodn. by synovial explants from RA patients.  LPS- and TNFα-stimulated prodn. of TNFα and IL-6 in rodents also was inhibited by pamapimod.  In murine collagen-induced arthritis, pamapimod reduced clin. signs of inflammation and bone loss at 50 mg/kg or greater.  In a rat model of hyperalgesia, pamapimod increased tolerance to pressure in a dose-dependent manner, suggesting an important role of p38 in pain assocd. with inflammation.  Finally, an analog of pamapimod that has equiv. potency and selectivity inhibited renal disease in lupus-prone MRL/lpr mice.  Our study demonstrates that pamapimod is a potent, selective inhibitor of p38α with the ability to inhibit the signs and symptoms of RA and other autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoImm011NnzW7Vg90H21EOLACvtfcHk0lhPB6PR8sjKbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtL3F&md5=9311aa6b1a51544ac755d1cc77cdd92f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.139006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.139006%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DDabbagh%26aufirst%3DK.%26aulast%3DPhippard%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSuttmann%26aufirst%3DR.%2BT.%26aulast%3DWelch%26aufirst%3DM%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DSong%26aufirst%3DK.%2BW.%26aulast%3DChang%26aufirst%3DK.-C.%26aulast%3DLeaffer%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DY.-N.%26aulast%3DRoberts%26aufirst%3DR.%2BT.%26aulast%3DZabka%26aufirst%3DT.%2BS.%26aulast%3DAud%26aufirst%3DD.%26aulast%3DDal%2BPorto%26aufirst%3DJ.%26aulast%3DManning%26aufirst%3DA.%2BM.%26aulast%3DPeng%26aufirst%3DS.%2BL.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DWong%26aufirst%3DB.%2BR.%26atitle%3DPamapimod%252C%2520a%2520novel%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibitor%253A%2520preclinical%2520analysis%2520of%2520efficacy%2520and%2520selectivity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26issue%3D3%26spage%3D610%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capolino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroe, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-tert-Butyl-2-<i>p</i>-tolyl-2<i>H</i>-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph-thalen-1-yl]urea (BIRB 796)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">4676</span><span class="NLM_x">–</span> <span class="NLM_lpage">4686</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030121k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4676-4686&issue=22&author=J.+Reganauthor=A.+Capolinoauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=R.+R.+Kroeauthor=J.+Madwedauthor=M.+Moriakauthor=R.+Nelsonauthor=C.+A.+Pargellisauthor=A.+Swinamerauthor=C.+Torcelliniauthor=M.+Tsangauthor=N.+Moss&title=Structure%E2%88%92Activity+Relationships+of+the+p38%CE%B1+MAP+Kinase+Inhibitor+1-%285-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl%29-3-%5B4-%282-morpholin-4-yl-ethoxy%29naph-thalen-1-yl%5Durea+%28BIRB+796%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm030121k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030121k%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DCapolino%26aufirst%3DA.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKroe%26aufirst%3DR.%2BR.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTorcellini%26aufirst%3DC.%26aulast%3DTsang%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DStructure%25E2%2588%2592Activity%2520Relationships%2520of%2520the%2520p38%25CE%25B1%2520MAP%2520Kinase%2520Inhibitor%25201-%25285-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl%2529-3-%255B4-%25282-morpholin-4-yl-ethoxy%2529naph-thalen-1-yl%255Durea%2520%2528BIRB%2520796%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D22%26spage%3D4676%26epage%3D4686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Nikas, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drosos, A. A.</span><span> </span><span class="NLM_article-title">SCIO-469 (Scios Inc.)</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1205-1212&issue=11&author=S.+N.+Nikasauthor=A.+A.+Drosos&title=SCIO-469+%28Scios+Inc.%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNikas%26aufirst%3DS.%2BN.%26aulast%3DDrosos%26aufirst%3DA.%2BA.%26atitle%3DSCIO-469%2520%2528Scios%2520Inc.%2529%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D5%26issue%3D11%26spage%3D1205%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Xing, Li</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadus, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span> </span><span class="NLM_article-title">Structure Bioinformatics-Based Prediction of Exceptional Selectivity of p38 MAP Kinase Inhibitor PH-797804</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6402</span><span class="NLM_x">–</span> <span class="NLM_lpage">6411</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi900655f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6402-6411&author=Li+Xingauthor=H.+S.+Shiehauthor=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+K.+Walkerauthor=B.+Devadasauthor=H.+R.+Hopeauthor=R.+P.+Comptonauthor=J.+F.+Schindlerauthor=J.+L.+Hirschauthor=A.+G.+Bensonauthor=R.+G.+Kurumbailauthor=R.+A.+Stegemanauthor=J.+M.+Williamsauthor=R.+M.+Broadusauthor=Z.+Waldenauthor=J.+B.+Monahan&title=Structure+Bioinformatics-Based+Prediction+of+Exceptional+Selectivity+of+p38+MAP+Kinase+Inhibitor+PH-797804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi900655f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900655f%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DLi%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DCompton%26aufirst%3DR.%2BP.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DBroadus%26aufirst%3DR.%2BM.%26aulast%3DWalden%26aufirst%3DZ.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DStructure%2520Bioinformatics-Based%2520Prediction%2520of%2520Exceptional%2520Selectivity%2520of%2520p38%2520MAP%2520Kinase%2520Inhibitor%2520PH-797804%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D6402%26epage%3D6411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hynes, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokross, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-<i>f</i>][1,2,4]triazine p38α Mitogen-Activated Protein Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4-16&author=J.+Hynesauthor=A.+J.+Dyckmanauthor=S.+Linauthor=S.+Wrobleskiauthor=H.+Wuauthor=K.+M.+Gilloolyauthor=S.+B.+Kannerauthor=H.+Lonialauthor=D.+Looauthor=K.+W.+McIntyreauthor=S.+Pittauthor=D.+R.+Shenauthor=D.+J.+Shusterauthor=X.+Yangauthor=R.+Zhangauthor=K.+Behniaauthor=H.+Zhangauthor=P.+H.+Maratheauthor=A.+M.+Doweykoauthor=J.+S.+Tokarskiauthor=J.+S.+Sackauthor=M.+Pokrossauthor=S.+E.+Kieferauthor=J.+A.+Newittauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Design%2C+Synthesis%2C+and+Anti-inflammatory+Properties+of+Orally+Active+4-%28Phenylamino%29-pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+p38%CE%B1+Mitogen-Activated+Protein+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm7009414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009414%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DWrobleski%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DLonial%26aufirst%3DH.%26aulast%3DLoo%26aufirst%3DD.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DPokross%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Anti-inflammatory%2520Properties%2520of%2520Orally%2520Active%25204-%2528Phenylamino%2529-pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520p38%25CE%25B1%2520Mitogen-Activated%2520Protein%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredup, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of new pyrrolo[2,1-<i>f</i>][1,2,4]triazines as potent p38α MAP kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2739</span><span class="NLM_x">–</span> <span class="NLM_lpage">2744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2739-2744&author=S.+T.+Wrobleskiauthor=S.+Linauthor=J.+Hynesauthor=H.+Wuauthor=S.+Pittauthor=D.+R.+Shenauthor=R.+Zhangauthor=K.+M.+Gilloolyauthor=D.+J.+Shusterauthor=K.+W.+McIntyreauthor=A.+M.+Doweykoauthor=K.+F.+Kishauthor=J.+A.+Tredupauthor=G.+J.+Dukeauthor=J.+S.+Sackauthor=M.+McKinnonauthor=J.+Doddauthor=J.+C.+Barrishauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Synthesis+and+SAR+of+new+pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+as+potent+p38%CE%B1+MAP+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DKish%26aufirst%3DK.%2BF.%26aulast%3DTredup%26aufirst%3DJ.%2BA.%26aulast%3DDuke%26aufirst%3DG.%2BJ.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520new%2520pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520as%2520potent%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2739%26epage%3D2744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Cambanis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobre, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niculescu-Duvaz, I.</span><span> </span><span class="NLM_article-title">Potential anticancer agents. V. Aromatic nitrogen mustards related to 3-[<i>N</i>,<i>N</i>-bis(2-chloroethyl)amino]-4-methylbenzoic acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00301a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1969&pages=161-164&author=A.+Cambanisauthor=V.+Dobreauthor=I.+Niculescu-Duvaz&title=Potential+anticancer+agents.+V.+Aromatic+nitrogen+mustards+related+to+3-%5BN%2CN-bis%282-chloroethyl%29amino%5D-4-methylbenzoic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm00301a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00301a043%26sid%3Dliteratum%253Aachs%26aulast%3DCambanis%26aufirst%3DA.%26aulast%3DDobre%26aufirst%3DV.%26aulast%3DNiculescu-Duvaz%26aufirst%3DI.%26atitle%3DPotential%2520anticancer%2520agents.%2520V.%2520Aromatic%2520nitrogen%2520mustards%2520related%2520to%25203-%255BN%252CN-bis%25282-chloroethyl%2529amino%255D-4-methylbenzoic%2520acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1969%26volume%3D12%26spage%3D161%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">PDB deposition number: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MVM">3MVM</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MVL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MVL','PDB','3MVL'); return false;">PDB: 3MVL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MVM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MVM','PDB','3MVM'); return false;">PDB: 3MVM</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100540x&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm100540x%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100540x" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998c88cc383cbe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
